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Summary
Adolescent idiopathic scoliosis (AIS) is a complex three dimensional deformity of the spine 
that affects 2-3 % of healthy adolescents. The cause is not known although genetic, hormonal, 
and environmental factors are involved. Idiopathic scoliosis in adolescents does normally not 
result in death, but affects health related quality of life. Brace treatment is recommended in 
JURZLQJDGROHVFHQWVZLWKPDMRUFXUYHV!ÛDQGVXUJHU\LVUHFRPPHQGHGIRUFXUYHV!ÛLQ
immature adolescents. Treatment outcomes were in the past mainly evaluated by radiological 
measures. In recent years, outcome evaluation is increasingly being based on the patient’s 
perspective in addition to evaluations of care providers. The Scoliosis Research Society 22 
questionnaire (SRS-22) is widely used to evaluate health related quality of life (HRQoL) in 
AIS patients. We have trans-culturally translated, validated, and adapted the SRS-22
questionnaire for use in Norwegian patients. The Norwegian version of SRS-22 questionnaire 
has acceptable validity and repeatability. Scoliosis progression is associated with rapid growth
of the spine. Early detection by screening allows for curve monitoring and timely initiation of 
brace treatment leading to reduced rates of surgery that may save costs, but its effectiveness is 
debated.  Screening was abolished in Norway in 1994 presumably for lack of efficacy and 
rising costs. In 2007-2008 we conducted screening on 4000, 12 year-old children. The study 
was originally designed to screen 12000 children, but was not supported by the Directorate of 
Health. The point prevalence of scoliosis was 0.55 %. We found acceptable sensitivity, 
specificity, and positive and negative predictive values. Screening performed once, was fast, 
simple and inexpensive, but did not detect any child suitable for bracing. During 2003-2011,
765 children were referred to our specialist clinic and their characteristics were evaluated. 
Close to 80 % were detected by non-health care providers. More than 45% were detected and 
referred too late for brace treatment. Compared to the period 1976-1988 when screening was 
still performed, fewer patients are currently treated with brace and more patients operated. 
The detection of scoliosis in the absence of screening in Norway is suboptimal; two years 
later than internationally recommended. The HRQoL of patients treated for scoliosis with 
brace and surgery has been reported to be equal in the long term. We performed a cost 
minimization analysis comparing relative costs in screening and non- screening settings.  
Costs are comparable to similar programs in Europe. Screening was cost saving when leading 
to high rates of bracing and low surgical rates. Cost saving was higher when girls only are 
selectively screened.
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Sammendrag på norsk 
Adolescent idiopatisk skoliose (AIS) er den vanligste formen for ryggskjevhet. De fleste 
tilfellene debuterer i forbindelse med puberteten, og skjevheten kan progrediere i takt med 
ryggvekst, kurvens størrelse og fleksibilitet. AIS forårsaker vanligvis ikke økt sykelighet og 
dødelighet, men påvirker helserelatert livskvalitet i form av smerte, fysisk funksjon, mental 
helse og selvfølelse. Tidlig diagnose er nødvendig for igangsetting av korsettbehandling som 
kan hindre progresjon og resultere i færre operasjoner. Tidligere ble AIS oppdaget ved skole 
screening for skoliose, men dette ble avskaffet i 1994, på grunn av antatte høye kostnader og 
tvil om screeningen førte til bedre behandling enn ikke -screening. 
Effekt av skoliosebehandling ble tidligere kun målt med radiologiske mål, mens evaluering av 
behandlingseffekten ut fra pasientens egen vurdering nå i økende grad blir benyttet ved 
kliniske undersøkelser, bruk av kvalitetsregistre, og ved helseøkonomiske overveielser. SRS-
22 er et skoliose spesifikt spørreskjema som er akseptert internasjonalt som et viktig verktøy 
for å måle livskvalitet og «utility» som kan benyttes i helseøkonomiske analyser. I den første 
artikkelen i denne doktorgradsavhandlingen har vi oversatt og fastsatt målenøyaktigheten av 
SRS-22 spørreskjemaet, og sammenlignet dette med et globalt helse relatert livskvalitets 
måleskjema (EuroQol EQ5D). Den norske versjonen av SRS-22 spørreskjema har akseptabel 
validitet og repeterbarhet
I den andre artikkelen reiser vi spørsmål om hvor mange ungdommer med ryggskjevhet vi 
kan forvente å oppdage ved en en-gangs screening av 4000 tolvåringer i forbindelse med 12 
års vaksinasjonen. Prevalensen av skoliose var 0.55% .Vi fant akseptabel sensitivitet, 
spesifisitet, og positive og negative prediktive verdier. Screening utført en gang, var rask, 
enkel og billig, men oppdaget ikke noen barn egnet for korsett behandling. I den tredje 
artikkelen har vi undersøkt om manglende screening kan ha spilt en rolle for hvor mange som 
ble behandlet for skoliose i perioden 2003-2011 sammenlignet med en tidligere periode 1976-
1988 da screening fortsatt ble utført i Norge. Uten screening ble de fleste tilfellene oppdaget 
sent, etter at de var blitt skjelettmodne og skjevhetene var blitt store, slik at de kom for seint 
til å ha nytte av korsettbehandling. Andel pasienter som ble operert økte derfor i forhold til 
antall korsett behandlede når man sammenlignet med den tidligere perioden med screening. I 
den siste artikkelen har vi analysert kostnader forbundet med selve screeningen, 
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konsekvensene etter screeningen, og med de aktuelle behandlingsprosedyrene uten å kunne 
vurdere kostnadseffektiviteten. 
Dette doktorgradsarbeidet har bidratt til økt oppdatert kunnskap om status når det gjelder 
forekomst og behandling av AIS i den norske befolkningen i vår samtid. Opplysningene er 
anvendt som grunnlagsmateriale for gjennomføring av en kostnadseffektivitets-analyse. En 
kostnad-nytte analyse er et redskap der bruk av resultatene vil kunne føre til praktiske 
konsekvenser med endring av rutiner og behandlingsprosedyrer, men dette vil være avhengig 
av hvordan pasienter og foreldre verdsetter tiltaket og hva samfunnet er villig til å betale. 
Arbeidene i denne avhandlingen vil kunne danne grunnlaget for fremtidige prospektive 
studier som kan måle livskvaliteten i QALY (quality adjusted life years) etter skoliose 
screening og behandling av AIS og derved utføre en fullstendig økonomisk evalueringsstudie. 
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Dissertation at a glance
Paper Research Question Patients and methods Measures Results Answer
I Is SRS-22 a valid tool for 
evaluation of health related 
quality of life in Norwegian 
patients with adolescent 
idiopathic scoliosis?
Cross-cultural 
adaptation of SRS-22
questionnaire. Test 
and retest in 55 
patients.
Internal 
consistency, 
reliability and 
repeatability. 
Concurrent 
validity with 
EQ5D and EQ-
VAS.
Moderate internal 
consistency, high 
reliability. Excellent 
repeatability. Poor 
concurrent validity 
with EQ-5D and 
EQ-VAS.
SRS-22 is a valid tool 
in evaluation of 
outcome measures in 
Norwegian patients 
with AIS.
II Is the point prevalence of 
idiopathic scoliosis in 12 year 
old children in agreement with 
previous studies? Is screening 
for scoliosis effective at that 
age?
Screened 4000 
children using 
forward bending test 
and scoliometer 
measurement > 7°.
Scoliosis > 10°, 
ATR > 7°. 
Sensitivity, 
specificity, PPV, 
NPV, likelihood 
ratios.
Point prevalence 
was 0.55% for 
scoliosis > 10°, and 
0.13% for > 20°. 
Sensitivity was 0.69, 
specificity 0.99, 
PPV 0.37, NPV 
0.99, LHR+ 69, and 
LHR- 0.31.
Point prevalence was 
slightly lower. 
Screening model has 
acceptable sensitivity 
and specificity, but 
was not effective in 
detecting scoliosis 
with indication for 
bracing.
III Is detection and referral rate of 
adolescent idiopathic scoliosis 
patients to specialist evaluation 
appropriate in the absence of a 
scoliosis screening program in 
Norway? Is rate of surgery 
higher and bracing lower 
without screening?
Prospective register 
of all patients 
referred for scoliosis 
evaluation from 2003 
to 2011.  Brace and 
surgical treatment 
records in screening 
period 1976-1988.
Patient 
demographics, 
maturity, family 
history of 
scoliosis, scoliosis 
detector, referral 
and treatments. 
Physical, 
radiological and 
neurological 
examinations.
752 patients 
registered. Mean 
detection age: 14.6 
years. Risser 3.6. 
Post-menarche: 
74%. Major curve: 
38°. Lay people 
detected 71%. Rate
of bracing was 
higher and surgery 
lower with 
screening.
Most patients were 
mature and had curves 
not suitable for 
bracing at first 
consultation. There is 
a delay of about 2 
years from detection 
to referrals. Rate of 
surgery was higher, 
and bracing was 
reduced without 
screening.
IV Is screening for adolescent 
idiopathic scoliosis cost 
saving?
Cost estimations of 
screening, brace and 
surgical treatments. 
Model based 
probabilistic analysis 
of non- screening 
scenarios.
Cost minimization 
analysis.
Incremental costs in 
non- screening 
scenarios with high 
treatment rates and 
high rates of surgery 
and lower rates of 
bracing.
Screening is cost 
saving when only girls 
are screened and when 
it leads to high rates of 
bracing and lower 
rates of surgery.
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1. Background
1.1 Adolescent Idiopathic Scoliosis
Idiopathic scoliosis is a complex three dimensional deformity of the spine in an otherwise 
healthy child. The deformity is characterized by lateral deviation, modification of the sagittal 
profile and axial rotation1-4. Usual classification is based on the age of onset: infantile, before 
the age of 4 years; juvenile, age 4 to 9; and adolescent, from 10 years until the end of growth5.
Recent research has suggested that the longitudinal growth in the juvenile phase proceeds at 
an even pace rather that in a spurt. Accordingly, the juvenile type has been divided into early 
onset juvenile; 4-7 years, and late-onset juvenile; 7-10 years types6. The adolescent type (AIS) 
is the most common form and it is often associated with rapid growth of the spine5;7;8. A 
recent different classification has been proposed; early onset from birth to 5 years and late 
onset beyond 5 years based on the knowledge that most early onset idiopathic scoliosis might 
resolve, or progress to affect pulmonary function, but late onset idiopathic scoliosis is less 
likely to affect pulmonary function6;9. With this terminology, AIS is increasingly referred to 
as “late-onset” idiopathic scoliosis10.
Figure 1. AIS in a 12 year- old girl. a) Standing PA view, b) Adam forward bending position, 
c) standing PA X-ray view of the 63° right thoracic convex curve, d) sagittal X-ray view
a b c d
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1.1.1 Etiology & Pathogenesis
The etiology has not been fully elucidated as no single cause has been identified11-14.
Biomechanically, abnormal growth and development, and asymmetrical growth of the 
vertebrae have been demonstrated, leading to vertebral rotation and the lateral curvature in 
idiopathic scoliosis15-18.
Genetic factors have been implicated as there is often a positive family history in AIS19-23.
Researchers have mapped genetic locus for AIS to chromosome 8,9,17, and 1924-28. No single 
locus has however been identified, as there are phenotypic or genotypic heterogeneity, 
incomplete penetrance, and variable expressivity of the multiple genes involved. Since the 
pattern of susceptibility is not clear, AIS is best considered as a complex genetic trait disorder 
affected by multiple environmental factors29-33.
Historically, studies have linked altered activity of the hormone melatonin to development of 
scoliosis, but later studies have not supported this hypothesis and the possible mechanism 
involved remains unknown34-41. Estrogen and calmodulin have been evaluated in the etiology 
of idiopathic scoliosis, but the evidence remains inconclusive42-45. Studies have suggested 
increased levels of testosterone and growth hormones in pre-pubertal and pubertal children 
with idiopathic scoliosis. Recent advances in the research methodology include genomic-wide 
association studies (GWAS). It is proposed that 270 genes may be associated with AIS46.
These genes point to AIS as an autosomal, multifactorial disorder that is not X-linked, and is 
not related to estrogen or melatonin receptors47.
1.1.2 Epidemiology
The reported  prevalence of AIS varies widely from 0.5% to 4.5%10;48-52. These variations 
may reflect differences in the definition of scoliosis used and the patient population being 
studied. Differences found in specific populations may be due to genetic factors and possibly 
environmental factors50;53;54. Most studies using the definition of scoliosis defined as a 
radiographically measured Cobb angle of the primary curve > 10°49;55, have reported the 
prevalence in the 2% -3% range48-50;52;56-62. Of all children with AIS, about 1.0-0.4% have 
primary curves > 20°49;51;63;64, and only 0.1% have curves > 40°49;65. Higher prevalence rates 
have been reported in the northern geographic latitudes in girls but not boys.(Finland 12%, 
Singapore 0.9%)66, but those differences could be linked  to environmental factors such as the 
difference in the onset of menses in the different geographic locations54. The exceptionally 
high prevalence rate of 12% reported in Finland was however not replicated in another study 
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in Scandinavia reporting a prevalence rate of scoliosis > 20° of 1.1% for girls and 0.1% for 
boys67. The prevalence of AIS is gender dependent, with the ratio of girls to boys being equal 
for minor curves, but rises for girls with curve magnitudes, reaching a ratio of 1:8 for those 
requiring brace treatment or surgery51;52;56;61;68-71.
Point prevalence is a measure of the proportion of people in a population who has a disease or 
condition at a particular time or at a particular age, for example one-month prevalence of back 
pain or prevalence of scoliosis at school screening in 12 year-old children. Point prevalence 
rates of idiopathic scoliosis > 10° increases with age; from 0.1% in the age-group of six to 
eight years, to 0.3% in the age-group of nine to eleven years, and 1.2% in the age-group of 
twelve to fourteen years10.
1.1.3 Natural history
Long term outcome studies on «untreated» patients with AIS do not show increased 
mortality72-74, although progression of thoracic curves to > 80º might lead to cardiopulmonary 
problems and psychosocial concerns72;75;76. The patients referred to in these studies were not 
strictly untreated; in one of the studies about half of the children had been braced72. There are 
other limitations in those studies, including the inclusion of non-idiopathic etiologies, and or 
early onset scoliosis, lack of radiographic data, loss of patients and small numbers77. The truly 
natural history is therefore difficult to obtain.
The risk of curve progression determines the natural history of AIS, which has been found to 
depend on gender, remaining growth, curve location, flexibility, magnitude and 
rotation68;72;78;79. The more skeletally and sexually immature the patient is, the greater the 
probability of curve progression68;72;80;81. Curves in girls progress more than in boys80, and 
this risk is increased 3 to 10 times in girls compared with boys82;83.
The remaining growth potential of the patient is estimated taking into consideration the 
patient’s age, growth spurt and radiographic parameters. Progression is most rapid during 
peak skeletal growth78;84. Menarcheal status and skeletal age helps determine the growth spurt 
in girls. Peak growth velocity occurs approximately 6 to 12 months prior to the onset of 
menses in girls and the onset of axillary and facial hair in boys85. In general, girls grow until 
14 years of age, while boys grow until 16 years of age86. Girls grow very rapidly until their 
first menstrual period, and then their growth generally slows down, but they continue to grow 
until 18 months to 2 years after their first menstrual period86.
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Several methods have been applied to estimate skeletal age including the Risser sign and the 
Greulich and Pyle left hand radiographic atlas87 which are in frequent use also in our hospital, 
but the subjective evaluation is encumbered with a relatively wide range of error88. The Risser 
sign measures the amount of ossification and eventual fusion of the iliac apophysis, on a scale 
of 0 to 589 (Figure 2). Patients who are Risser 0 and 1 are growing rapidly, while patients who 
are 4 and 5 have stopped growing78;81;89. Biological maturity can also be found from elbow 
radiographs (Sauvegrain’s method)90;91. This method is simple, precise and reliable and 
allows skeletal age to be evaluated in regular six-month intervals during the phase of peak 
height velocity. Recently, a reliable method of correlating the maturity of the hand epiphyses 
(The Sanders digital maturity scale) to curve acceleration phase during the adolescent growth 
spurt has been developed from the Tanner-Whitehouse-III descriptors system6. This system 
has been found to be reliable, and correlates more strongly with the behavior of idiopathic 
scoliosis than the Risser sign or the Greulich and Pyle radiographic atlas92.
These markers of maturity are however variable and may not exactly identify the adolescent 
growth spurt72;74;93;94. A recent critical review of the Risser sign has revealed its limitations 
and suggests that it should not be used as the sole maturity indicator47.Closure of the tri-
radiate cartilage of the acetabulum has been identified as a radiographic sign, which may 
closely approximates the time of peak growth velocity85;91, but there is a large variation in 
growth and two years of adolescent growth may remain after the closure of the tri-radiate 
cartilage. It has therefore been suggested that the tri-radiate cartilage should be used in 
addition to the Risser sign in determining maturity6;95;96. Larger curves at presentation have 
higher risks of progression both before, and after maturity78;80. Curves > 50º at maturity are 
likely to progress into adulthood72;73;94;97-99. Thoracic curves and double curves progress more 
than lumbar curves81;97.
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Figure 2. Markers of maturity X-ray images: a) Risser stages; b) not yet ossified tri-radiate 
cartilage; c) centers of ossification in the hand ©Trobisch P, Suess O, Schwab F100.
Figure 3. Spine development and scoliosis progression. The graph of Duval-Beaupére 
represents the progression history of scoliosis84. It has been developed for neuromuscular 
scoliosis, but it fits quite well also for idiopathic scoliosis, in which anyway generally the 
slope of each single tract of the graph is reduced
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1.1.4 Effects on health related quality of life 
AIS may affect the social life, and the health related quality of life( HRQoL) of the affected 
patients72;73;101-106. Few of the patients with AIS have risks of developing curves > 80° which 
may increase the risk of cardiopulmonary problems, and even death7;72;73;75;76;106;107.
There are few reports on marriage, childbearing, and sexual function of previously treated 
AIS patients108. Since larger curves are more prevalent in girls than in boys51;52;61;68;70;71,
pregnancy, and childbearing are often a concern. One study reported that patients who 
previously had surgery or were braced functioned well with regard to marital status and 
number of children borne. A few had minor problems during pregnancy and delivery, but 
scoliosis did not increase as a result of childbearing. Some patients, however, experienced a 
slight negative effect in their sexual life compared to healthy controls108. Studies in the past 
reported progression of scoliosis during pregnancy109;110. Newer studies found no increase in 
curve magnitude, back pain or obstetrical outcome in scoliosis patients compared to controls 
who had never been pregnant77;111;112.
Studies on the effect of adolescent scoliosis on the HRQoL have shown conflicting 
results73;113;114. Some studies have reported poor self-image and poor social functioning in 
AIS patients115-117. Others  have shown lower scores on pain, general level of activity, self-
image and mental health domains of SRS outcome questionnaires compared with controls118.
The pain is  however, usually not disabling73;97;115;119;120, and there is minimal differences in 
function and physical disability between patients with AIS and controls due to back pain73;121-
123. The back pain is usually not associated with curve size, gender, family history of scoliosis,
or limb-length discrepancy, but with mature age, skeletal maturity and
overweight72;73;97;119;124. Curve pattern may be associated with increased pain, where
thoracolumbar curves seem more painful than double curves94.  In a large recent long term
study from our department it was found that comorbidity significantly reduced HRQoL in
adult life125. Cultural differences are reported with respect to HRQoL113;114. Studied on the
other hand have reported that, patients with untreated  AIS do not appear to have different
outcome measures of work and disability than the normal population72. Two recent
Norwegian studies that included patients 24 years on average after bracing126;127 and a similar
study from Sweden101;102 that included both braced and operated patients reported that long-
term disability was comparable or just slightly lower than in the normal population.
Studies reporting minimal clinical important difference(MCID) when evaluating HRQoL in 
adolescents have been lacking113. A recent review applying MCID of SRS outcome 
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questionnaire reported that AIS patients scored well in function/activity and mental health 
domains and differences from those unaffected rarely reached clinically significant values128.
Pain and self-image scores were statistically lower in patients with AIS than controls but only 
self-image was clinically significant. 
1.1.5 Treatment options
Treatment of any disorder is an attempt to alter its natural history; therefore, long-term studies 
of both the natural history and treatment outcomes are necessary129. The treatment of AIS is 
based on the knowledge of the risk of curve progression and patient maturity. Observation for 
curve progression, physical therapy, brace and surgery are the usual treatment modalities for 
AIS worldwide3;77;81;115;129;130. Currently, there is lack of high quality evidence to support the 
effectiveness of  physical therapy, chiropractic treatment, electrical stimulation or 
biofeedback in preventing progression of AIS131-134.
Observation
Curves < 25° in immature patients are usually observed with regular X-ray-examinations for 
progression3;77. Follow-ups depend on the patient’s rate of growth. Adolescents are observed 
every six months until growth is complete. Juveniles are observed every three to six to twelve 
months depending on their rate of growth. Because of concerns of radiation exposure, care is 
taken to limit the radiation exposure by replacing the anteroposterior view with the 
posteroanterior view thereby reducing the lifetime risks of breast and thyroid cancers135. It is 
now known that the radiation exposure using current day radiographic techniques, including 
digital radiography, is significantly smaller than in the past136. Some patients with curves > 
50° on cessation of growth have the risk of progression into adulthood73. Those patients are 
also observed with standing radiographs every few years in order to monitor the progression 
of the curves. Recently, the Society on Scoliosis and Rehabilitation Treatment (SOSORT) 
reached a consensus with recommendations to reduce x-ray exposures in patients with 
scoliosis137.
Physical therapy
In some countries, comprehensive physical therapy programs are applied alone or in 
combination with bracing to prevent curve progression particularly for small curves (< 25°) 
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117;138-146. The evidence for effectiveness of physical therapy in preventing progression of AIS 
has been inconclusive132;134. While some of the newer studies have provided low-quality 
evidence in favor of physical exercises in AIS, well-designed randomized controlled trials are 
lacking117;142-145. A recent Cochrane systemic review found lack of high quality evidence to 
recommend the use of scoliosis specific exercise (SSE) for AIS145. Because of tradition and 
the lack of evidence of effectiveness, physical therapy is not routinely used in Norway as a 
treatment modality to reduce progression of AIS, but physiotherapy is used in many patients 
for treatment of back pain and disability126;147. It has however  been estimated that 1/3 of all 
patients use physical therapy after surgery and for the treatment of small curves126;147.
Bracing
The aim of brace treatment is to prevent and or limit progression and reduce surgery79;148-152.
Brace is usually recommended for growing adolescents with curves > 25Û115;129;148;152. The 
current recommended indication for brace treatment is age of 10 to 15 years, Risser grade of 
RUDQGD&REEDQJOHIRUWKHODUJHVWFXUYHRIÛWRÛ150. Many different types of 
braces are available, but the thoracolumbar models are usually used. Prefabricated types such 
as the Boston brace is most commonly used in North America and Norway126;127;152;153, whilst 
custom-made braces such as the Cheneau corset are common in Europe154;155. The efficacy of 
brace treatment in limiting progression and reducing surgery has been investigated in 
numerous studies148;152;156. But its effectiveness in the long term remained controversial until 
recently. A Cochrane review concluded that there was low evidence from well-designed 
scientific studies to support the use of braces to treat scoliosis as the majority consisted of 
prospective observational studies 149 . But recently, a randomised study of high quality 
reported that bracing was effective in reducing curves to the threshold of surgery152. The study 
also showed that the benefit increased with better compliance and that the success rate was > 
90% in patients who used their brace 18 hours or more daily. The number needed to treat 
(NNT) in order to prevent surgery was 3.0 (95% CI, 2.0 to 6.2), and the reduction in relative 
risk with bracing was 56% (95% CI, 26 to 82). In addition, approximately 40 to 50% of 
DGROHVFHQWVDVVLJQHGWRREVHUYDWLRQRUZKRZRUHWKHLUEUDFHKRXUVSHUGD\DOVRDFKLHYHG
treatment success (reduction to < 50Û,WKDVWKHUHIRUHEHHQVXJJHVWHGLQWKHOLJKWRIWKHVH
findings that indications for bracing need to be refined to prevent unnecessary bracing of 
patients who are unlikely to benefit from it157,158. A large long-term follow-up study from our 
department found out that the risk of surgery is markedly reduced in patients with good 
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compliance153. Other studies have also shown that compliant patients who wear the brace > 20 
hours daily have reduced risks of curve progression and reduced rates of surgery148;156;159-161.
Figure 4. Treatment with the  Boston brace in a 12-year old girl with AIS. a) Standing PA X-
ray before brace treatment of right convex thoracic curve of 42°, and left convex lumbar 
curve of 39°, b) standing PA X-ray in brace with reduction of the thoracic curve to 29° and 
the lumbar curve to 25°, c) front view of brace, d) posterior view of brace
Surgery
The generally agreed indication for surgery in adolescents is a primary curve > 45-50°115;129.
Objectives of scoliosis surgery are to stop progression, achieve correction of the deformity in 
three planes, balance the trunk, and reduce complications both in the short and long 
terms115;129;162;163. Posterior instrumentation is the mainstay of treatment for most idiopathic 
curves. Anterior surgery is usually performed on thoracolumbar and lumbar major
curves115;129.
Modern instrumentation has evolved from the Harrington distractive rods164;165, Cotrel-
Dubousset (CD)system which introduced the hook system in the1980s166 to the ISOLA hybrid 
system that combined pedicle screws, hooks and wires, and recently to the segmental all 
a b c d
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pedicle screws, originally pioneered by Suk167, which allows  stable correction in the coronal, 
sagittal and transverse planes168;169. Surgery for AIS is effective in deformity correction and 
the magnitude of curve correction has increased from the Harrington rods to the all pedicle 
screw constructs167;170-174.
There are risks associated with surgery for AIS. Complications with modern scoliosis surgery 
have however decreased substantially despite its complexity115;175-178. Death is very unlikely 
but can occur, especially in patients operated as adults179. Complete spinal cord injury is 
rare47.  SRS Morbidity and Mortality Database showed a 0.02%, mortality rate  and 0.8%  
neurological complication rate for AIS patients180. Others have reported 0.5% rates of 
neurological deficit181. SRS data also shows a reduction of the rate of neurological 
complications for all cases of spine deformity of 0.94% from 1965–71 to 0.49% in 2001–03
for AIS patients aged 10–17 years182;183. The reduction in the neurological complication rates 
are mainly due to the use of intraoperative spinal cord monitoring during scoliosis surgery 
which can allow early recognition and treatment of spinal cord dysfunction184;185.
Other complications include acute and delayed deep infection with reported rates between 
0.5-10%, pseudarthrosis, and implant prominence186. Low-virulence organisms such as 
Propionibacterium acnes are usually the main cause of delayed infections following posterior 
spinal fusions. Instrumentation removal and a course of antibiotics is normally successful in 
eradicating the infections187;188.  
Rates of reoperations after primary posterior instrumentation, and fusion are reported to vary 
between 4 to 19% mainly due to infections, pseudoarthrosis, postoperative curve progression 
of the adjacent unfused spine and implant removal due to pain or prominence147;175.
Reoperation due to late operative site pain (LOSP) of no apparent cause has been reported to 
be 19% in the literature regardless of implant type (Harrington, CD, ISOLA). Implant 
removal was successful in pain relief in the majority of patients189. All screw constructs have 
been reported to have lower revision rates than hooks and hybrid constructs190.
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Figure 5. Posterior surgery in AIS. a) Standing PA X-ray of 72° thoracic right convex, and 
lumbar left convex curve of 83° before surgery, b) sagittal view before surgery, c) standing 
PA view after posterior surgery with reduction of the thoracic curve to 25° and the lumbar 
curve to 15°, d) sagittal view after surgery, e) Standing PA view before surgery, f) AFBT 
position before surgery, showing a 10° ATR, g) standing PA view after surgery, h) AFBT 
position after surgery with normalising of  the ATR.
a b c d
e f g h
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Newer techniques
New techniques have evolved in recent years for the treatment of AIS. Convex-side vertebral 
stapling has been developed as an alternative to bracing191-195. The indications and outcomes 
are not entirely clear, but it has been suggested that for thoracic and lumbar curves of < 35°, 
the results with vertebral body stapling are comparable with those of bracing. However, for
thoracic curves of between 35° and 44°, the results with vertebral body stapling are reported 
to be poor196.
1.1.6 Outcome measurement 
Health care costs are rising. Uncertainties exist in medical care, often because evidence of 
therapeutic efficacy is lacking. Selection of treatment options must therefore be based on 
standardized parameters designed to evaluate which treatment options produce the best patient 
outcome86. There are different types of questionnaires to collect information from patients that 
can be used for useful and valid comparisons of different treatment methods.  Both generic 
and disease specific questionnaires measure quality of life in a patient following a medical or 
surgical intervention. The Medical Outcome Study Short Form-36 (SF-36) is the most widely 
used generic outcome measuring HRQoL197. EuroQol (EQ-5D and EQ-VAS) is a similar 
measure which includes a utility index that can be used in cost-benefit analyses198. Another 
commonly used utility index; Short Form 6D (SF6D) has recently been reported to be better 
suited in evaluating spine treatment compared to the EQ-5D199. The Pediatric Quality of Life 
Inventory (PedsQL), another generic quality-of-life instrument used in studies of acute and 
chronic illness, is also frequently used in accessing HRQoL in AIS treatment152;200;201. The 
PedsQL is based on a modular approach, and consists of a 15-item core measure of global 
HRQoL and eight supplemental modules assessing specific symptom or treatment domains202.
Patients with AIS were in the past commonly monitored by clinical evaluation and objective 
radiological measures203. Clinical outcome research now focuses more on outcome from the 
patient’s perspective. Disease-specific outcome measurement assesses the results of treating a 
specific disease using a specific procedure86. The SRS has developed a simple, practical, 
disease-specific, patient-based assessment for AIS118;204-208. The SRS-22 questionnaire is 
currently accepted internationally for assessment of HRQoL in AIS. The SRS-22 has been 
translated and validated in Spanish, Turkish, Japanese, and Chinese and other languages209-
223,but not in Norwegian until Paper I of the present work. The SRS-22 has been concurrently 
validated against the generic questionnaire SF-36205;207;209;212;213;216;219;220;222-224, the back-
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specific Roland  Morris Questionnaire221, the Quality of Life for Spine Deformities Profile 
(QLSDP)214, and Child Health Questionnaire CF 87 (CHQ-CF87)225, and SF-12226,  but not 
the EuroQol. In the validation process of the SRS-22 questionnaire, the developers of the 
original questionnaire and subsequent validators have limited the assessment of 
reproducibility to calculation of intraclass correlation coefficiency (ICC)204;209;211;213;214;216.
This statistical measure of reliability describes the ability to discriminate between individuals, 
but agreement parameters are required for evaluation of measurement error in order to 
estimate if a real change has occurred in follow-ups227.The SRS-22 is now the primary 
outcome measure of function of patients with AIS115;224;225. The SRS-22 questionnaire has 
been also been tested in adults with scoliosis and found to be valid and responsive to surgical 
treatment115;228;229. SRS-22 is also used for evaluating HRQoL in kyphosis230;231, and 
secondary scoliosis232. Recently, a short form (SRS-7) of the SRS-22 has been developed by 
the Rasch analysis (RA) with the aim of improving the HRQoL measures of AIS233. RA is a 
statistical procedure which turns questionnaire ordinal scores into interval measures. 
Measures from Rasch-compatible questionnaires can be used, similar to body temperature or 
blood pressure, to quantify disease severity progression and treatment efficacy234.
Outcome measurement in brace treatment
The outcome of brace treatment is usually measured in reduction of progression, surgical rates 
and on its effects on HRQoL. Outcome is usually measured at maturity defined as Risser 
grade 4 for girls or 5 for boys and a Sanders digital maturity stage of 7 (closure of all physes 
of the phalanges92 and  curve progression to > 50° (treatment failure) or < 50° (treatment 
success)152. In the newly publisher randomized study on brace treatment152, the rate of 
treatment success was 72% in the bracing group, and 48% in the observation group. When 
adjusted for propensity-score quintile and duration of follow-up, the odds ratio for a 
successful outcome associated with bracing was 1.93 (95% CI 1.08 to 3.46).
Studies in the past reporting the effects of bracing on HRQoL did not use measurements on 
validated questionnaires. These studies have suggested that bracing had a negative 
psychological impact, causing low self-esteem and a more negative self-image in the short 
term, but no psychological changes in the long term235-238. Other studies found decreased 
mental health, perception of discrimination and lower satisfaction of overall wellbeing during 
the treatment phase of bracing but no difference between the patients and controls at final 
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follow-up 7 years later237. Most of these studies have included patients with the Milwaukee 
brace and lack of adequate age-matched controls235;237.
Current studies have measured the outcome of underarm brace treatment on HRQoL in the 
short term using the SRS-22 scores of patients with progressive curves, and matched with 
patients with similar curves who were observed. The patients who were observed had 
significantly better function and self-image domain scores than those braced, especially those 
with curves < 20º. The scores did not improve significantly with duration of brace wear, 
suggesting little adaptation239. Studies based on the Boston brace did not however, produce a 
negative impact on body image and did not decrease the quality of life of adolescents 
compared with healthy controls240;241. Differences may thus result from the type of brace 
used, as well as differences in culture and the attitudes of patients. In the newly published 
randomized brace study using mostly the Boston brace, there were no significant differences 
between bracing and observations groups  measured by PedsQL scores or with respect to 
negative psychological impact, or other adverse effects like pain152.
Outcome measurement in surgical treatment
The role of surgery in AIS is to stop curve progression and improve the HRQoL in the 
affected patients. The rate of curve correction has improved from 40% to over 70% with 
modern surgery242 243. The level of evidence is however weak on the improvement of HRQoL 
by scoliosis surgery129;244-249. One study reported higher mental health scores on the SF-36
questionnaire but lower physical activity levels compared to normal controls, 2 years after 
surgery for AIS250. Prospective studies suggest that the magnitude of surgical curve correction 
correlates with patient satisfaction and improvement in the self-image domain of SRS-22
questionnaire251-254. However, other factors may play a role in patient’s self- image and 
satisfaction174;251;255. Patient’s response on quality of life measures correlate more strongly 
with physical appearance than radiographic parameters. Multi-center studies of the outcome 
of surgical treatment of AIS using the SRS outcome instrument reported statistically 
significant improvement in pain, self- image, function and general level of activity in the short 
term, and 2 years after surgery203;252. It was shown that, patients with pre-operative curves less 
than or equal to 54° were slightly more satisfied than those with pre- operative curves of > 
55°, but at present there is no conclusive evidence that improved radiographic outcomes in 
patients with AIS correlate with enhanced function, self-image, or health196.
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In general, the long term outcomes are favorable compared to control subjects at 15-20 years 
for segmental instrumentation180 and at 20-25 years for Harrington instrumentation101;102;256.
Spinal fusion may have an isolated negative effect on HRQoL measures  mostly due to a 
decrease in “activity” domain scores,  but an improvement in the HRQoL due to improvement 
in deformity correction257.
The HRQoL however remains the same in AIS patients treated with brace or surgery both in 
the short term as well as the long term103;115;126;127.
1.1.7 Screening
Screening for scoliosis allows for early detection, timely institution of brace treatment, 
leading to reduced surgical rates, and has been practiced for many years56;64;83;136;258-263.
School screening for scoliosis goes beyond its scope of early identification of AIS and has 
provided valuable knowledge about prevalence, etiology, natural history, and has contributed 
to the field of research on idiopathic scoliosis49;51;63;65. Numerous factors that are implicated in 
the etiology of AIS including biological factors such as menarche, lateralisation of the brain, 
handedness, the thoracic cage, the intervertebral disc, and the role of melatonin have been 
studied in children referred from school screening programs264.
The effectiveness of scoliosis screening has been debated in many studies58;64;65;136;258;264-279.
Some studies have reported decreased rates for surgery after the introduction of 
screening64;258;276;280. Objections to scoliosis screening are largely based on the low prevalence 
rate of clinically significant scoliosis, the inverse relationship of sensitivity and specificity in 
the screening process, high rates of false-positive cases, high inter-observer variations and the 
costs involved mainly because of over-referrals281;282. The challenge in scoliosis screening 
programs therefore is to achieve an acceptable rate of false positive results and to increase 
specificity at a low cost. 
The policies of scoliosis screening vary considerably worldwide. Prior to the 1990’s, scoliosis 
was usually detected in Norway through school screening programs employing the forward 
bending procedure as a screening tool. In 1996, The United States Preventive Services Task 
Force (USPSTF) concluded that there was insufficient evidence to make a recommendation 
for, or against scoliosis screening265;266. Their recommendation suggested that scoliosis 
screening did not meet established criteria for screening of diseases, because of over-referrals, 
high costs and little evidence that early treatment prevents surgery. Later publications suggest 
that they might not fully recognize data answering some of their objectives at the time of their 
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recommendation146. In 2004, the USPSTF changed their position and recommended against 
routine screening of adolescents for idiopathic scoliosis267. Based on the recommendations of 
the USPSTF, routine scoliosis school screening programs have been discontinued in many 
Western countries. In Scandinavian countries, Sweden has conducted school screening for 
many years and has an on-going scoliosis screening program81. In Denmark, there has been an 
attempt to perform school screening, but screening programs have not been successfully 
implemented283. In recent years, The SRS and the American Academy of Orthopaedic 
Surgeons, (AAOS), the Paediatric Orthopaedic Society of North America, (POSNA), and the 
American Academy of Paediatrics (AAP), have endorsed scoliosis screening as a means of 
preventing late presentation of large curves136;268;278;284. In Canada, school scoliosis screening 
has been discontinued since 1979 when the Canadian Task Force on the Periodic Health 
Examination did not recommend screening285;286. The British Orthopaedic Association and the 
British Scoliosis Society also do not recommend screening287.
The international task force of the SRS on scoliosis screening recently found screening to be 
effective with regards to technical, program, and treatment dimensions, but lack studies on 
cost and economic valuations in order to make a statement on cost effectiveness288. The 
impact of discontinuation of school scoliosis screening programs on detection and referral 
patterns of scoliosis has been studied in Canada, and in the United Kingdom226;289. They 
reported that many patients were detected late mainly by laypersons, when curves were large 
and unsuitable for brace treatment. The discontinuation of the school screening programs was 
therefore followed by a suboptimal appropriateness of referrals for bracing. In Norway, the 
impact of discontinuation of school screening on the detection, patient characteristics, referral 
patterns, and treatment patterns has not been previously evaluated.
1.1.8 Health economic evaluation of screening 
There has been a growing interest for economic evaluation of health care interventions in 
recent years in view of limiting health resources in order to provide health care decision 
makers with information on the relative value of money offered by alternative treatments. 
Economic evaluations therefore seek to systematically compare the costs and health outcome 
options employed in the delivery of health care290.  As opponents of scoliosis screening 
mainly cite the costs involved and the lack of effectivity of the programs, it is therefore 
important to perform an appropriate economic analysis comparing costs and outcomes in 
settings where screening is performed compared to settings where screening is not performed. 
The results will enable health care providers and policy makers to determine whether to 
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recommend screening or not from a health economic perspective. There are several studies 
reporting on the cost of performing scoliosis screening70;275;277;282;291-296, but few studies have 
reported the cost of bringing cases found on screening to treatment282;292-294. There are no 
studies to date conducting partial or full economic evaluations according to recommended 
reporting standards of scoliosis screening and treatment.
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2. Aims
As described in the background section, the consequence of the abolition of scoliosis 
screening in Norway in 1994 on current detection, patient characteristics, treatment, and 
referral patterns has not yet been studied. The methodology of scoliosis screening, its direct 
costs, and costs of follow-ups, treatment modalities, and economic evaluation is not known. 
The point prevalence of scoliosis in 12 year old children is also not known. The SRS-22
questionnaire has been internationally accepted as a valid instrument in measuring the 
HRQoL and outcome measure of treatment of patients with AIS. For SRS-22 to be used in 
Norwegian patients with AIS there is a need for it to be translated, validated and adapted into 
Norwegian language.
The specific aims of the study were therefore:
I. To evaluate the reliability, and the repeatability of the SRS-22 questionnaire and to
evaluate its concurrent validity with EQ-5D for evaluation the HRQoL in AIS patients.
II. To evaluate the point prevalence of 12 year-old children in Norway, and to evaluate the
validity of one single screening in detecting patients for bracing. To estimate the
sensitivity, specificity, positive predictive value, and negative predictive value screening
method employed.
III. To evaluate the patient characteristics at first presentation in the absence of scoliosis
screening and to explore the appropriateness of referrals for idiopathic scoliosis. To
compare the proportion of patients braced and operated in a time-period with and without
scoliosis screening.
IV. To evaluate the cost of school screening, brace and surgical treatment of AIS in Norway,
and to perform an economic evaluation of screening compared to non-screening.
30
3. Methods  
3.1 Study design
Different study designs were used for specific aims in the study. Paper I was designed as a
prospective study in order to conform to the guidelines on trans-cultural adaptation of HRQoL 
questionnaires163-165. Paper II was designed as a cross-sectional study to screen 12 year olds 
once in combination with a vaccination program, and to determine the point prevalence of 
AIS in the age group. Paper III was designed as a prospective study to evaluate the 
characteristics of patients during the period 2003-2011 without screening, and to compare 
these with prospective data from the period 1976-1988 when screening was performed. The 
surgical rates were obtained retrospectively from surgical protocols for both periods. Paper IV 
was designed as a model based cost minimisation analysis (CMA) of screening and treatment 
modalities in screening and non-screening scenarios assuming equal outcomes in the patients. 
Table 1. Summary of study designs, participants, inclusion and exclusion criteria
Paper Study design Participants Inclusion and exclusion criteria
I Prospective study of cross-
culture adaptation, validity, 
reliability measurement of 
SRS-22 questionnaire
Answered first 
time:76
Answered second 
time: 57 
Patients with AIS with previous brace 
and surgical treatment, or currently in 
brace treatment, or scheduled for 
surgery. 
II Cross-sectional study. 
Screening of 12 year olds 
once within a vaccination 
program 
4000 school 
children
12 year old boys and girls in Health 
Region South of Norway
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III Prospective study to 
evaluate the characteristics 
of AIS patients in 2003-
2011(without screening)
To compare treatment rates 
with  control data during the 
period 1976-1988 with 
screening
752  patients
(2003-2011) 
793  patients
(1976-1988)
Late-juveniles and adolescents referred 
to idiopathic scoliosis evaluation for the 
first time. Patients with infantile and 
early juvenile idiopathic, neuromuscular, 
congenital or syndromic scoliosis were 
excluded
IV A cost minimization        
analysis of scoliosis 
screening and treatment 
assuming equal outcomes
4000 screened in 
Norway
115190 screened 
in Hong Kong
Norwegian and Hong Kong screening 
data. Treatment data in 2012 in Norway
3.2 Setting
Data was collected from hospital care only in Paper I and from primary, local and specialized 
hospital care in Papers II, III, and IV. In Paper II, public health/community health nurses and 
physical therapists in the study region were engaged as screeners. These were invited to a 
one-day intensive course at the Oslo University Hospital (OUS) - Rikshospitalet to improve 
their knowledge about AIS in preparation of the screening program. Additional courses were 
arranged at the various county centers for those who were not able to attend. The Norwegian 
Directorate of Health did not support the study with a recommendation, so participation was 
lower than expected. 
The salary and social costs for hospital staff in Paper IV were estimated using the mean salary 
at the OUS. Salary and social costs of public health nurses were based on data from the 
Norwegian Nurses organization and data from the local communities in Norway. Estimates of 
the overhead were based on data from the Norwegian Central Bureau of Statistics297.
3.3 Participants 
Paper I included 57 AIS patients, 48 (84%) females and 9 (16%) males. Twelve (21%) had 
previous brace treatment, 6 (11%) had current brace treatment. Twenty-two (39%) had 
previous surgery and 17 (29%) were scheduled for surgery. In Paper II, 4000, 12 year old 
school children participated in screening in 2006/2007. Paper III included 752 patients 
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registered from 2003-2011 when there was no screening. In the period of screening (1976-
1988), data was based on 793 patients (on average, 41 were braced and 20 had surgery each 
year). Paper IV included screening of 4000, 12-year old children in Norway in 2006/2007, 
data from a screening study of 115190 children in Hong Kong and patients treated with brace 
or surgery at the orthopedic department, OUS-Rikshospitalet in Norway in 2006. Included 
additionally, were 122 adolescents who were treated for scoliosis in 2012in Norway,
according to administrative data from the three scoliosis clinics. Of these, 51(42 %) were 
braced and 71(58 %) had surgery, and about 10% of them having both brace and surgery.
3.4 Methodology
In Paper I, the English version of the SRS-22 was first translated into Norwegian and 
retranslated back to English by two independent bilingual translators–one whose mother 
tongue is English and the other whose mother tongue is Norwegian. A review committee 
composed of one specialist in physical medicine and rehabilitation, one public health nurse, 
two spine surgeons, and the two translators further assessed the forward and backward 
translations, and a consensus was achieved on the final translation. The EuroQol (EQ-5D) has 
already been cross-culturally adapted to Norwegian patients with back pain. The final version 
of the SRS-22, and the EQ-5D, and EQ-VAS questionnaires were mailed to AIS patients of 
various ages and severity of curves under treatment with a stamped return envelope. 
In Paper II, screeners were taught about scoliosis and the screening procedure of Adam 
Forward Bending Test and measurement of the angle of inclination using the scoliometer. In 
addition, a scoliosis screening manual was provided to all participants and follow-up
teachings were provided as needed. The screening procedure (Figures 2 & 3) combined the 
standing visual inspection of the back, the Adam Forward Bending Test and the scoliometer 
(OSI-scoliometer Orthopedic Systems Inc, Hayward, California, USA) measurement of angle 
of trunk rotation (ATR). Seven degrees of ATR was chosen as cut-off point for referral to 
radiography281;298.
Radiographic results of screening from local hospitals were mailed to the Department of 
Orthopedics at OUS-Rikshospitalet.
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Figure 6. Scoliosis screening technique. The AFBT a) when the patient stands upright; b) 
when she bends forward, spinal rotation becomes evident through the appearance of a 
hunched rib cage on the right.. ©2010 Trobisch P, et al100.
Figure 7. Measuring ATR with a Scoliometer a) The AFBT position for scoliometer 
measurement, (b) the scoliometer measuring ATR. . ©2010 Patias et al; licensee BioMed 
Central Ltd
In Paper III, data of patients referred to the specialized clinic for evaluation of AIS for the 
first time was registered by specialist orthopedic surgeons. Patient interviews, clinical 
examinations, radiological and neurological examinations were conducted.
a b
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Table 2. Characteristics registered from the patient interviews, clinical, neurological, and 
radiological examinations.
Source Characteristics 
Patient interview Age, gender, menarcheal status, family history 
of scoliosis, age at detection, back pain and 
perception of  muscle fatigue
Clinical examination Adam forward bending test, angle of rotation, 
height and weight, shoulder, and truncal 
asymmetry, coronal balance.
Neurological examination Muscle weakness, sensory weakness, reflexes
Radiology Cobb angle, Risser sign
Recommended treatment (up to 6 months 
follow-up)
Brace, surgery, further observation, discharge
Hospital records
Surgical protocols
Referral patterns of primary physicians, 
physical therapist, chiropractors and hospital 
specialists. Duration from time of detection to 
referral and time to clinical evaluation. Actual 
number of patients who were operated yearly 
during the period 2003-2011, and estimates of 
the number of patients treated with brace or 
surgery during the years 1978-1988.
In Paper IV, we used a model approach to compare costs in screening with non-screening 
scenarios. The main mathematical equation on which the model was based is shown in 
Appendix Paper IV. Cost estimation was based on micro costing, case-mix, and market prices 
to estimate the cost of screening, bracing and surgery. The study perspective in relation to 
costs was based on a health sector budget perspective focusing on the costs related to 
orthopaedic treatment in hospital care 290, and in addition, we included costs for the society 
due to transportation and parents’ use of time during treatment of their children.
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The strategies we compared were treatment in screening setting and estimated reduced 
treatment rates of 90%, 80%, and 70% of those treated in screening settings. This is based on 
the assumption that screening for scoliosis may lead to over-referrals to X-rays and outpatient 
evaluations, increased rates of bracing, but reduced surgical rates compared to settings when 
children are not screened 258,280. Additionally, in non-screening settings, many children are 
diagnosed late when they are matured, with curves not suitable for bracing 226,280,289.
In all non-screening scenarios, we simulated different distribution rates of brace and surgery 
based on the available non-screening data from Norway, (58% surgery and 42% brace). Since 
AIS is more prevalent in girls and 90% of those treated are girls 126,152, separate analyses were 
performe for girls.
Uncertainty was characterised by deterministic and probabilistic sensitivity analyses (PSA).
3.5 Outcome measures
In Paper I, the outcome measures were the SRS-22 and the EuroQol. In Paper II, outcome 
measures were asymmetry of the trunk on visual inspection of the back and an ATR RQ
the Adam forward bending test. In the hospital care setting the outcome measure were Cobb 
angle > 10° on standing radiographs, which is classified as AIS according to the criteria 
proposed by the SRS299. Patients with scoliosis between 10° to 20° were classified as 
moderate, and referred to a new radiographic examination within 6 months at the local 
hospital. Patients with a Cobb angle > 20° were referred for physical, and clinical 
examinations and new standing X-rays including iliac crest exposure for Risser sign grading.
In Paper III, outcome was the characteristics outlined in Table 2. 
In Paper IV, outcome measure was incremental cost which was defined as the cost of 
treatment in a non-screening scenario minus the cost of treatment and cost incurred in 
conducting the screening. Hence, a positive incremental cost implies that screening is more 
cost saving compared to the non-screening scenario. We also estimated incremental cost 
changes by varying the ratio of bracing to surgery in the non-screening scenarios. The 
probability of the incremental cost being > 0 was estimated in all cases.
Cost estimations
Costs were estimated for screening, brace and surgical treatments.
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Screening
All activities directly involved in the screening and follow-up of patients were measured, 
valued, and costs calculated.
Bracing and surgery
Two hospital health economics, assisted by one orthopedic surgeon, a physical medicine 
specialist and one nurse estimated the costs of brace and surgical treatments based on data 
extracted from hospital treatment records. For bracing, we estimated the costs of the brace 
equipment, transportation, radiographic and clinical examinations during the period of brace 
wear, hospital hotel services for 4 days for the child and one parent during brace fitting. 
Additionally, the costs of reimbursements for wear and tear of clothing and beddings from the 
National Insurance Scheme were included.
For surgery, we estimated the costs of implants, salaries of anaesthesiologists and staff at the 
theatre, intensive care, intermediate postoperative care, and regular ward costs. Surgery was 
usually performed using either a hybrid construct with an average of 5 pedicle screws, 8 
hooks, and 5 to 6 sublaminar wires or an all pedicle-screw construct using 15 to 17 pedicle 
screws. Two surgeons usually performed the surgery using an estimated average time of 180 
minutes. One anesthesiologist, one anesthesiologist nurse and two scrub nurses assisted them 
working on average for 300 minutes. After surgery, patients stayed in hospital for an average 
of 10 days. No braces were used postoperatively.  During the first postoperative year, patients 
had two follow-up consultations. In addition, costs of radiological examinations, outpatient 
visits for follow-ups, transportation, and costs of complications and re-operations during the 
first year were measured. Costs were estimated using micro costing (MI), case-mix group 
(CA) and market price (MA) methods. For MI, the cost per hour for different health 
professionals was included by multiplying the salary (inclusive income tax), other social costs 
(pension, insurance, sick-leave, training etc) of employment (27%) and overhead (40%).
Currency, price date and conversion
All prices and costs were converted from 2006 to 2012 NOK (Norwegian kroner) by using an  
inflation rate of 3.21% per year based on the yearly rate of change of one unit value within the 
Diagnosis –Related Group(DRG)  System in Norway. The exchange rate was pegged at 
8NOK = 1Euro.
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Time horizon for cost estimations
The time horizon for estimating costs was six years from the first screening at 11 years. We 
assumed two screenings per child, based on the recommendations of the SRS136 at the age of 
11 and 13 years, and anticipated that 60% of the scoliosis cases were detected at the first 
screening and the rest at the second. For the non-screening scenarios we also assumed a 
dispersion of the expected cost (bracing and surgery) of 10%, 15%, 20%, 20%, 15% 10%, and 
10% for each age group from 11 to 17 respectively. When aggregating costs over time, we 
used an annual social discount rate of 4% as recommended by the Norwegian Directorate of 
Health to calculate the present value of costs. The social discount rate is an interest rate used 
to bring future value into the present when considering the time value of money 290
Table 3. Outcome parameters. Summary of independent variables and scales
Independent variables Scale Used in Paper
Patient demographics
Mean age Years
I, III
Gender Male / Female I, II III,IV
Menarcheal status (age) Yes / No (Years) II,III
Age at scoliosis detection Years III
Clinical examination III
Adam forward bending test Positive / Negative II, III
Angle of rotation Degrees (Scoliometer) or 
Centimeter(ruler)
II, III
BMI Kg/m² III
Physical examination of 
trunchal asymmetry
Inspection / Description
Plumb line deviation
II,III
Truncal shift Cm III
Back pain and perception of 
muscle fatigue
Point scale: 0 to 5 Verbal scale: 
no pain to pain all the time
III
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Neurological examination
Sensory
Motor
Reflexes
Present/ absent 
Present/ absent
Present/absent
III
Treatment options
Observation
Brace
Surgery
Number
Number
Number
I, II, III, IV
I, II, III, IV
I, II, III, IV
Patient Outcome
SRS-22
EuroQol EQ5D
EQ5D-VAS
1-5
0-10-100
0-100
III
Radiology
Cobb angles
Risser sign
Degrees
0-5
I, II, III
I, II, III
Health economic evaluation
Costs and resources 
Incremental costs and outcomes
Euro
Euro
IV
IV
3.6 Statistical methods
Descriptive statistics of means, standard deviations, and frequencies were measured for 
numerical data, to evaluate the construct validity, internal consistency, repeatability, and 
reliability of the SRS-22 questionnaire in Paper I, and to evaluate test reliability of screening 
by estimating sensitivity, specificity, PPV, NPV, likelihood ratios (LH+, LH-) in Paper II.  
Descriptive statistics in Papers III and IV included numbers, or percentages, means and mean 
differences (95% confidential interval).
Chi-square statistics was employed to compare the differences in the rate of treatment during 
periods of screening to non-screening (categorical variables in two independent samples) in 
Paper III. The proportions of the treatment modalities in the two periods, mean difference 
between the proportions, odd ratio (OR) and 95% confidential intervals were calculated. 
Multivariable logistic regression was applied to estimate the association between back pain as 
the outcome variable, with gender, curve size, and BMI as predictor variables. Included 
covariates in the regression analysis were curve size and BMI as possible confounding factors 
on the assumed association between back pain and gender. The Hosmer-Lemeshow test was 
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used to assess the logistic model adequacy. Effect sizes were measured by OR (95% 
confidential intervals). 
Uncertainty of the input variables in Paper IV was assessed by one-way and multi-way 
sensitivity analyses. Parametric uncertainty was also analysed by means of PSA, where all 
uncertainties in the relevant parameters were accounted for simultaneously290;300. The PSA 
was used to analyse the distribution of incremental cost estimations in all scenarios (100000 
interactions), to estimate the confidential intervals for total incremental costs, and formed the 
basis for the Tornado diagram. In the PSA, we used gamma distributions for estimation of 
unit cost, beta distributions for the number of hours used and probabilities. Poisson 
distributions were used for the number of children treated with brace or surgery.
Analyses were performed using Statistical Package for Social Science (SPSS), version 14.0 
(SPSS Inc., Chicago, IL) except in the evaluation of repeatability where Altman plots were 
constructed using MedCalc 9. The model simulations in Paper IV were performed using The 
Decision Tools Suite software component "@risk6". 
Table 4. Overview of statistic methods used in the studies
Paper Measure Analysis
I Construct validity 
Internal consistency 
Reliability 
Repeatability
Concurrent validity
Cronbach alpha
Intraclass correlation coefficient
Altman Bland plots, repeatability coefficient 
Pearson’s  r correlation coefficient
II Test effectivity Sensitivity, specificity, PPV, NPV, likelihood 
ratios (LH+, LH-)
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III Association between back pain and 
other characteristics
Logistic model adequacy
Effect size
Comparison of brace and surgical 
treatment during two periods
Multivariable logistic regression
Hosmer-Lemeshow
Odds ratio, Chi- square statistics
IV Estimation of costs and resources
Analysis of uncertainty
Methodological uncertainty
Parametric uncertainty
Micro-costing (MI), case-mix group (MI), 
market price (MA) methods
One-way and multi-way sensitivity analysis
Probabilistic sensitivity analysis (PSA) and 
Tornado diagrams. PSA used to estimate 
confidential intervals for cost of treatment 
alternatives, and incremental costs. Gamma 
distributions for unit cost estimation, beta 
distributions for no. of hours used, probabilities 
and Poisson distributions for no. of children 
treated for scoliosis
3.7 Ethical considerations
All studies were conducted in conformity with the Helsinki Declaration. The study design in 
all parts and protocols were approved by the Regional Ethical Committee for Medical 
Research in Norway, and Ethic committee of OUS-Rikshospitalet. Where applicable, patients 
or parents received oral and written information about the project and gave their informed 
consent.
In Paper II, written information about the screening, and the results were provided to the 
children and their parents (Apendix Paper II). Signed consent forms from parents were 
received before screening was performed. Parents of those with confirmed scoliosis on X-rays 
were also informed about the results and follow-up regimes. No children or parents declined 
to partake in the screening program.
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4. Synopsis
4.1 Paper I
Repeatability, Reliability, and Concurrent Validity of the SRS-22 Questionnaire and EuroQol 
in Patients with Adolescent Idiopathic Scoliosis. Adobor RD, Rimeslåtten S, Keller A, Brox 
JI. Spine 2010; 35: 206-209
Background: SRS-22 is widely used for evaluation of health-related quality of life in AIS. Its 
repeatability, which is essential for use in follow-up studies, and concurrent validity with 
EuroQol, which can be used for cost-utility analysis, has not yet been assessed. The objective 
was to evaluate the repeatability, reliability, internal consistency, and concurrent validity of an 
adapted Norwegian version of the Scoliosis Research Society 22 questionnaire (SRS-22) and 
the generic health-related quality of life instrument EuroQol (EQ-5D and EQ-VAS).
Methods: The forward-backward translation of the English version of the SRS-22 was 
performed according to the guidelines for cross-cultural adaptation of outcome questionnaires. 
Fifty-seven patients with AIS of various ages and severity of deformity completed 
questionnaires including SRS-22, EQ- 5D, and EQ-VAS twice with a two-week interval. 
Results: The study demonstrated moderate internal consistency and high reliability of the 
SRS-22 questionnaire, with Cronbach alpha and ICC ranging from 0.76 to 0.93 for the 5 
domains. Repeatability was excellent for all domains of SRS-22, with repeatability 
coefficients < 1. Concurrent validity with EQ-5D was poor to moderate, with Pearson’s r 
ranging from 0.01 to 0.58. However, total scores of the two instruments showed satisfactory 
agreement. 
Conclusions: The SRS-22 outcome instrument has satisfactory repeatability, but the poor to 
moderate concurrent validity of the SRS-22 with EQ-5D suggests that the disease specific and 
the generic questionnaires measure different parameters.
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4.2 Paper II
School screening and point prevalence of adolescent idiopathic scoliosis in 4000 Norwegian 
children aged 12 years. Adobor RD, Rimeslåtten S, Steen H,Brox JI.
Scoliosis 2011; 6:23
Background: Early diagnosis of idiopathic scoliosis allows for observation and timely 
initiation of brace treatment in order to halt progression. Screening allows for the early 
detection and has contributed to the study of the etiology of idiopathic scoliosis, but its 
effectiveness is debated. The prevalence of idiopathic scoliosis in adolescents is variable. The 
aim of the study was to describe the point prevalence of AIS and to evaluate the effectiveness 
of school screening in 12-year-old children.
Methods: Community nurses and physical therapists in the Southern Health region were the 
screeners. They fulfilled an educational course to improve their knowledge about AIS and to 
learn the screening procedure, including the Adam Forward Bending Test and measurement 
of angle of rotation using a scoliometer.
Results: There were 12000 twelve year old children in the study population. About 4000 were 
screened. The prevalence of idiopathic scoliosis defined as a positive Adam Forward Bending 
Test, ATR > 7° and primary major curve on radiographs > 10°, was 0.55%. Five children 
(0.13%) had a major curve > 20°. Bracing was not indicated in any child; all children were 
post menarche; four had Risser sign of 4, and one with Risser 1 did not have curve 
progression > 5° at later follow-up. In one of these 5 children however, the major curve 
progressed to 45° within 7 months after screening and the girl was operated.
Conclusions: The point prevalence of AIS in 12-year old children is in agreement or slightly 
lower than found in previous studies. The screening model employed demonstrates acceptable 
sensitivity and specificity and low referral rates. Screening at the age of 12 years only was not 
effective for detecting patients with indication for brace treatment.
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4.3 Paper III
Scoliosis detection, patient characteristics, referral patterns and treatment in the absence of a 
screening program in Norway. Adobor RD, Riise RB, Sørensen R, Kibsgård TJ, Steen H, 
Brox JI. Scoliosis 2012, 7:18
Background: School scoliosis screening programs were abolished in Norway in 1994 for lack 
of efficacy and for the costs involved .The objective of the study was to evaluate the 
detection, patient characteristics, referral patterns and treatment of idiopathic scoliosis at a 
scoliosis clinic during the period 2003-2011, when there was no screening, and to compare 
treatment modalities to the period 1976-1988 when screening was performed.
Methods: Patient demographics, age at detection, family history, clinical and radiological 
charts of consecutive patients referred for scoliosis evaluation during the period 2003-2011,
were registered. Maturity was estimated according to Risser sign and menarcheal status. 
Severity of pain was recorded by a verbal 5-point scale from no pain to pain at all times. 
Referral patterns were recorded. Treatment modalities in the current period were compared to 
the period 1976-1988.
Results: We registered 752 patients from 2003-2011. Eighty-six percent were girls. Mean age 
at detection was 14.6 (±1.9) years. Sixty percent had Risser sign 3, whilst 74% were post 
menarche with a mean age at menarche of 13.2 years. The mean major curve at first 
consultation was 38° (10°-95°). About 40% had a major curve > 40°. Seventy-one percent 
were detected by patients, close relatives, and friends. Orthopedic surgeons referred 61% of 
the patients. The mean duration from detection to the first consultation was 20 (0-27) months. 
The proportion of the average number of patients braced each year was 68% during the period 
with screening compared to 38% in the period without screening, while the proportion for 
those operated was 32% and 62%, respectively (p=0.002, OR 3.5, (95% CI 1.6 to 7.5). 
Conclusions: In the absence of scoliosis screening, lay persons most often detect scoliosis. 
Many patients presented with a mean Cobb angle approaching the upper limit for brace 
treatment indications. The frequency of brace treatment has been reduced and surgery is 
increased during the recent period without screening compared with the period in the past 
when screening was still conducted.
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4.4 Paper IV
A health economic evaluation of screening and treatment in patients with adolescent idiopathic 
scoliosis.  Adobor RD, Joranger P, Steen H, Navrud S, Brox JI.
Scoliosis 2014, 9:21
Study design:  Model based cost minimisation analysis using hospital’s costs and administrative 
data, and market prices to estimate costs in screening, bracing and surgical treatment. Uncertainty 
was characterised by deterministic and probabilistic sensitivity analyses. Time horizon was 6 years 
from first screening at 11 years of age.
Objective: To compare estimated costs in screening and non-screening scenarios (reduced 
treatment rates of 90%, 80%, 70% of screening, and non-screening Norway 2012).
Summary of background data: Adolescent idiopathic scoliosis can progress and affect the health 
related quality of life of the patients. Research shows that screening is effective in early detection, 
allowing for bracing, and reduced surgical rates, and may save costs, but still controversial from a 
health economic perspective. 
Methods: Data was based on screening and treatment costs in primary health care and in hospital 
care settings. Participants were 4000,12-year old children screened in Norway, 115190 children 
screened in Hong Kong and 112 children treated for scoliosis in Norway in 2012. We assumed 
equivalent outcome of health related quality of life, and compare only relative costs in screening 
and non-screening settings. Incremental cost was defined as positive when a non-screening 
scenario was more expensive relative to screening. 
Results: Screening per child was € 8.4 (95% CI 6.6 to10.6), € 10350 (8690 to 12180) per patient 
braced, and € 41690 (35250 to 49480) per child operated. Incremental cost per child in non-
screening scenario of 90% treatment rate was € 12.3 (2 to 25), increasing from € 0.3 (-7 to 8) to € 
27.0 (14 to 42) as surgical rates increased from 40% to 80%. For the 80% treatment rate non-
screening scenario, incremental cost was € 4.8 (-5 to 16) compared to screening all, and € 10.7 (3 
to 20) compared to screening girls only. For the non-screening Norwegian scenario, incremental 
cost per child was € -3.1(-16 to 11). Bracing and surgery were the main cost drivers and 
contributed most to uncertainty.
Conclusions: With the assumptions in the present study, screening is cost saving when performed 
in girls only, and when it leads to reduced treatment rates. Cost of surgery was dominating in non-
screening whilst cost of bracing was dominating in screening. The economic gain of screening 
increases when it leads to higher rates of bracing and reduced surgical rates.
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5. Discussion
5.1 Methodological considerations
5.1.1 Cross-cultural adaptation of the SRS-22 questionnaire
It has been recommended that clinicians and researchers who lack a suitable health-related 
quality of life measure in their own language either develop a new measure, or translate and 
evaluate a measure previously validated in another language, known as a cross-cultural 
adaptation. Specific guidelines have been proposed for the cross-cultural adaptation process 
which includes recommendations for obtaining semantic, idiomatic, experiential and 
conceptual equivalence in translation by using back-translation techniques and committee 
review, pre-testing techniques and re-examining the weights of scores301-305. It has also been 
suggested that health related quality of life measures should have three objectives: 
discriminate between individuals and groups, predict outcome, and evaluate change in health 
status over time301-305. In Paper I, the recommended methodology was followed. The study 
was conducted in a clinical setting and AIS patients under different treatment phases were 
included. 
Construct validity and reliability
The strength of the psychometric attributes such as validity, reliability and responsiveness 
determine the overall quality of an instrument. Construct validity of a questionnaire relates to 
the question of what the instrument is measuring. Reliability addresses how much of the 
variation that is attributed to chance or random errors, and describes the ability to discriminate 
between individuals. In  Paper I, two measures of reliability were estimated: internal 
consistency by Cronbach alpha306, and Intraclass Correlation Coefficient (ICC: 2, 1).  
Repeatability 
Developers of the original SRS-22 questionnaire and subsequent validators have limited the 
assessment of reproducibility to calculation of intraclass correlation coefficiency (ICC)204;208-
212;214-223;225;239. Agreement parameters are required for evaluation of measurement error
125;172-175. We therefore employed the statistical measure proposed by Altman and Bland to 
estimate repeatability, which is a measure based on the variation within individuals227;307-310.
We based the measurement of repeatability on the standard error of measurement (SEM) 
which is calculated by extracting the square root of the mean within subject variance term in 
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the one-way analysis of variance table. The coefficient of repeatability (CR) is then calculated 
from the formula: CR = SEM × 1, 96[square root] 2. The difference between two 
measurements for the same subject is expected to be less than the CR for 95% of pairs of 
observations. This measure defines the smallest detectable change between two measurements 
on the same individual and has been designated the minimal detectable change (MDC)227;310.
Diagrammatically, plots of the difference between test and retest against the mean of the sum 
scores were constructed for detecting any evidence of increasing variability with higher mean 
scores (heteroscedasticity). The SD of the difference was subtracted or added to the mean 
difference to create limits of agreement which were drawn as lines in the plots, as 
recommended by Bland and Altman308;309.
Few other studies have assessed the smallest detectable change measured on the SRS-22. One 
study determined the MCD, and based on that, determined the MCID, which is the threshold 
that is clinically relevant to the patient on a 90% probability level311. Another study 
determined the MCD based on 95% probability312 as in  Paper I. In this study, two methods 
were used to calculate the MID. The anchor-based MID defined as the mean 
preoperative/follow-up difference in SRS-22 scores in the group of patients who stated they 
were much better than before surgery. They used the same anchor criterion, the optimal cut-
off value to identify patients that had improved from the receiver operating characteristic 
(ROC) curve. Additionally, the distribution-based MID was calculated by using the standard 
error of measurement method312.
5.1.2 Validity of scoliosis screening
Sensitivity and specificity
The sensitivity and specificity measures the efficiency of a screening test. Combining the 
Adam forward bending test with the scoliometer increases specificity and sensitivity313.  The 
use of the scoliometer has been shown to increase the sensitivity and the specificity in 
detecting a Cobb angle of > 20° in one report313. A scoliometer reading of 5° has been shown 
to have a sensitivity of 100%, but only 47% specificity, whereas a scoliometer reading of 7° 
increases the specificity to 86% and decreases the sensitivity to 83%314.  A scoliometer
reading of 7° has therefore been recommended as cut-off point for referral to 
radiography298;315;316. In Paper II, we designed our screening to conform to these 
recommendations. 
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Predictive validity 
The positive predictive value (PPV) of visual inspection and the forward-bending test varies 
with the degree of curvature by which a true positive is defined, the prevalence of scoliosis in 
the screened population, and the skills of the examiners58;317. In order to increase the PPV of 
the screening test in Paper II, we designed the study by organizing courses for the examiners 
thereby improving their skills. In addition, likelihood ratios (LH) ratios were calculated to 
increase the predictive validity of the screening test.
WHO criteria
Supporters of screening programs suggest that earlier detection allows for bracing that can 
reduce the need for surgery136;258;276;277;280;288;318. Whilst opponents of screening programs 
suggest that AIS lacks the characteristics that render a disease as a good candidate for 
screening265;266;319;320. These characteristics include high prevalence, high burden of suffering, 
preclinical phase, acceptable test and treatment, and reasonable costs.  It is hereby discussed 
whether AIS satisfy the 10 specific criteria laid down by WHO that a screening program must 
satisfy321-324.
1. The condition should be an important health problem
AIS is an important health problem that affects the teenage population during their most 
vulnerable years. Scoliosis > 10° affect 2.0-3.0% of teenages10;48;49;52;56-62. However, curves > 
20° affect only 1.0-0.4%48-51;56;57;63;64, and curves > 40° are present in only 0.1%, of the 
affected population10;51;65;152. The deformity may represent a burden both physically and 
psychologically in the affected patients. AIS patients have increased suicidal thoughts and 
increased concerns related to body development and peer interactions compared to age 
matched controls325. Patients’ views of their condition are usually influenced by culture, 
environment, peer groups and their own experience326. They also  have decreased perception 
of their health status, even after brace and surgical treatment104;327;328. Long-term studies from 
Scandinavia in the past have reported that untreated scoliosis may lead to poor self –image, 
back pain, and psychological problems during both childhood and limited job opportunities, 
and lower marriage rate in adulthood329-332.  But these studies lack internal controls and it is 
likely that many patients with spinal conditions other than AIS were included265;266. Other 
long-term studies suggest a poor correlation between the magnitude of curves and the extent 
of psychosocial complaints82. Current data on the psychosocial effects of scoliosis and poor
cosmetics are however limited.
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Outcome studies increasingly suggest that scoliosis affects the HRQoL aspects of disability, 
pain, mental health and self- image of the affected adolescents both in the short term and in 
the long term72;73;101-106 as described in the background chapter.
2. There should be a treatment for the condition
Treatment of any condition is an attempt to alter its natural history73. Long-term studies of 
both the natural history and treatment outcomes are therefore necessary in evaluating the 
efficacy of the treatment of AIS. The treatment of AIS is based on the knowledge of the risk 
of curve progression and the maturity of the patient. Three main treatment options: 
observation, bracing, surgery are used in treatment of AIS as discussed in the background 
section.
3. Facilities for diagnosis and treatment should be available
The diagnosis of AIS requires clinical and radiological examination333. Radiographs are 
required to confirm cases of AIS suspected on clinical examination, or scoliosis screening in 
order to determine the severity of the curves, and to evaluate the skeletal maturity (risk of 
progression) of the patients. The diagnosis of AIS is confirmed if the primary curve is > 10° 
and other reasons for scoliosis are excluded83;334. Facilities for scoliosis diagnosis and 
treatment are available in Norway, and worldwide. 
4. There should be a latent stage of the disease
Screening identifies unrecognized disease in individuals without signs and symptoms. 
Screening for scoliosis is performed in apparently normal children without signs or symptoms 
of scoliosis. The latent stage of a disease is the time from onset to the first symptoms or signs 
appear and the patient seeks medical care. This depends on the population’s awareness of the 
disease and the available access to health care. Scoliosis can develop quickly in some 
adolescents, and may be missed without a specific screening program. The scoliosis curvature 
itself may be too subtle to be noticed, even by observant parents. Early manifestations of 
underlying scoliosis like asymmetries of the neck, shoulder, ribs, waistline and hips may be 
noticed earlier by screening. Waistline asymmetry may be observed as straightening or 
excessive indentation of the waistline on one side, increasing hip prominence, tilting of the 
hem or waistband of a skirt, or uneven alignment of leg pant legs that may be evident to the 
dressmaker86. Other early manifestations of underlying scoliosis could be breast asymmetry in 
girls335 or prominence of lower coastal margins that will be most noticeable to the patient.
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In the absence of a screening program, scoliosis is most likely to be detected by patients 
themselves, close family and friends or other lay persons when curves are larger and the 
surface deformity is evident, but patients are not suitable for brace treatment226;289 as reported 
in Paper III.
Screening is reported to detect scoliosis at a younger age with smaller curves, leading to brace 
treatment and reduction of surgical rates258;280. In a case control study in the Netherlands 
involving 108 patients who were operated for idiopathic scoliosis and 216 controls 
demonstrated that patients detected through screening had significantly smaller Cobb angles 
at diagnosis, compared to otherwise-detected patients (34° versus 46°, p<0.01), Patients were 
also diagnosed at a significantly younger age than otherwise detected patients (10.8 versus 
13.4 years)336. In that study, patients detected through screening had a threefold greater 
chance of being treated with brace before surgery (OR = 3.1; 95% CI =1.3 to 7.0). Similar 
findings were demonstrated in their cross sectional study involving 125 patients who had 
completed treatment with brace or surgery or with brace followed by surgery280. They found 
in that study also that patients detected through screening had significantly smaller Cobb 
angles at diagnosis, and younger at detection compared to otherwise-detected patients (28° 
versus 40°, p<0.01 and 9.9 versus 12.6 years, p<0.01).
5. There should be a test or examination for the condition
The Adam forward bending test and a surface device measuring the angle of rotation like the 
scoliometer is normally applied in the screening test of AIS. There is a large variation of 
detection rates of scoliosis because of different standards of various examiners, and this is 
thought to be one of the main causes of the ineffectiveness of school screening for scoliosis57.
The use of the Adam Forward Bending Test alone has low sensitivity and specificity and is 
thus insufficient274. Higher referral rates and lower PPV’s are reported271;337-339. The Moiré 
topography has also been applied to the screening program in the past, but has led to a large 
number of false positive findings58;277;315;340-346. The use of the scoliometer to measure the 
ATR was introduced to increase the effectiveness of the screening programs313;315.
6. The test should be acceptable to the population
For a screening test to be acceptable to the population, it should cause no harm, and have 
benefits. The screening procedure of scoliosis is safe, and non-invasive. There is however a 
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concern that the screening test might cause stress, psychological labeling, anxiety, discomfort, 
and radiation exposure. The latter is generally reduced with the current techniques of 
shielding, the use of special films, and digital radiography136. In Paper II, 38 children were 
falsely diagnosed as AIS. They had positive screening, but a normal spine on radiography. If 
screening was performed yearly nationwide, the total estimated number of children with 
negative radiographs (Cobb angle < 10°) in 60000 children aged 12 years in the Norwegian 
population is estimated to about 570, which might be a concern for health authorities. In Paper 
II, the concern of safety has been addressed by making attempts to limit psychological 
labeling through provision of adequate verbal and written information to children and parents 
before and after screening, informing them about the results and follow-up regimes. We 
applied a relatively high cut-off angle $75RIÛDVLQGLFDWLRQWRUHIHUUDOWRUDGLRJUDSK\DQG
applied the accepted SRS’s definition of curvature > 10° as scoliosis299, thereby reducing 
over- referrals and limiting the exposure to radiation and reducing costs.
The acceptability of screening in patients and their parents has however not been
systematically evaluated. 
7. The natural history of the disease should be adequately understood
The risk of progression of scoliosis and its effects on HRQoL and pulmonary function in 
patients with large curves is of concern for patients, parents, and care providers. Knowledge 
of the natural history of AIS will enable these to make informed decisions about the treatment 
options available. The main risks of progression of AIS, its effects on HRQoL and pulmonary 
functions have been already discussed in the background section. 
8. There should be an agreed policy on whom to treat
The policy on whom to treat for AIS is based on the available knowledge of the risk of curve 
progression, the natural history and effects on HRQoL, and pulmonary functions discussed
above.  It is generally agreed that, children whose curves are < 25º and still growing, should 
be observed for curve progression. Brace treatment should be initiated when curves are > 25º-
40º in patients who are growing. Curves > 50º in patients who are mature will continue to 
slowly progress over time72;73;94;97-99, and these patients are recommended surgery47. The 
evidence for effectiveness of physical therapy in preventing progression of AIS has been 
inconclusive, and the policy on treatment of AIS with physical therapy and other alternative 
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methods varies worldwide. In some countries, comprehensive physical therapy programs are 
applied alone or in combination with bracing to prevent curve progression, particularly for 
small curves (< 25°)117;138-146.
9. The total cost of finding a case should be economically balanced in relation to medical
expenditure as a whole
There are concerns that screening can involve costs and use of medical resources on a 
majority of people who do not need treatment (over-referrals). Scoliosis screening will be cost 
saving in relation to medical expenditure as a whole if early diagnosis through screening 
results in bracing and costs saved by reduced surgical rates as suggested in Paper IV.  In 
Paper III, we reported higher rates of bracing and reduced surgical rates during a period of 
screening. Other studies have reported similar results258;280.
There are reports from several countries that have estimated the cost involved in scoliosis 
screening56;70;275;277;277;282;292-296;346;347. These estimates vary considerably and are not easily 
comparable. Programs have been conducted under different settings, variable scoliosis 
definitions have been employed with some programs performing multiple screenings in 
different age groups. Some studies have reported only the direct costs associated with the 
screening, whilst others have reported the costs of diagnosis and follow-ups in addition, and 
some have reported costs of treatment of cases detected through screening282;292;296. In these 
studies, the cost of screening per child varied from $ 0.07 to $ 43.7 and $ 149 per child and up 
to $ 4000 for each case brought to treatment depending on how the costs were calculated. 
Studies that assessed the economic impact of school scoliosis screening programs by only 
examining the costs paid by the school have generally reported lower costs56;277;346. The few 
studies that included total costs282;292,as in Paper IV, suggest long-term cost saving if early 
detection leads to brace treatment, and reduced surgical rates. It has been postulated that the 
costs involved with scoliosis screening are relatively low on a societal level and may justify 
the procedure to detect those children who will be at risk for developing scoliosis136.  In 
screening for scoliosis, there is an added value not necessarily linked to improvement in 
health state, but to the value of information and reassurance about the absence of scoliosis in 
those found negative on screening. There is currently a debate about whether there is a value 
from the process of receiving information and care, independent of the outcome348.
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10. Case-finding should be a continuous process, not just a “once and for all” project
Based on the knowledge of age and sex- specific prevalence of scoliosis, and the length of 
time between detection and treatment, it has been suggested that scoliosis screening programs 
should be planned as a continuous process and not just a once and for all project65.  There is a 
possibility of missing out some cases if screening is performed once, since the screening test 
lacks complete accuracy.
A single screening test can however be used to establish the diagnostic sensitivity and 
specificity for example by the use of the scoliometer313. However, the effectiveness of 
scoliosis screening is best determined by evaluating the complete school screening program, 
including the sensitivity and PPV and reproducibility of the series of screening tests for 
scoliosis diagnosis and treatment349;350.  The optimal age for scoliosis screening is under 
debate. A recent international task force of the SRS found the literature difficult to interpret 
on the optimal age of screening288. They agreed that ideally screening should be performed in 
girls before the onset of menses, and 1-2 years later for boys as females achieve adolescence 
about two years before males and AIS is more prevalent in girls. Previously, the SRS 
recommended that school screenings should be performed annually between the ages 10 to 14 
years in conjunction with a school health examination. The AAP has recommended scoliosis 
screening at routine health supervision visits at ages 10, 12, 14, and 16351.  In recent years, the 
AAOS, SRS, POSNA, and AAP all suggest screening girls twice at ages 10 and 12 years, and 
boys once at age 13 or 14 years136.
In paper II, we performed prevalence screening in 12 year-old children once in conjunction 
with a vaccination program, and this was not effective in detecting cases for bracing. In this 
study, the screeners were public health nurses and physical therapist. It is possible that other 
health professionals like physical education teachers could be engaged as screeners to perform 
the screening as a continuous process. 
5.1.3 Characteristics of scoliosis detected in the absence of screening 
In Paper III, we designed a prospective study, in which a standardized simple scoring sheet 
was used to evaluate patients with late juvenile and adolescent scoliosis patients referred for 
scoliosis evaluation for the first time at the specialist clinic during the period 2003–2011. The 
study appropriately included only late-juveniles (7 years and older) and adolescents, and 
excluded patients with non-idiopathic aetiology. Relevant aspects including patient 
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demographics, scoliosis detector, family history, perception of pain and muscle fatigue, was 
registered. Clinical and neurological examinations were performed in order to exclude non 
idiopathic scoliosis. Referral patterns of primary physicians, physical therapists and 
community health nurses, chiropractors, and hospital specialists to the scoliosis clinic were 
noted. The duration from time of detection to referral and evaluation was also recorded. 
Recommended treatment was appropriately registered.
Surgical protocols were used to validate the number operated during both periods and the 
number braced during the years 1976–1988 was registered prospectively. The results of brace 
treatment in these patients has been reported in 3 publications126;127;153. The indications for 
bracing and surgery were the same during the two observation periods.
The number obtained from surgical protocols was considered as the best estimate of the true 
number of actually operated patients. 
5.1.4 Health economic evaluation of scoliosis screening 
The most appropriate economic evaluation method of analysis depends on the problem being 
tackled, the institutional framework, the practical measurement challenges, and the 
perspective of the analyst290;352. It is important to perform appropriate economic evaluation of 
treatment options in relation to costs of scoliosis screening. AIS as a deformity in teenagers, 
can lead to increased morbidity, and may affect the social and the HRQoL of the affected 
patients72;73;101-106, but rarely death7;75;76;106. There is however, lack of validated utility 
measures in AIS in order to perform a full cost-effectiveness analysis (CEA), cost-utility 
analysis (CUA) or cost-benefit analysis (CBA). Paper IV was not designed as a prospective 
trial using utility measures in order to perform a full economic evaluation analysis. We 
therefore performed a partial economic evaluation of cost minimization analysis (CMA), 
assuming that long term effects of treatment options (brace and surgery) are not different in 
patients whose scoliosis was detected through screening or otherwise, and compared only 
relative costs.
CMA being a partial health economic evaluation has been criticized for not answering the 
effectiveness questions290;352. Compared with CEA, the CMA is more prone to bias and 
overestimation or underestimation of the value of information and the probability that 
treatment is cost effective353.
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In Paper IV, many of the input variables had uncertainties. We assumed equal prevalence and 
natural history of scoliosis in Hong Kong and Norway and based the evaluation on data from 
both Hong Kong and Norway. The uncertainty of input variables was assessed by one-way 
and multi-way sensitivity analyses. Parametric uncertainty was also analyzed by means of 
probabilistic sensitivity analysis (PSA), where all uncertainties in the relevant parameters 
were accounted for simultaneously290;300. We also performed sensitivity analyses for the most 
uncertain variables. Total costs were estimated for screening and treatment based on our own  
data when available, otherwise we supplemented data from the largest reported longitudinal 
study of screening cohorts354.
5.2 Statistical methods 
The choice of statistical methods in Papers I to III have been discussed. In Paper IV, we 
appropriately applied the recommended reporting standards and statistical analyses355. We 
used PSA to estimate the confidence intervals for total and incremental costs, and performed 
sensitivity analysis as illustrated in the Tornado diagram. In a tornado diagram, the categories 
appear from the top to the bottom according to the magnitude of contribution to uncertainty. 
This enables a decision maker to focus on the variables that contribute most to the variability 
of outcome356. In the PSA, we used gamma distributions for estimation of unit cost, beta 
distributions for the number of hours used, and probabilities. Poisson distributions were used 
for the number of children treated with brace or surgery. Boot-strapping based on 100000 
interactions was used to analyse the distribution of incremental cost estimations in all 
scenarios.
5.3 Methodological strengths
The main strengths in Paper I were adequately sized population of patients and presuming that 
the condition was unchanged between questionnaire administrations. Patient data was 
collected and evaluated using the recommended methods.
In Paper II, screeners were adequately prepared and educated in order to improve their skills, 
as the sensitivity and specificity depends largely on the skills of the examiner. Studies have 
shown that adequate preparation and teaching of the screeners increase sensitivity and 
specificity of scoliosis screening314. The combination of the Adam forward bending test and a 
scoliometer reading of 7º most likely increased test effectivity. Screening was combined with 
a vaccination program in order to reduce costs.  The accepted definition of scoliosis of 10º 
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primary curve was employed. Statistical tests included LH ratios which are commonly used 
for evaluating a screening test. 
The main strengths of Paper III were the prospective design, the large sample size, and the 
use of data from periods with and without screening and the prospective registration on 
bracing. 
The main strength of Paper IV was the recommendations developed by the Consolidated 
Health Economic Evaluation Reporting Standards (CHEERS)355 which were applied. This 
gives more transparency, and complete reporting of methods and findings that will facilitate 
interpretation and comparison of similar studies. In addition, analyses were performed to 
characterize uncertainty. Input data was based on Norwegian data (Paper II) and from the 
largest reported longitudinal study of screening cohorts292 which may increase the 
generalizability of the findings of study.
5.4 Methodological limitations
In Paper I, the Consensus-based Standards for the selection of health measurement 
Instruments (COSMIN) checklist which contains standards for design requirements and 
preferred statistical methods of studies on the measurement properties of health measurement 
instruments357;358, was not rigorously followed. The checklist is usually used to check if a 
study on measurement properties meets the standards for good methodological quality. In 
Paper I, aspects of construct validity were estimated, but hypothesis testing was not used and 
responsiveness was not evaluated. The coefficient alpha could not be adjusted for errors 
caused by factors external to the instrument such as differences in testing situations and 
responders over time359.
The main limitation in Paper II is that the true point prevalence in Norwegian school children 
aged 12 year could not be calculated because only those with a positive screening test were 
referred to X-ray examination. The Scoliometer has good measurement reproducibility, but 
lacks a correlation between the ATR measured by the Scoliometer and the size of lateral 
deviation measured on a radiograph using the Cobb angle83;313. A lower threshold value for 
the Scoliometer test would have increased the number referred to X-rays, but because of the 
poor correlation between lateral deviation and spinal rotation in the younger age group360, as 
in Paper II, the effect of lowering the threshold is questionable. In Paper II, we found a 
relatively high number of false positive screens and the number of false negative screens is 
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suspected to be considerably lower. Nevertheless, the point prevalence estimated in Paper II is 
most likely lower than the true point prevalence.
The general limitations to screening of scoliosis are the low prevalence of AIS requiring 
treatment56;115;129;259;261;262;361, which increases the likelihood that a positive screen could be 
false positive. There is also the likelihood of negative screen for people who will develop 
scoliosis later (false negative). False positive screening might cause unnecessary anxiety, and 
stress, time lost from school or work for follow-up or specialty care, radiation exposure, and 
adverse psychosocial effects (for example related to brace wear)3;265;267. In one study, 450 
children were screened to detect one child who needed treatment62. Some studies question  the  
benefit of preclinical detection of scoliosis through screening, and argue that most cases 
detected through screening do not progress to the point of surgery, and that most cases
requiring surgery were detected without screening267;336;362;363. In general, the number needed 
to screen (NNTS) to identify a child with a Cobb angle of > 10° ranges from 48 to 58, and to 
identify one child who subsequently need treatment (> 20-25°) ranges from 429 to 
46648;52;56;58;59;61;62;71;342.
If the screening population is selected for any reason, the selection bias can make the 
screening test look better or worse than it is for a random sample. In Paper II, 12-year olds 
were selected. Time biases are perceived with screening when a disease is diagnosed earlier 
by screening than without screening. Without screening, the disease may be discovered later, 
when symptoms or signs appear more clearly. As discussed earlier, screening leads to early 
detection280;336 which allows for more bracing and less surgery258;280 if compliance with brace 
treatment is good148;156;159-161. It has been suggested that there will be an added burden for 
patients who must live with knowledge of scoliosis longer because of earlier detection 
through screening. 
In Paper II we planned to include 12000 children in the screening program and follow them in 
a cohort study and compare treatments with those referred from other regions (from a similar 
population of about 30000 in Health Region East and Northern Norway) referred to the 
scoliosis clinic at the OUS-Rikshospitalet. We were however able to screen only 4000 out of 
the 12000. Since screening has been discontinued in Norway, the Directory of Health in 
Norway was not willing to support the program with a recommendation. Many community 
health nurses and physical therapists were therefore not willing to conduct a task that was not 
recommended by the health authorities and participation in the program was therefore lower 
than anticipated.
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In Paper III, resident orthopedic surgeons with variable experience in scoliosis management 
participated in the study. The inter-tester reliability was not tested. This variability in 
experience most likely influences evaluation of patient characteristics and the recommended 
treatment options. The physician filled in registration chart has not been validated. Back pain
recorded by a physician is likely to be less valid than self-assessment by patients. At the 
beginning of the study the validated adapted version of the Norwegian SRS-22 questionnaire 
(Paper I) was not available for evaluation of baseline HRQoL.
Findings in Paper III suggest that the absence of screening for scoliosis has resulted in less 
patients being treated with brace and more patients having surgery. However, technical 
advances in scoliosis surgery in recent years coupled with changes in surgeon attitudes may 
contribute to the observed variation in treatment trends exhibited over the two periods. 
Surgical treatment of scoliosis has evolved from the one- dimensional Harrington distraction 
rods to the three dimensional CD instrumentation and later third generation instrumentation 
with segmental all pedicle screws construct. During the period of screening, bracing was 
administered by one spine surgeon, while different spine surgeons were involved in brace 
treatment during the period without screening. There was probably less enthusiasm for 
bracing in the last period. These factors are possible confounders contributing to the observed 
difference in bracing and surgery during the two periods. 
There are limitations to the use of CMA as a health economic evaluation method as in Paper 
IV. In order to use CMA as an appropriate health economic method, it is necessary to
generate unambiguous evidence of clinical equivalence between the alternatives being
compared364. However, high quality evidence evaluating HRQoL in patients detected by
scoliosis screening versus no screening is lacking. Ideally, randomised studies or controlled
prospective studies are needed to compare outcome in scoliosis treatment with or without
screening. Since the prevalence of scoliosis is low it is difficult to include an adequate study
sample even within a large country or internationally. Utility scores may differ in shorter
periods during treatment, for example by wearing a rigid brace, or postoperatively, and there
are no long-term results from controlled studies. Another limitation is the assumption of equal
prevalence and natural history of AIS in Norway and Hong Kong in performing the analysis.
However studies show regional variations in the prevalence of AIS, like higher prevalence in
girls but not boys in higher latitudes than in lower latitudes66. But those differences could be
linked to environmental factors  such as the difference in the onset of menses in different
geographic locations54 and different cultures and not related to genetics. It is also likely that
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mechanisms of referral may be very different in the two settings and different countries due to 
healthcare systems structures and barriers to access. The presentation of AIS has also been 
reported to be linked to socioeconomic status and race 365. A recent study however found 
equal prevalence of AIS in 12 years old children in Malaysia and Norway366;367. In performing 
the CMA; we limited our the study perspective to only costs related to expenses in an 
orthopedic department. We did not include costs related to primary health care, paramedics 
and alternative costs in relation to referred patients.  In addition, we did not systematically 
register costs of patients’ out of pocket expenses like transportation in relation to adjuvant 
treatment for scoliosis. These could underestimate our total costs.
5.5 General discussion of the findings 
5.5.1 Reliability and agreement of outcome questionnaire in AIS
Outcome data are considered reliable when measurements are reproducible with low levels of 
random error. An instrument is considered valid if it measures what it is intended to measure. 
In Paper I, we found satisfactory score distribution, internal consistency, reliability, and 
repeatability for all domains of SRS-22 and for EQ-5D and EQ-VAS. Internal consistency 
(Table 5) for the function domain was higher compared with the Turkish209, Spanish211 and 
German221 versions, and in agreement with the original version118;204. The inconsistencies 
have previously been traced to question 15 (Are you and/or your family experiencing 
financial difficulties because of your back?) and question 18 (Does your back condition limit 
your going out with friends/family?). In Paper I, we pointed out that, these questions may 
reflect socio-cultural aspects (economy and participation) which may differ from function in 
terms of the ability to perform activities of daily living. The Cronbach alpha for the remaining 
questions of the function domain compare well with the original version 118;204. Later 
modification and refinement of question 15 and 18 has resulted in a higher Cronbach alpha 
value for the function domain207.
SRS-22 scores in normal adolescents of various ages, gender and race without scoliosis have 
been published212;368;369. In the study from the USA, scores were lower as age increased from 
11 to 19 years. Females had lower mental scores than males, and Caucasians scored higher in 
function, pain and self-image than other groups368. Also, in the study from China, females 
were reported to have lower scores for self-image and pain domains than males. Function 
domain was higher for males aged > 15.9 than females369.One study in the validation studies 
of the SRS-22 questionnaire included healthy adolescents and patients with non-clinically 
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significant scoliosis, and the SRS-22 discriminated between patients with AIS and controls212.
Boys had higher scores than girls and scores worsened with age, and with increasing body 
mass index212. The ICCs in Paper I are in agreement with previous studies and support the 
conclusion that SRS-22 is a useful instrument for discrimination between 
patients204;205;209;211;213;214;216.
In evaluating the concurrent validity of the SRS-22, it has shown high correlation coefficients 
to the corresponding domains of the various generic outcome instruments SF-
36205;207;209;213;216;219;220;222-224, SF-12212, the Child Health Questionnaire CF 87225, and the 
Roland Morris Questionnaire221. We found poor correlations between SRS-22 and EQ-5D for 
the domains of pain, mobility, function, and mental health. The self-image and satisfaction to 
treatment domains are not comparable between the two instruments. The low correlation 
coefficient observed in Paper I may reflect poor intrinsic correlation between the two 
instruments rather than a validity problem of the translated questionnaire. Another possible 
reason is that the EuroQol has been validated for use in adult populations with back pain in 
Norway370, but not in the younger population with spine deformity as in the study population 
in Paper I. 
Repeatability
While reliability parameters are recommended for instruments that are used for discriminative 
purposes, agreement parameters are required for use in follow-up studies. In Paper I, we 
calculated the repeatability coefficient using 95% probability. Other authors have evaluated 
the minimal detectable change (MDC) of the SRS-22 questionnaire using 90% probability311.
Bago et al also estimated the MDC (but called it the minimal important difference (MID) 
using a 95% probability312. Their results ranged from 0.3 to 0.8 for the function, pain, self-
image, and mental health domains and are lower than the results in Paper I. We found the 
coefficients of repeatability for the 5 domains of pain, self-image, function/activity, mental 
health, and satisfaction with treatment, to vary from 0.7 to 1.0. The practical interpretation is 
that the lowest detectable average change for each domain is slightly lower than one step on 
verbal scales with response categories from 1 to 5. This means that the measurement error for 
an individual patient ranges from about 15 to 20% for the different domains. A smaller 
change between two subsequent measurements is indistinguishable from the measurement 
error, and the given limit represents the minimum detectable difference. The variation 
between two measurements in the same individual should be considered when assessing 
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follow-up results after treatment and in the planning of prospective studies. Repeated 
measurements may reduce the measurement error and increase the validity of observations371.
The estimates of both agreement and reliability parameters reported in Paper I supplement 
current knowledge of clinometric properties of questionnaires for use in patients with AIS. 
Table 5. Overview of psychometric properties of the SRS-22 in various languages.
P=Pain, F=Function, MH=Mental health, SI= Self-image, S=Satisfaction with treatment
NCSS= Non clinically significant scoliosis
QLSDP=Quality of Life for Spine Deformities Profile 
Language/Author/ 
Publication year
Internal consistency 
&URQEDFKĮ
Reliability ICC Concurrent reliability 
Global outcome 
measure
Original article in 
English Haher)
P=    0.80
SI=   0.70
F=    0.71
S=    0.78
1.0
0.98
N/AN/A
0.69
1.0N/A
SF-36
English, Asher 
2003(original 
reliability study)
P=     0.92
SI=    0.75
F=     0.86
MH= 0.90
S=     0.88
P=     0.96
SI=    0.90
F=     0.90
MH= 0.87
S=     0.85
SF-36
English, Asher, 
2005
P=     0.80
SI=    0.81
F=     0.77
MH= 0.89
S=     0.88
Not examined SF-36
Spanish , Bago 2004
Climent 2005
P=     0.81
SI=    0.73
F=      0.67
MH=  0.83
S=      0.78
P=       0.93
SI=      0.94
F=       0.83
MH=   0.94
S=       0.98
QLSDP
(Climent)
Turkish 
Alanay, 2005
P=     0.72
SI=    0.80
F=     0.48
MH= 0.72
S=     0.83
P=     0.80
SI=    0.82
F=     0.76
MH= 0.78
S=     0.81
SF-36
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Japanese
Hashimoto, 2007
P=     0.88
SI=    0.79
F=     0.75
MH= 0.85
Not examined SF-36
Chinese,(Hong 
Kong) Chenug, 2007
P=
SI=
F=
MH=
S=
P=    0.87
SI=   0.78
F=    0.86
MH=0.87
S=    0.53
SF-36
German
Niemeyer, 2009
P= 0.75
SI=     0.84
F=      0.67
MH=  0.88
S=      0.67
P=    0.76
SI=   0.87
F=    0.80
MH=0.85
S=    0.83
Roland Morris
French Canadian 
Beausejour, 2009
AIS=    0.88
NCSS= 0.81
C=        0.79
P=    0.79
SI=   0.67
F=    0.68
MH=0.79
S=    0.69
SF-12
Greek
Antanarakos, 2009
P=     0.85
SI=    0.87
F=     0.72
MH= 0.87
S=     0.67
Not examined Not examined
Polish
Glowacki,2009
P=     0.81
SI=    0.77
F=     0.81
MH= 0.80
S=     0.69
Not examined Not examined
Norwegian,
Adobor, 2010(Paper 
I)
P=     0.93
SI=    0.93
F=     0.87
MH= 0.89
S=     0.90
P=     0.87
SI=    0.87
F=     0.76
MH= 0.80
S=     0.82
EuroQol
Persian
Mousavi,2010
0.68 to 0.78 0.79 to 0.87 SF36
Brazilian
Rosanova, 2010
Not examined Not examined SF-36
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Korean
Lee, 2011
P=     0.83
F=     0.85
SI=    0.75
MH= 0.81
S=     0.61
P=     0.81
SI=    0.84
F=     0.83
MH= 0.88
S=     0.87
Not examined
Tai
Sathira-Angkura, 
2012
P=      0.78
F=      0.74
MH=  0.80
SI=     0.83
Not examined SF-36
Repeatability examined only in the study by Adobor (Paper I).
5.5.2 Reliability of scoliosis screening
The sensitivity and specificity of scoliosis screening depends largely on the skills of the 
examiner and the magnitude of the scoliosis being sought.  The use of scoliometer has been 
shown to increase the sensitivity and the specificity in detecting a Cobb angle of > 20°313. In 
Paper II, using a scoliometer reading of 7°, an estimated point prevalence rate of scoliosis of 
0.8%, and a scoliosis definition of > 10° in 12 year- old children, we found sensitivity of 69% 
and specificity of 99% in detecting AIS in the study population. A scoliometer reading of 5° 
has been shown to have a sensitivity of 100%, and 47% specificity for identification of 
scoliosis, whereas a scoliometer reading of 7° increases the specificity to 86% but decreases 
the sensitivity to 83%314. The reliability of screening procedure in Paper II is thus satisfactory, 
although the sensitivity was low.
The PPV of visual inspection and the forward-bending test varies with the degree of curvature 
by which a “true positive” is defined, the prevalence of scoliosis in the screened population, 
and the skills of the examiners58;317. In Paper II, we found the PPV to be 37%.  A study found 
PPV of 54% for curves > 10° with a predicted prevalence of 2%, and 24% for curves > 20° 
with an estimated prevalence rate of 0.3%58. The magnitude of PPV is thus inversely related 
to the degree of curvature used to define scoliosis since the prevalence of small curves is 
greater than large curves. In a study from Australia, the PPV was 78% for curves > 5° in a 
population with an estimated prevalence of 3%317. A meta-analysis of the clinical 
effectiveness of school scoliosis screening citing 34 studies reported that the pooled PPV for 
curves > 10°, curves > 20°, and treatment were 28.0%, 5.6% and 2.6%, respectively271.
A LH ratio > 1 indicates that a test result is associated with a disease and a LH ratio < 1 
indicates that a test result is associated with the absence of a disease. It is when the positive 
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LH ratio is > 5 or the negative LH ratio is < 0.2 that LH ratios can be applied to the pre-test 
probability of a patient having a specific diagnosis. In Paper II, the LH+ ratio was calculated 
to be 69 and the LH- ratio was 0.3. The screening model was sensitive enough to reduce the 
number of false positive results. However, since the number of abnormal radiographs of Cobb 
angle > 10° (true scoliosis) is not known in the study population, the true PPV cannot be 
known. 
5.5.3 Prevalence rates in screening
In Paper II, using the scoliometer and radiographic examination of those who had a positive 
screening, at age 12 we found a point prevalence rate of 0.55% of scoliosis > 10°; 0.40% in 
girls and 0.15% in boys. Point-prevalence is the prevalence based on a single examination of 
the target population at one point in time, which will probably underestimate the true 
prevalence of AIS. The prevalence of AIS has been reported to vary from 0.5% to 5%10;48-52.
The variation is mostly due to different definitions of scoliosis being used and different ages 
being examined. Prevalence rates are higher (5%) when a spine deformity of 5° is being
sought58. Using a Cobb angle of 10° for the definition of scoliosis49;55, prevalence rates for 
AIS ranges from 2% - 3% range48-50;52;56-62, 1.0% for curves > 20°49;51;63;64, and only 0.1% 
have curves > 40°49;65.
There are few reports of age-specific prevalence of idiopathic scoliosis in the literature10;71;293.
These studies report a low prevalence in children between six to ten years, increasing to 
1.37% for girls at age 11 to 12 years and 2.22% for girls aged 13 to 14 years. The point 
prevalence specifically in 12 year old children has not been reported in the literature. One 
study reported a point prevalence rate of 0.35% in the 9-11 year group, and 1.2% in the 12-14
year group10.  The low prevalence rate in our study could be due to the large variety of the 
start of puberty and scoliosis, which could underestimate the true prevalence of AIS. The true 
prevalence of AIS is not known since false negative cases cannot be detected without an X-
ray examination of the study population. In addition, only 12-year-old children were 
examined once, and there are inaccuracies in the screening test employed. As reported in 
earlier studies, we also found a higher prevalence of scoliosis in girls compared with 
boys52;56;70;71.
5.5.4 Characteristics of scoliosis detected in the absence of screening
In the absence of scoliosis screening, the majority of patients detected with scoliosis in Paper 
III were skeletally mature and had curves that were not suitable for brace treatment. The mean 
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chronological age at detection was 14 years, which is 2 years older than the ideal age148;276.
Other signs of maturity were consistent with this observation: 60% had Risser sign > 3 and 
78% of the girls were post menarche. A large SURSRUWLRQRISDWLHQWVDOVRKDGFXUYHV!ÛDW
first presentation, which is beyond the international recommendation for initiation of brace 
treatment148;150. Findings are in agreement with two previous studies that have assessed the 
impact of discontinuation of scoliosis programs on detection, referral patterns and 
management. In a Canadian study, 32% of patients with AIS were referred too late for brace 
treatment226. Another study conducted in England, showed that about 70% of the patients 
were detected by non-health care providers, either by patients themselves, close family 
PHPEHUVRUIULHQGVDQGWKDWZHUHGHWHFWHGZLWKSULPDU\FXUYHV!ÛDQGWKHUHIRUH
were not suitable for brace treatment289. Contrary to previous studies, we found no differences 
between patient maturity and curve sizes in scoliosis detected by patient and families 
compared to those detected by healthcare providers. 
In Paper III, 59% of all patients reported some, but not disabling back pain and only between 
1-3% had back pain almost all the time. Our findings are consistent with other studies on back 
pain in AIS73;97;116-118. We found a significant association between back pain and gender, with 
girls reporting more pain compared with boys, but no association between back pain, curve 
size, and BMI. This is in agreement with one previous study reporting less postoperative pain 
in male patients with AIS372.
5.5.5 Referral rates in screening
The use of objective criteria was introduced to increase the effectiveness of screening 
programs. Without the use of objective criteria, referral rates have been reported to be as high 
as 21%, but reduced to about 2% by the use of the scoliometer274;315;333. In Paper II we found 
a referral rate of 1.5% using a Scoliometer reading of 7°. Generally, a referral rate of 12% has 
been predicted using 5° Scoliometer  reading, and 3% referral rate using 7° Scoliometer 
reading315. A meta-analysis that included 34 studies  reported a pooled referral rate to 
radiography of 5%271. It is an agreement that referral rates should be in the range of 2% to 3% 
in school screening for scoliosis274;281;315;373.
Referral rates are high in scoliosis screening because screening for scoliosis using the 
Scoliometer, or any surface topographic measurement devise does not reveal scoliosis per se, 
but detects thoracic deformity281;360. The radiographic measured thoracic Cobb angle is better 
correlated to the rib-index in the 14-18 years age group than in smaller curves usually found 
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in the younger age group360. Thus, it is not possible to reliably predict the Cobb angle from 
surface topography in the age group that is screened315;360. This lack of association of the 
surface asymmetry (hump) and Cobb angle in the younger group such as in Paper II, creates a 
burden of false positive referrals in school screening programs360. It has been reported that, in 
typical screening settings where the prevalence and positive predictive value are relatively 
low, for every curve > 10° detected, there are 1-5 false positives; similarly, for every curve > 
20° detected, there are 3-24 false-positives265;360.  In practical terms, in order to detect 10 
patients with scoliosis > 20º there would be 60 to 240 negative X-ray examinations. This 
number of false positive children on screening must be accepted if those with asymmetry, 
who might develop scoliosis should be detected. The high number of false positive children 
referred for x-ray examination is a concern of harm in screening.
5.5.6 Referrals of scoliosis detected without screening
The detection and referrals of scoliosis patients to specialised scoliosis clinics for evaluation
is suboptimal in many countries without a screening program226;289;360. In Paper III, similar 
findings were reported as discussed above. In order to ensure uniformity and quality of care 
for scoliosis patients, it is important that persons involved in child health care like physical 
therapists, community health nurses, chiropractors, sports instructors, primary physicians and 
orthopaedic surgeons be better informed about guidelines for scoliosis detection, and prompt 
referrals to specialised scoliosis clinics without unnecessary delay226. In Paper III, 2/3 of all 
patients were first observed by orthopedic surgeons at local hospitals on average 16 months 
before being referred to the specialist clinic for scoliosis. One third of patients were referred 
directly by primary physicians, physical therapists or community health nurses to the 
specialist clinic. The mean waiting time from referral to specialist evaluation was only 4 
months, which is at an acceptable level for a specialist’s evaluation of pediatric cases.
In Norway, the general guideline for primary physicians is to refer suspect cases of AIS to 
local orthopaedic surgeons for diagnosis or refer directly to specialist evaluation of high risk 
patients for progression. Recommended guidelines for referrals to orthopaedic surgeons in 
JHQHUDOLQFOXGH$75&REEDQJOHDQGDSURJUHVVLRQRI&REEDQJOH3;316.
Orthopaedic surgeons at local clinics are authorized to diagnose and observe AIS patients for 
progression and to refer without unnecessary delay progressive curves > 20° in inmature 
patients to specialist clinics for evaluation. Results in Paper III suggest that this strategy 
caused a delay in the referrals to specialist evaluation either due to the non-awareness of 
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existing guidelines, or failure of education on these guidelines. In the absence of or as an 
alternative to school screening, direct referral to specialist clinics should be considered as a 
more appropriate strategy for young patients with scoliosis. However, without objective 
screening test, proper training and clear guidelines for referrals, there is a risk of inappropriate 
referrals to the specialized care setting if community health nurses, physical therapists, 
chiropractors, sports instructors, refer patients directly to scoliosis specialist evaluation 
without first referring to local orthopaedic surgeons. The magnitude of the eventual 
inappropriate referrals is not known. Local orthopaedic surgeons still play important roles as 
gatekeepers while offering reassurances to the families and proper follow-up for mild cases. 
The emphasis is to better inform all persons involved with child health care about the 
guidelines for scoliosis detection. This includes the examination of asymmetries of the back in 
the routine examination of the child226, and in cases of confirmed scoliosis in immature 
patients, refer to specialized evaluation without unnecessary delay. 
5.5.7 Health economic evaluation of scoliosis screening 
Scoliosis screening programs are often criticized for high costs due to over referrals and lack 
of efficacy of the programs. The effectiveness of a screening program thus depends on the 
costs involved and the number of cases detected early that results in bracing and less surgery 
compared to a non-screening setting. Results of Paper III and other studies have shown that 
discontinuation of screening has led to late detection and high rates of surgery226;289;374.
In Paper IV, we used model based analysis to compare costs of screening and treatment in 
screening and non-screening settings assuming equivalent long term outcomes of brace and 
surgical treatment. We found that screening may be cost saving when it leads to high bracing 
and low surgical rates. Results also suggest that the cost saving of screening is larger when 
only girls are screened. Selective screening of girls is most cost saving because they constitute 
about 90% of those treated for scoliosis. The model applied in the present study show positive 
incremental costs in non-screening scenarios with high rates of surgery and lower rates of 
bracing suggesting that screening is cost saving in these scenarios. Screening only increases 
costs compared to non-screening when both treatment rates and surgical rates are very low in 
comparative non-screening scenarios. In the extreme non- screening scenarios where 
treatment rates are approaching those of screening, screening both boys and girls was not cost 
saving. Likewise in the extreme non –screening scenario where treatment rates were very low 
approaching 60% of those treated in screening, non-screening becomes cost saving. However, 
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these scenarios are the least likely to occur. In the non-screening scenarios where treatment 
levels are 90-100% of those in screening, patients are probably younger at detection, and 
according to guidelines and the results of the recent RCT study on bracing152, these patients 
are likely to be recommended bracing. This implies that the ratio of bracing/surgery is likely 
to be >1 and bracing will be the dominating treatment option. On the contrary, when 
treatment levels in non –screening scenarios are in the 60% to 70% range of that of screening, 
patients are likely to be older and curves too large and not suitable for bracing374 and surgery 
is most likely to be the dominating treatment option(ratio of brace to surgery likely to be < 1).
These findings are in agreement with one previous study that found screening to be cost 
effective294. The researchers recommended screening only for high-risk groups such as girls. 
They argued that this will reduce over-referrals and over-treatment. The most recent systemic 
review on cost analysis of screening  on the other hand could not conclude from the seven 
studies in the review whether screening was cost effective or not375. Both reviews however 
did not adher to the recommended health economic evaluation principles355 in conducting and 
reporting of the studies. Other publications from various countries have reported studies with 
information related to costs and cost effectiveness58;261;282;292;295 without following the 
recommended guidelines on conducting and reporting health economic evaluations355. The 
reported costs vary widely in these studies depending on whether all cost items were included 
or not. In Paper IV, we based our evaluations on total costs and performed a health economic 
evaluation of scoliosis screening. Thus, to date prior to our study (Paper IV) has no 
researchers performed partial or full economic evaluation of cost effectiveness of scoliosis 
screening following recommended health economic evaluation principles355 .
Results of our study indicate that the cost of scoliosis screening was low. Combining 
screening with a vaccination program and only referring children with significant curves for 
specialist evaluation most likely reduced costs. Costs were only increased compared to non-
screening scenarios with unrealistically low treatment rates, high bracing, and low surgical 
rates.
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6. Conclusions
From the specific aims of the present dissertation, the following conclusions are drawn: 
I. SRS-22 is a valid tool for evaluation of Norwegian patients with AIS. The Norwegian 
version of the SRS-22 has satisfactory reliability, repeatability, and concurrent validity with 
the EuroQol.
II. The point prevalence of AIS in school children aged 12 years in Norway was slightly lower 
compared with studies from other countries. The screening model applied had acceptable 
sensitivity and specificity and was neither time consuming nor expensive compared to similar 
screening programs in Europe. A single screening at 12 years of age was not effective in 
detecting scoliosis with indication for bracing. 
III. In the absence of screening in Norway, most patients were detected late by close family 
members and friends and were not suitable for brace treatment. There was a delay of about 2 
years from detection to specialist evaluation. Rates of surgery were increased and bracing 
reduced in a period without screening compared to a period of screening.
IV. Screening is not likely to increase costs unless both treatment and surgical rates are very 
low in settings when screening is not performed. Screening may save costs when girls are 
selectively screened, and when it leads to high rates of bracing and lower rates of surgery.
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7. Implications of the findings in the study
The translated, validated and the adopted Norwegian version of the SRS-22 questionnaire has 
been used in Norwegian studies125-127;153 and is used in the Norwegian Quality Registry for 
Surgery of Spinal Deformities.  
In the absence of scoliosis screening in Norway today, there is a delayed detection of 
scoliosis, and inappropriate and non-uniform referral practices of child health-care providers 
cause a delay in specialists’ evaluation. To ensure uniformity and quality of care for scoliosis 
patients, the study suggests that persons involved in child health should be better informed 
about guidelines for scoliosis detection. Immature patients with radiographically confirmed 
scoliosis should be referred to specialized clinics without unnecessary delay.
The establishment of a screening procedure and the analysis of the cost of scoliosis screening 
and treatment modalities provide valuable information to health authorities and policy makers 
to consider the reintroduction of screening in Norway. The modeling used in the economic 
evaluation study (Paper IV) could be employed worldwide with local cost estimate variations. 
The results provide the economic evidence for health policy makers and healthcare providers 
to consider reintroduction of scoliosis screening worldwide.
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8. Recommendations for future research
The responsiveness to change of SRS-22 with brace and surgical treatments should be 
evaluated in future studies. As the quality of the EQ-5D as a utility index for cost-benefit 
analyses is questioned, other measures should be evaluated. We suggest a full health 
economic evaluation comparing costs and outcomes as cost-benefit evaluation or cost utility 
evaluation and parents’ willingness- to- pay for screening and gain in QALY to be assessed. 
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Appendix I
Norwegian Version of SRS-22 Questionnaire (Paper I)
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Alle svar vil bli behandlet konfidensielt
Del 1: Besvares av alle pasienter.
1. Hvilket av de følgende utsagn passer best til din smerte opplevelse de siste 6 månedene?
͘ Ingen
͘ Mild
͘ Moderat
͘ Moderat til sterk
͘ Sterk 
2. Hvilket av de følgende utsagnene beskriver din smerte opplevelse den siste måneden?
͘ Ingen
͘ Svak
͘ Moderat
͘ Moderat til sterk
͘ Sterk 
3. Har du vært nervøs i løpet av de 6 siste månedene?
͘ Aldri
͘ Litt av tiden 
͘ Noe av tiden 
͘ Mesteparten av tiden
͘ Hele tiden
4. Hva ville du synes om å måtte tilbringe resten av livet med ryggen slik den er nå?  
͘ Svært tilfreds
͘ Ganske tilfreds
͘ Verken tilfreds eller utilfreds
͘ Litt utilfreds
͘ Svært utilfreds
5. Hva er ditt nåværende aktivitetsnivå?
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͘ Sengeliggende/rullestol 
͘ Hovedsaklig ikke i aktivitet
͘ Lett arbeid, slik som daglige gjøremål i hjemmet
͘ Moderat manuelt arbeid og moderate sportsaktiviteter, som gå-turer og sykling
͘ Full aktivitet uten begrensinger
6. Hvordan tar du deg ut i klær?
͘ Svært godt
͘ Godt
͘ Akseptabelt
͘ Dårlig
͘ Svært dårlig
7. Har du følt deg så nedfor de 6 siste månedene at ingenting kan muntre deg opp?
͘ Veldig ofte
͘ Ofte
͘ Noen ganger
͘ Sjelden
͘ Aldri
8. Har du vondt i ryggen i hvile?
͘ Svært ofte
͘ Ofte
͘ Noen ganger
͘ Sjelden
͘ Aldri
9. Hva er ditt nåværende aktivitetsnivå, jobb eller skole?
͘ 100%  
͘ 75% 
͘ 50% 
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͘ 25% 
͘ 0% 
10. Hvilket av disse utsagnene beskriver best utseende av overkoppen din, definert som
kroppen med unntak av hodet, bena og armene?
͘ Svært godt
͘ Godt
͘ Akseptabelt
͘ Dårlig
͘ Svært dårlig
11. Hvilke medisiner tar du for tiden mot ryggsmertene? (marker alle relevante)
͘ Jeg tar ingen medisiner
͘ Reseptfrie medisiner ukentlig eller sjeldnere (Feks Ibux eller Paracet)
͘ Reseptfrie medisiner daglig
͘ Sterke medisiner ukentlig eller sjeldnere (Feks Paralgin Forte / Pinex Forte / Nobligan)
͘ Sterke medisiner daglig
͘ Andre (angi nedenfor)
Medisiner:
________________________
Hvor ofte:(Brukt ukentlig/sjeldent/daglig)
_________________________
12. Begrenser ryggen deg med hensyn til aktiviteter og gjøremål hjemme?
͘ Aldri
͘ Sjelden
͘ Av og til
͘ Ofte
͘ Veldig ofte
13. Har du følt deg rolig og harmonisk de siste 6 månedene?
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͘ Hele tiden
͘ Nesten hele tiden
͘ Noe av tiden 
͘ Litt av tiden
͘ Ingen følelse av ro og harmoni    
14. Føler du at helsetilstanden din innvirker negativt på ditt forhold til andre mennesker?
͘ Nei
͘ Ubetydelig 
͘ Lett grad
͘ Moderat grad
͘ Betydelig grad
15. Har du eller din familie økonomiske problemer som følge av din rygg?
͘ Betydelig
͘ I moderat grad
͘ I lett grad
͘ Ubetydelig 
͘ Ingen
16. Har du følt deg nedstemt og deprimert i løpet av de 6 siste månedene? 
͘ Aldri 
͘ Sjeldent 
͘ Noen ganger 
͘ Ofte 
͘ Veldig ofte
17. Hvor mange dager har du vært borte fra jobb eller skole på grunn av ryggsmerter de siste 
3 månedene?
͘ 0
͘ 1
͘ 2
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͘ 3
͘ 4 eller flere
18. Går du ut like mye som dine venner?
͘ Mye mer
͘ Mer
͘ Like mye
͘ Mindre
͘ Mye mindre
19. Føler du deg attraktiv med ryggen slik den er?
͘ Ja, svært 
͘ Ja, litt
͘ Verken attraktiv eller ikke
͘ Nei, ikke særlig
͘ Nei, overhodet ikke
20. På en skala fra 1 til 9, hvor 1 er svært dårlig og 9 er svært godt, hvordan vil du beskrive 
ditt selvbilde?
͘9
͘8
͘7
͘ 6
͘ 5
͘ 4
͘ 3
͘ 2
͘ 1
Del 2:Besvares kun dersom du har fått behandling.
21. Er du fornøyd med resultatet av behandlingen?
͘ Svært godt fornøyd
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͘ Ganske fornøyd
͘ Verken fornøyd eller misfornøyd
͘ Litt misfornøyd
͘ Veldig misfornøyd
22. Ville du ønsket samme behandling på nytt dersom du hadde de samme plagene?
͘ Definitivt ja
͘ Sannsynligvis ja
͘ Usikker
͘ Sannsynligvis ikke
͘ Definitivt ikke
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Appendix II
Informasjonsbrev om SRS-22 spørsmål skjema
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Kjære…………………………………………….
Vi vurderer din ryggskjevhet ved hjelp av røntgenbilder og vi spør deg om hvordan 
ryggskjevheten påvirker din helsetilstand.  Det finnes flere spørreskjemaer som er spesielt 
utviklet for pasienter med skoliose. Vi har fått oversatt det mest brukte til norsk og vi ønsker å 
teste ut om det egner seg for norske pasienter.  Vi har i tillegg tatt med noen spørsmål som 
brukes for ulike andre pasientgrupper. Vi vil be deg om å besvare vedlagte spørsmål så godt 
du kan. 
Etter 14 dager får du tilsendt et nytt skjema som vi ber deg besvare. 
Du kan når som helst trekke deg fra undersøkelsen.
Oslo,………………..
Vennlig hilsen
Raphael Adobor            Silje Rimeslåtten                              Jens Ivar Brox 
Prosjektlege                  Prosjektsykepleier                            Seksjonsoverlege
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Appendix III           
Information and Consent form/ Informert samtykke skjema (Paper II)
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Informert samtykke
Til foreldre og foresatte                           Dato:
Rikshospitalet er i gang med et forsknings-prosjekt i Helse-Sør. ”Vil screening for skoliose 
ved 12-års alder i Helse Sør bidra til å senke alder for førstegangskonsultasjon ved 
ortopedisk poliklinikk?” Hvor vi vil undersøke om screening (i dette tilfelle; visuell 
undersøkelse av ryggen) i 12-års alder vil gjøre at skoliose (skjevhet i ryggen) oppdages på et 
tidligere tidspunkt enn pr dags dato. 
Tidligere ble skoliose oppdaget i forbindelse med screening av alle skolebarn. I dag er 
skolehelsetjenesten i stor del falt bort på dette området og skoliose oppdages mer eller mindre 
tilfeldig og ofte for seint.
På nåværende tidspunkt finnes det ingen måte å forebygge skoliose på. Målet med denne 
skole-undersøkelsen er å oppdage skoliose så tidlig som mulig. Ved tidlig oppdagelse og 
observasjon, kan man skreddersy et behandlings opplegg til hver enkelt og redusere forverring 
av skoliosen. Dette medfører at man kan rette opp eller hindre videre utvikling på et tidligere 
tidspunkt, og kan gi pasienten den best tilpassede behandlingen. I denne forbindelse vil 
ryggen til alle barn bli undersøkt av helsesøster/fysioterapeuter ved 12 års alder. Det er viktig 
at denne undersøkelsen gjøres før barnet er utvokst og skjelettet er blitt modent. 
Det mistanke om at _____________________________ kan være skjev i ryggen. Han/hun vil 
derfor få tilsendt time til røntgen for å avkrefte /bekrefte dette. Han/hun vil også få oppfølging 
ved Rikshospitalet hvis det er behov for dette. 
Det er frivillig å delta i denne undersøkelsen. Fordelen ved å delta er at barnet vil få avkreftet 
eller bekreftet om ryggen er skjev. Ved skjevhet vil barnet få oppfølging på Rikshospitalet 
som innehar en av landets beste kompetanser på dette området. Dere får full rett til innsyn i 
barnets journal og dere kan trekke dere når som helst fra studien og alle data vil bli slettet om 
ønskelig. Ellers vil alle data bli slettet i utgangen av 2018. Behandlingen barnet vil motta er 
etter de retningslinjene som er gjeldende for Rikshospitalet pr dags dato og er den samme 
behandlingen vi gir barna som ikke er med i studien. Behandlingen blir gitt etter skjevhetens 
alvorlighetsgrad og vil være enten: kun oppfølging, korsett og/eller evt operasjon. 
Databehandleransvarlig er Rikshospitalet - Radiumhospitalet HF. Opplysningene vil ikke bli 
utlevert til andre. Prosjektet er godkjent av personverneombudet ved RH-RR HF. 
Ansvarlige for prosjektet: 
Jens Ivar Brox, Seksjonsoverlege, Prosjektveileder
Raphael Adobor, Spesialist i ortopedi, Prosjektleder
Silje Rimeslåtten, spesial sykepleier, Prosjektmedarbeider
Ryggseksjonen, ØPO-klinikken, Rikshospitalet-Radiumhospitalet HF
Kontakt informasjon:
Silje Rimeslåtten, Ortopedisk avdeling
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Sognsvannsveien 20
0027 Oslo 
Tlf: 23076032 (ons-fre) E-mail: silje.rimeslatten@rikshospitalet.no
Samtykke
Jeg har lest og forstått informasjonen, og gir mitt/vårt samtykke til å delta i undersøkelsen.
______________________________              ________________               ____________ 
Underskrift 
(foreldre/foresatte)                                                          Sted                              Dato
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Appendix IV
Informasjonsbrev til foreldre etter screening
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I forbindelse med skole screening for skoliose, var det mistanke om ryggskjevhet hos barnet 
ditt.
Røntgen fotografering viser
o ingen ryggskjevhet
o liten grad av ryggskjevhet
o moderat grad av ryggskjevhet
o storstor grad av ryggskjevhet.
Vurdert etteretter behandlingsopplegg for ryggskjevheter ved ortopedisk avdeling 
Rikshospitalet:
o Trenger barnet ditt ingen behandling eller oppfølging ved ortopedisk avd, 
Rikshospitalet
o Trenger barnet ikke behandling nå, men vil få oppfølging ved vår avdeling.
o Barnet få derfor time for poliklinisk undersøkelseundersøkelse om ……….. uker.
Mvh
Raphael Adobor
Prosjektlege
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Appendix V
Patient questionnaire at first consultation/ Registreringsskjema for 1.gangsvurdering av 
skoliose (Paper III)
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PASIENTENS NAVN
KONSULTASJONS
DATO:
HENVISENDE LEGE: (sett kryss)
Fastlege
Sykehuslege
Annet: 
NÅR BLE DEN OPPDAGET: HENVISNINGSDATO:
OPPDAGET AV HVEM: FAMILIEANAMNESE:
LENGDE: VEKT: KJØNN: MENARCHE:
SKULDERASSYMETRI: BALANSE: TRUNCAL SHIFT:
THORACAL GIBBUS: LUMBAL GIBBUS: BENLENGDEFORSKJELL:
Refleks Høyre Venstre
Bukrefleks
Patellasenerefleks
Akillessenerefleks
HØYRE/VENSTREKONVEKS SKOLIOSE COBB 1:
HØYRE
VENSTRE COBB 2:
Fylles kun inn ved 
dobbeltkurve
COBB ØVRE KOMPENSATORISKE 
KURVE:
COBB NEDRE KOMPENSATORISKE 
KURVE:
RISSER: HÅNDSKJELETT: SPONDYLOLISTESE:
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VIDERE TILTAK/KOMMENTARER
Registreringskjema for 1. gangsvurdering av skoliose.
Vennligst svar på følgende så godt som du klarer. Du setter et kryss for tretthet og et for 
smerte.
På forhånd takk.
Aldri Svært 
sjelden
Noen 
ganger
Ofte Nesten 
alltid
Alltid
Tretthet i 
ryggen
Smerter i 
ryggen
KING-MOE Klassifikasjon. Vennligst sett et kryss ved aktuelle kurve.
(Fylles ut av lege)
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Appendix VI 
The mathematical model (Paper IV)
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A.1: Introduction
In this supplementary data, we show the core equation on which the simulation model was 
based. We begun by presenting the equations for estimating the cost of the different 
interventions: screening, diagnosis of scoliosis, confirming scoliosis > 20º, brace treatment 
and surgery. Then we estimated the fraction of children receiving the each category of 
interventions in the various scenarios. In the end we merged the estimated costs and the 
estimated fractions to estimate the cost pr child for each category of intervention and for 
the different scenarios.
The methodology used in the cost-minimizing analysis and discounting are presented in the 
main text of the manuscript and based on general literature on health economic evaluation 
290,376. Methods for performing decision models probabilistic are based on Briggs et al 377.
The simulation model was built in Microsoft Excel. For the probabilistic sensitivity 
analysis we used the software @risk which is a part of the Decision Tools Suite software. 
The software @risk works is an extension to Excel.  
A2: Estimation of cost of screening, brace treatment and surgery – all scenarios
Estimating the cost of the school screening:
Cs = (u1 • uc1) + m + s
u1 = Number of minutes (units) used pr child pr examiner (se row 1 in table 4).
uc1 = Cost pr minute (unit cost) used pr examiner (se row 1 in table 4).
m = Cost of materials and supplies.
s = Cost of scoliometer.
Estimating the cost of diagnosis scoliosis:
Ccon = tcon + radcon
tcon = Cost of transportation to/from X-ray exam (se row 4 in table 4).
radcon = Cost of radiographs (se row 5 in table 4).
Estimating the cost of the confirming scoliosis > 20º:
Ccon>20 = tcon>20 + qcon>20 + radcon>20
tcon = Transport to/from specialist evaluation (se row 6 in table 4).
qcon>20  = Specialist evaluation (se row 7 in table 4).
radcon>20 = Radiographs (se row 8 in table 4).
Estimating the cost of brace treatment:
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Where j = 9 to 16 in table 4. 
Estimating the cost of surgery:
&VX LPWȈKLKFLȈXMXFM
im = Utilities/implants cost per operation
t = Cost for transportation home after surgery.
hi =  Hour used of health personal category i.
hci =  Cost pr hour pr person of health personal in category i.
uj = Number of units used of category j.
ucj = Cost pr unit of category j.
Where i = 18 to 21 in table 4, and j = 22 to 30 in table 4. 
For each child receiving surgery, 15% were assumed to be re-operated.   
A3: Estimating the fraction of children receiving each category of interventions
A3.1The screened group
The fraction of the screened children receiving the different category of interventions:
Fscj = TrHKj /ChHK 
Fscj =the fraction of children in the screening group receiving intervention category j. 
TrHKj =the number of children in the Hong Kong study receiving intervention category j.
ChHK = the number of children participating in the Hong Kong study. 
Here, j = 31 to 34, were 31 means diagnosis scoliosis, 32 means confirming scoliosis > 20º, 
33 means brace treatment and 34 means surgery. 
A3.2 The non-screening group
A3.2.1 Non-screening scenario Norway
The fraction of children receiving surgery or brace treatment:
FnscNj = TrNj/ChN 
FnscNj = the fraction of children receiving intervention category j. 
TrNj = the number of children 2012 in the Norway receiving intervention category j.
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StN = the number of children in the age cohort in year 2012. 
Here, j = 33 and 34, were 33 means brace treatment and 34 means surgery. 
The fraction of children confirmed for scoliosis or scoliosis > 20º:
FnscNj   =   (((TrHKj /ChHK) • ChN) • Fr-conf) / ChN)  =   ((TrHKj /ChHK) • Fr-conf)  
Fr-conf = the fraction of the screened children confirmed for scoliosis or scoliosis > 20º, who 
also would be confirmed for scoliosis or scoliosis > 20º if the same group was not 
screened. 
Here, j = 31 and 32, were 31 means confirmed for scoliosis and 32 means confirmed for 
scoliosis > 20º. 
A3.2.2: Non-screening scenario 70%, 80% and 90%
We illustrate by using the 80% non-screening scenario. The same type of equations was used 
for the 70% and 90% scenarios.  
The fraction of children in a year cohort receiving surgery or brace treatment for the 80% 
non-screening scenarios:
Fnsc80j = Tr80j/ChN 
Fnsc80j = the fraction of children receiving category j treatment for the 80% non-screening 
scenario.
Tr80j = the number of children receiving category j of treatment in the 80% non-screening 
scenario. 
Here, j = 33 and 34, were 33 means brace treatment and 34 means surgery. 
In the 80% non-screening scenario, number receiving brace treatment and surgery, 
respectively: 
Tr8033 = ((TrN33/ (TrN33 + TrN34)) * TrNifHK) * 0.8     
Tr8034 = ((TrN34/ (TrN33 + TrN34)) * TrNifHK) * 0.8
Tr8033 = the number receiving brace treatment for the 80% non-screening scenario 
Tr8034 = the number receiving surgery for the 80% non-screening scenario
TrNifHK = Total number treated with brace or surgery  
7U1LI+. Ȉ7U+.M&K+.&K1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Here, j = 33 and 34, were 33 means brace treatment and 34 means surgery. 
A4: Estimating the cost pr child 
A4.1: The screened group
Here we estimate the cost pr child in a cohort (here defined as the selected one year cohort) 
for the different interventions. 
CChSsc = 1 * Cs 
CChScon = Fsc31 * Ccon  
CChScon>20 = Fsc32 * Ccon>20  
CChSb = Fsc33 * Cb  
CChSsu = Fsc34 * Csu  
CChSsc = Cost of school screening pr child screened. 
CChScon = Cost of confirming scoliosis pr child screened.
CChScon>20 = Cost of confirming scoliosis > 20º pr child screened.
CChSb = Cost of bracing pr child screened.
CChSsu = Cost of surgery pr child screened.
A4.2: The non-screening group
Here we use the 80% scenario as an example.
CChN-Scon = FnscN31 * Ccon  
CChN-Scon>20 = FnscN32 * Ccon>20  
CChN-Sb = Fnsc8033 * Cb  
CChN-Ssu = Fnsc8034 * Csu  
CChN-Scon = Cost of confirming scoliosis pr child not screened.
CChN-Scon>20 = Cost of confirming scoliosis > 20º pr child not screened.
CChN-Sb = Cost of bracing pr child not screened.
CChN-Ssu = Cost of surgery pr child screened.
FnscN31 and FnscN32 were, as a simplification used in the model, the same as we used for 
the Norwegian non-screening scenario.   
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These cost pr child pr intervention was dispersed over a 6 year period as described in the main 
text of the manuscript. The incremental cost was estimated by subtracting the total 
discounted cost pr non-screened child from the total discounted cost pr screened child. 
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School screening and point prevalence of
adolescent idiopathic scoliosis in 4000 Norwegian
children aged 12 years
Raphael D Adobor1*, Silje Rimeslatten2, Harald Steen3 and Jens Ivar Brox1
Abstract
Background: School screening for adolescent idiopathic scoliosis (AIS) is discussed. The aim of the present study
was to describe the point prevalence of AIS and to evaluate the effectiveness of school screening in 12-year- old
children.
Methods: Community nurses and physical therapists in the Southern Health region of Norway including about
12000 school children aged 12 years were invited to participate. All participating community nurses and physical
therapists fulfilled an educational course to improve their knowledge about AIS and learn the screening procedure
including the Adam Forward Bending Test and measurement of gibbus using a scoliometer.
Results: Sub-regions including 4000 school children participated. The prevalence of idiopathic scoliosis defined as
a positive Adam Forward Bending Test, gibbus > 7° and primary major curve on radiographs > 10°, was 0.55%. Five
children (0.13%) had a major curve > 20°. Bracing was not indicated in any child; all children were post menarche;
four had Risser sign of 4, and one with Risser 1 did not have curve progression > 5° at later follow-up. In one of
these 5 children however, the major curve progressed to 45° within 7 months after screening and the girl was
operated.
Conclusion: The point prevalence of AIS in 12- year old children is in agreement or slightly lower than previous
studies. The screening model employed demonstrates acceptable sensitivity and specificity and low referral rates.
Screening at the age of 12 years only was not effective for detecting patients with indication for brace treatment.
Background
There is a wide variation in the reported prevalence of
adolescent idiopathic scoliosis (AIS). One study suggests
that about 2.0% of adolescent children are found with
screening to have scoliosis with a Cobb angle of > 10°,
about 0.5% > 20°, and only 0.1% > 40°[1]. A review of
twenty peer-reviewed papers shows a wide range variation
of AIS prevalence in different countries with higher preva-
lence rates in the northern geographic latitudes and lower
prevalence rates as the latitude is approaching the equator.
(Finland 12%, Singapore 0.9%.) [2]. The prevalence of sco-
liosis > 20° in Scandinavia is reported to be 1.1% for girls
and 0.1% for boys in another study [3]. Point prevalence is
a measure of the proportion of people in a population
who has a disease or condition at a particular time or at a
particular age, by example one-month prevalence of back
pain or prevalence of scoliosis at school screening in 12
year-old children. Point prevalence rates of AIS have been
shown to increase with age; from 0.1% in the age-group of
six to eight years, to 0.3% in the age-group of nine to ele-
ven years, and 1.2% in the age-group of twelve to fourteen
years [4].
Screening for scoliosis has been practiced worldwide
for many years and has provided valuable knowledge
about prevalence, aetiology and the natural history of
idiopathic scoliosis. School screening for scoliosis beyond
its scope of early identification of AIS has contributed to
the field of research for aetiology of idiopathic scoliosis.
Numerous factors that are implicated in the aetiology of
AIS including biological factors such as menarche, latera-
lisation of the brain, handedness, the thoracic cage, the
intervertebral disc, and the role of melatonin have been
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studied in children referred from school screening pro-
grammes [5]. Early diagnosis allows for bracing that is
reported to be effective by numerous outcome studies
[6-8], although the evidence is weak according to a recent
Cochrane report [9]. In 1995, The United States Preven-
tive Services Task Force advised against scoliosis screen-
ing [10,11]. Later publications suggest that they might
not fully recognise data answering some of their objec-
tives at the time of their recommendation [6]. In recent
years, The Scoliosis Research Society and the American
Academy of Orthopaedic surgeons, the Paediatric Ortho-
paedic Society of North America, and the American
Academy of Paediatrics have endorsed scoliosis screening
while The Canadian Task Force on the Periodic Health
examination, the British Orthopaedic Association, and
the British Scoliosis Society do not recommend screening
[12,13].
The effectiveness of scoliosis screening is therefore still
under debate. Objections to scoliosis screening are lar-
gely based on the low prevalence rate of clinically signifi-
cant scoliosis, the inverse relationship of sensitivity and
specificity in the screening process, high rates of false-
positive cases, high inter-observer variations and the
costs involved mainly because of over-referrals [14,15].
The challenge in scoliosis screening programmes there-
fore is to decrease the sensitivity to an acceptable rate of
false positive results and to increase specificity in order
to reduce over-referrals thereby reducing costs for the
patients and society.
Based on the recommendations from 1995, routine
scoliosis school screening programmes have been discon-
tinued in many Western countries including Norway in
the last 10-15 years. In Scandinavian countries, Sweden
has conducted school screening for many years and has
an ongoing scoliosis screening programme [7]. In Den-
mark, there have been attempts to perform school
screening, but no specific scoliosis screening programmes
have been successfully implemented (personal communi-
cation with Andersen, M.O.)
The effects of the discontinuation of scoliosis school
screening programmes in Norway have not been thor-
oughly evaluated. However, a preliminary review of the
referral records at the Oslo University Hospital suggests
that fewer children with AIS are being detected early
enough to benefit from brace treatment (unpublished
data).
In Canada, school scoliosis screening has been discon-
tinued since 1979 when the Canadian Task Force on the
Periodic Health Examination did not recommend
screening. The impact of this discontinuation has
recently been examined. This report shows that, in sub-
jects with confirmed AIS, 32% were classified as too late
referrals with regards to brace treatment. The disconti-
nuation of the school screening programmes was
therefore followed by a suboptimal appropriateness of
referrals for bracing [16].
The optimal age for scoliosis screening is still under
debate. School screening has generally been performed
between the ages of 10 to 14 years in conjunction with
a school health examination [10,17]. The Scoliosis
Research Society has recommended annual screening of
all children aged 10-14 years. The American Academy
of Orthopaedic Surgeons has recommended screening
girls at 11 and 13 years and screening boys at age 13 or
14 years. The American Academy of Paediatrics has
recommended annual scoliosis screening with the for-
ward bending test at routine health supervision visits.
The combination of the Adam forward bending test
and the scoliometer measurement of the angle of trunk
rotation (ATR) has been shown to be the simplest,
quickest, most reliable, and least expensive objective
measure of trunk deformity [18]. It has been recom-
mended that an inclination above 7° or ATR > 1 cm is a
positive screening sign and should be followed-up with
an X-ray for further evaluation of the curve [19].
The present study was designed to evaluate the point
prevalence, and the effectiveness of school screening of
AIS in a Norwegian population of 12000 children aged
12 years.
Methods
Study design
Screening of idiopathic scoliosis was performed in con-
junction with the ordinary school health examination
and vaccine programme in 12 year- old children in the
Health Region South of Norway which has a population
of about 12000 children at this age.
Sample selection
There is a similar distribution of girls and boys in the
population at target and in the population screened.
The sex distribution in the group with positive screening
and in those with scoliosis at x-ray examination, are
reported in the results section.
Preparation for school screening
Public health/community nurses and physical therapists
in the study region were engaged as screeners. They were
invited to a one-day intensive course at the Oslo Univer-
sity Hospital, Rikshospitalet to improve their knowledge
about AIS. Additional courses were arranged at the var-
ious county centres for those who were not able to
attend. Participants were taught about scoliosis and the
screening procedure of Adam Forward Bending Test and
measurement of the angle of inclination using the scoli-
ometer. In addition, a scoliosis screening manual was
provided to all participants and follow-up teachings were
provided as needed.
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Screening technique
The screening procedure combined the standing visual
inspection of the back, the Adam Forward Bending Test
and the scoliometer (OSI-scoliometer Orthopaedic Sys-
tems Inc, Hayward, California, USA) measurement of
angle of trunk rotation (ATR). Seven degrees of ATR was
chosen as cut-off point for referral to radiography [20-22].
Referral criteria and treatment
Radiographic results from screening at local hospitals were
mailed to the Department of Orthopaedics at Oslo Univer-
sity Hospital-Rikshospitalet. A Cobb angle > 10° on stand-
ing radiographs were classified as AIS according to the
criteria proposed by the Scoliosis Research Society [23].
Scoliosis between 10° to 20° were referred to a new
radiographic exposure within 6 months and Cobb angles >
20° were referred for physical examination and new stand-
ing X-rays including crista crest exposure for Risser sign
grading.
Statistical analysis
We estimated that the population of boys and girls were
equal in the examined population and calculated the point
prevalence of AIS. We also estimated the point prevalence
of scoliosis > 10° from the reported prevalence in two pre-
vious epidemiological studies [24]. Based on these studies,
we used 0.8% as the point prevalence rate of scoliosis in
the study population to estimate the sensitivity and specifi-
city of the screening procedure used.
Sensitivity is a measure of a test’s ability to identify posi-
tive results. It is calculated from the ratio of true positives
to combined true positive and false negatives. Specificity
measures a test’s ability to identify negative results. Specifi-
city is calculated from the ratio of true negatives to com-
bined true negatives and false positives.
Additional parameters determining reliability of the
screening procedure such as positive predictive value,
(PPV), negative predictive values, (NPV) and likehood
ratios (LR+, and LR-) were also calculated [25].
Positive predictive value (PPV) is the proportion of
patients with positive test results who are correctly diag-
nosed, and negative predictive value (NPV) is the propor-
tion of patients with negative test results who are correctly
diagnosed.
Likelihood ratios are normally used for assessing the
value of performing a diagnostic test. They use the sen-
sitivity and specificity of the test to determine whether a
test result usefully changes the probability that a condi-
tion exists. Two versions of the likelihood ratio exist,
one for positive and one for negative results.
Results
Of the 12000 twelve year- old children living in different
regions of Health Region South, we were able to screen
only sub-regions including 4000 twelve year old school
children. Since screening has been discontinued in
Norway, the Directory of Healthy in Norway was not
willing to support the programme with a recommenda-
tion. Many community nurses and physical therapists
were not willing to conduct a task that was not recom-
mended and participation in the programme was there-
fore lower than expected.
Sixty pupils were found positive on both standing, for-
ward bending test and scoliometer measurements > 7°.
There were 39 (65%) girls and 21 (35%) boys. Twenty-
two were confirmed with scoliosis on standing radio-
graphs, 16 (73%) girls and 6(27%) boys. Thirty-eight of
which 23 (60%) girls and 15 (40%) boys had normal
spine curvatures on X- ray examination (false positive).
These were followed up until maturity and none pro-
gressed to > 25°. The referral rate to radiography from
screening was 1.5% and point prevalence of confirmed
scoliosis was 0.55%.
Five girls with clinical and radiographic significant sco-
liosis (> 20°) were discovered with screening, (Table 1). All
were post menarche. Four had Risser sign of 4 and were
more than 1 year post menarche. Brace treatment was
therefore not indicated in any of them. One girl had Risser
1, but was more than one year post menarche; the major
curve did not progress > 5° within 6 months, and brace
treatment was therefore not indicated. Scoliosis in four of
the girls did not progress > 5°during long-term follow-up.
In one of them the scoliosis progressed from 37°to 45°
within 7 months after screening and she was operated.
The point prevalence of curves > 20° was 0.13% in girls
and 0.0% in boys.
Eleven girls and 6 boys had curves between 10° and
20° and they were observed for further progression until
maturity. None of them progressed to > 25°.
With an estimated point prevalence rate of scoliosis of
0.8% in 12 year- old children, the sensitivity was calcu-
lated to be 69%, the specificity was 99%, positive predic-
tive value was 37%, and the negative predictive value
was 99%. The positive likelihood ratio (LR+) was 46 and
the negative likelihood ratio (LR-) was 0.55 (Table 2).
Discussion
There is a wide variation in the reported prevalence of
AIS. Most studies have reported that about 2.0% of adoles-
cent children are found on screening to have scoliosis with
a Cobb angle > 10°[1]. Point-prevalence is the prevalence
based on a single examination of everyone in the popula-
tion at one point in time which will probably underesti-
mate the true prevalence of AIS.
The point prevalence applied in the present study was
based on examination in 12 year-old children and because
there is a large variety of the start of puberty and scoliosis,
the study could underestimate the true prevalence of AIS.
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The present study has shown a point prevalence of 0.55%
for scoliosis.
The observed point prevalence rate in 12- year- old
children in the current study corresponds well with pre-
vious studies reporting the age-specific prevalence for 9-
11 and 12-14 years.
The prevalence rates in previous studies however are
not easily comparable because they do not exclusively
refer to AIS and different age groups are usually
included. The prevalence rate could be different if var-
ious Cobb angles of > 5°, 10°or 20°were used and if non-
structural scoliosis were included. The point prevalence
of AIS in 12-year- old children in the present study was
0.40% in girls and 0.15% in boys which reflects the later
onset of puberty in boys.
Optimal age of screening
The optimal age for scoliosis screening is still under
debate. School screening has generally been performed
between the ages of 10 to 14 years in conjunction with
a school health examination. Ideally screening should be
performed in girls before the onset of menses and 1-2
years later for boys. The challenge in screening is to
detect clinically significant curves in immature children
which have the potential of progression.
The girls with a significant scoliosis curve of > 20° in
the present study were all judged to be too mature for
brace treatment. This suggests that screening should
have been performed one year earlier. The prevalence
rate of 0.55% in the present study as compared with 1.1%
in girls in previous studies most likely reflects the wide
range of onset of puberty [3], and the fact that only 12-
year-old children were examined. Age at menarche is
considered a reliable prognostic factor for AIS and varies
in different geographic latitudes. AIS prevalence has also
been reported to be different in various latitudes, with
higher values in northern countries. The point prevalence
of AIS in 12 year-children in the present study does not
compare well with the reported 12% prevalence of AIS in
Finland [2], but rather with the 1.1% rate found in
another report about of AIS prevalence in the Scandina-
vian countries [3].
Radiological skeletal maturity was evaluated by Risser
sign only in the present study, while bone age assessment
from the left hand (Greulich & Pyle, 1959) or elbow (Sau-
vegrain) is most used world-wide [26]. In one of the girls
with Risser sign of 4, and 1 year post-menarche at
screening, her major curve progressed from 37°to 45°
within 7 months. Additional assessment of skeletal age at
screening might have provided important supplemental
information.
Rationale behind scoliosis screening
The prediction of scoliosis progression depends largely on
skeletal maturity and curve magnitude. Larger curves in
immature patients have higher risks of progression than
smaller curves in more mature patients. The rationale
behind screening is therefore to enable early detection of
curves > 20° in immature patients that permits initiation
of bracing which may halt progression, or allow surgery at
appropriate time and avoid the complications of surgery of
advanced scoliosis.
Effectiveness of scoliosis screening
Direct evidence of the effectiveness of scoliosis screening
would require controlled prospective studies demon-
strating that persons who receive screening have better
outcomes than those who are not screened. Documenta-
tion is limited, but few studies including a recent study
Table 1 Follow-up of children with scoliosis > 20° at screening
Patient Age at screening Major curve
at screening
Risser sign Post Menarche Major curve at follow up Treatment status
1 13 37° thoracic
32° lumbar
4 12 months 45° thoracic
43° lumbar
Posterior fusion
2 12 27° thoracic
16° lumbar
1 16 months 27° thoracic
21° lumbar
Observation
3 12 16° thoracic
24° lumbar
4 16 months 19° thoracic
24° lumbar
Observation
4 12 30° thoracolumbar 4 2 months 30° thoracolumbar Observation
5 12 29° thoracic 4 24 months 29° thoracic Observation
Table 2 Contingency table showing the calculations of
parameters of reliability of the screening test
Population 4000
Children with
Scoliosis
Children without
scoliosis
Positive Screening True Positive (TP) 22 False Positive(FP) 38
Negative
Screening
False Negative(FN) 10 True Negative(TN) 3962
Sensitivity = TP/(TP+FN) 22/32 = 0.69
Specificity = TN/(FP+TN) 3962/4000 = 0.99
PPV (positive predictive value) = TP/(TP+FP) 22/60 = 0.37
NPV (negative predictive value) = TN/(FN+TN) 3968/3962 = 0.99
LR+ (positive likelihood ratio) = Sensitivity/(1- specificity) 0.69/0.01 = 69
LR-(negative likelihood ratio) = 1-sensitivity/(specificity) 0.31/0.99 = 0.31
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from the Netherlands, have demonstrated that scoliosis
cases detected through screening had lower chances of
having surgery than otherwise detected patients [27,28].
There are some studies reporting that patients with sco-
liosis detected by screening are younger than referred
cases, have smaller curve size, and reduced risk to pro-
gress to > 45°, and thereby having surgery. On the other
hand, the number of referrals to local scoliosis clinics is
increased by screening [29-32].
The current study was designed to screen 12000,
twelve year old children but we were able to screen only
4000. Since screening has been discontinued in Norway,
the health authorities did not support the study with a
recommendation that could have boosted participation
in the study. The study did neither include sufficient
school children nor a follow up to evaluate whether
those children screened have a better outcome than
those not screened.
Accuracy of screening tests
The sensitivity and specificity of scoliosis screening
depends largely on the skills of the examiner and the mag-
nitude of the scoliosis being sought. The use of scoli-
ometer has been shown to increase the sensitivity and the
specificity in detecting a Cobb angle of > 20° [33]. A scoli-
ometer reading of 5° has been shown to have a sensitivity
of 100%, and 47% specificity for identification of scoliosis,
whereas a scoliometer reading of 7° increases the specifi-
city to 86% but decreases the sensitivity to 83% [34]. In the
present study, using a scoliometer reading of 7°, the sensi-
tivity was 69% and the specificity was 99% in detecting
AIS in the study population.
The positive predictive value of visual inspection and the
forward-bending test varies with the degree of curvature
by which a “true positive” is defined, the prevalence of sco-
liosis in the screened population, and the skills of the
examiners [35,36]. The magnitude of PPV is thus inversely
related to the degree of curvature used to define scoliosis
since the prevalence of small curves is greater than large
curves. In a study from Australia, the PPV was 78% for
curves > 5° in a population with an estimated prevalence
of 3% [37]. In another study, the PPV was 54% for curves
> 10° with a predicted prevalence of 2%, and 24% for
curves > 20° with an estimated prevalence rate of 0.3%
[36]. A meta-analysis of the clinical effectiveness of school
scoliosis screening citing 34 studies reported that the
pooled PPV for curves > 10°, curves > 20°, and treatment
were 28.0%, 5.6% and 2.6%, respectively [38]. In the pre-
sent study, the PPV was found to be 37% applying the
accepted > 10° definition of scoliosis and an estimated
point prevalence of 0.8% in 12 year- old children.
A likelihood ratio > 1 indicates that a test result is asso-
ciated with a disease and a likelihood ratio < 1 indicates
that a test result is associated with the absence of a
disease. It is when the positive likelihood ratio is > 5 or
the negative likelihood ratio is < 0.2 that likelihood ratios
can be applied to the pre-test probability of a patient hav-
ing a specific diagnosis. In this present study, the positive
Likelihood ratio was calculated to be 69 and the negative
likelihood ratio was 0.3. The screening model was sensi-
tive enough to reduce the number of false positive
results. However, since the number of abnormal radio-
graphs of Cobb angle > 10° (true scoliosis) is not known
in the study population, the true PPV cannot be known.
Referral rates
Referral rates have been reported to be as high as 21%
without the use of objective criteria, but reduced as
much as 90% by the use of objective criteria [20,39,40]. A
3% referral rate has been predicted using 7° scoliometer
reading, as compared to a referral rate of 12% using 5°
scoliometer reading [20]. A Meta-analysis of the clinical
effectiveness of school scoliosis screening citing 34 stu-
dies reported the pooled referral rate to radiography of
5% [38]. It is now widely agreed upon that referral rates
should be in the range of 2% to 3% in school screening
for scoliosis [20,39,41,42]. In the present screening study
the referral rate was 1.5% based on a scoliometer reading
of 7° which may reflect that screening was conducted on
12 -year- old children only.
In the present study, 38 children were falsely diagnosed
as AIS (positive on screening but had normal spine on
radiography). If screening was performed yearly nation-
wide, the total estimated number of children with nega-
tive radiographs (Cobb angle < 10°) in 60000 children of
12 years in the Norwegian population of 5 million inhabi-
tants will be 570 which might be a concern for health
authorities.
Screening for scoliosis using the scoliometer does not
reveal scoliosis per se but detects thoracic deformity.
The radiographic measured thoracic Cobb angle has
been shown not to correlated to the rib-index (that is
the surface deformity) in the younger group but only in
the 14-18 years-old age group [43]. This lack of associa-
tion of the surface asymmetry (hump) and radiological
asymmetry (Cobb angle) in the younger group such as
in our study, is creating the burden of false positive
referrals and the negative attitude of several health deci-
sion boards to discontinue school screening programs in
the various countries. Thus, it is not possible to reliably
predict the degree of curvature from surface topography
in the age group that are screened [6]. It has been
reported that, in typical screening settings where the
prevalence and positive predictive value are relatively
low, for every curve > 10° detected, there are 1-5 false-
positives; similarly, for every curve > 20° detected, there
are 3-24 false-positives [11,43]. This number of false
positive children on screening must be accepted if those
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with asymmetry, who might develop scoliosis should be
detected.
The goal of screening is to detect those who will be at
risk for developing scoliosis in the school- age population.
In evaluation of the effectiveness of screening for scoliosis
it should also be taken into account the knowledge gained
and contribution it offers in clinical research of idiopathic
scoliosis aetiology. The lack of a deeper insight on school
screening issue, its value and negative impact of its discon-
tinuation in some countries was the trigger for a recent
decision of the Scoliosis Research Society (SRS) presiden-
tial line to create an International task Force for the better
study of the school screening issue and creation of a
“white paper” with recommendations based on recent
knowledge on the topic [42].
Potential adverse effects
It has been argued that screening could have psychological
labelling effects to subjects, and increase exposure to
radiographs. In the present study, attempts have been
made to limit psychological labelling by providing ade-
quate verbal and written information to children and par-
ents before and after screening. We also tried to limit
exposure to radiography by choosing a high cut-off ATR
of 7° and providing adequate training for our screeners
thereby reducing false positive findings which in turn
reduce unnecessary exposure to radiography.
Conclusion
The point prevalence of AIS in the present study is in
agreement or slightly lower than results from earlier stu-
dies. The screening model employed demonstrates accep-
table sensitivity and specificity, and low referral rates. The
calculated likehood ratios are acceptable for a screening
test. In the present study screening for scoliosis at the age
of 12 years only was not effective for detecting patients
with indication for brace treatment. Screening should
probably be initiated one year earlier for girls and one year
later for boys, or be conducted more than once. The costs
and the use of health care resources and the radiation
exposure should be considered when the screening criter-
ion is chosen.
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Abstract
Background: Early diagnosis of idiopathic scoliosis allows for observation and timely initiation of brace treatment
in order to halt progression. School scoliosis screening programs were abolished in Norway in 1994 for lack of
evidence that the programs improved outcome and for the costs involved. The consequences of this decision are
discussed.
Objectives: To describe the detection, patient characteristics, referral patterns and treatment of idiopathic scoliosis
at a scoliosis clinic during the period 2003–2011, when there was no screening and to compare treatment
modalities to the period 1976–1988 when screening was performed.
Methods: Patient demographics, age at detection, family history, clinical and radiological charts of consecutive
patients referred for scoliosis evaluation during the period 2003–2011, were prospectively registered. Patients were
recruited from a catchment area of about 500000 teenagers. Maturity was estimated according to Risser sign and
menarcheal status. Severity of pain was recorded by a verbal 5-point scale from no pain to pain at all times.
Physical and neurological examinations were conducted. The detector and patient characteristics were recorded.
Referral patterns of orthopedic surgeons at local hospitals and other health care providers were recorded. Patient
data was obtained by spine surgeons. Treatment modalities in the current period were compared to the period
1976–1988.
Results: We registered 752 patients with late onset juvenile and adolescent idiopathic scoliosis from 2003–2011.
There were 644 (86%) girls and 108 (14%) boys. Mean age at detection was 14.6 (7–19) years. Sixty percent had
Risser sign ≥ 3, whilst 74% were post menarche with a mean age at menarche of 13.2 years. Thirty-one percent had
a family history of scoliosis. The mean major curve at first consultation at our clinic was 38° (10°-95°). About 40%
had a major curve >40°. Seventy-one percent were detected by patients, close relatives, and friends. Orthopaedic
surgeons referred 61% of the patients. The mean duration from detection to the first consultation was 20(0–27)
months. The proportion of the average number of patients braced each year was 68% during the period with
screening compared to 38% in the period without screening, while the proportion for those operated was 32% and
62%, respectively ( p=0.002, OR 3.5, (95%CI 1.6 to 7.5).
Conclusion: In the absence of scoliosis screening, lay persons most often detect scoliosis. Many patients presented
with a mean Cobb angle approaching the upper limit for brace treatment indications. The frequency of brace
treatment has been reduced and surgery is increased during the recent period without screening compared with
the period in the past when screening was still conducted.
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Background
Idiopathic scoliosis is a complex three dimensional deform-
ity of the spine characterized by a lateral deviation and axial
rotation [1-3]. Classification is according to the age of
onset; infantile, from birth to 3 years; juvenile from 3 to 8
years, and adolescent from 10 years to maturity [4]. Idio-
pathic scoliosis is also classified into early onset (<5 years)
or late onset (>5years) [5]. Adolescent idiopathic scoliosis
(AIS) is the most common form and is often associated
with rapid growth [4].The prevalence rate of idiopathic
scoliosis as proposed by the Scoliosis Research Society
(Cobb angle >10°) [6] is reported from 0.5% to 3%, but
only 5% of these patients have curve progression to >30°
[7,8]. We recently performed screening in 4000 twelve
years old Norwegian children and found a 0.55% point
prevalence of AIS [9]. The ratio of girls to boys is equal
for minor curves, but rises for girls as the curve magni-
tudes, reaching a ratio of 1:8 for those requiring treat-
ment [10].The etiology is not known, but several genetic
predisposing factors have been described [11-16].
Early detection of scoliosis allows for monitoring of
the development and progression of the deformity, and
timely initiation of bracing that is reported to be effect-
ive by non-randomised studies [17-21], although the
scientific evidence is weak according to a recent
Cochrane Review [7]. After scoliosis has been detected,
skeletal growth (Risser sign 0 and 1) gender and curve
location has consistently been reported to increase the
risk of progression [2,4,22-24], while conflicting risk is
reported for curve magnitude with some studies report-
ing larger curves increasing the risk of progression,
whilst some studies do not [10]. Curve flexibility (initial
correction in brace) is reported to reduce the risk of
progression in braced patients [25]. Progression is most
rapid during peak skeletal growth, which precedes me-
narche in girls and occurs 6 to 12 months after the
onset of axillary and facial hair in boys [26]. Several
methods have been applied to estimate skeletal age in-
cluding the Risser sign and Greulich and Pyle radio-
graphic atlas [27]. The Risser sign is the most common
method used to assess remaining growth in patients with
idiopathic scoliosis [28].
Bracing to prevent or limit scoliosis progression is usu-
ally recommended for progressive curves >25°[19]. Surgi-
cal treatment is considered for curves >45°-50° to limit
further progression, and correct the deformity [29-31].
Screening for scoliosis allows for early detection and has
in addition, provided valuable knowledge about preva-
lence, aetiology and the natural history [32,33]. However,
there are objections to scoliosis screening based largely on
the low specificity of the screening test and the costs
involved because of over-referrals [8,34,35]. In our re-
cently published screening program, we found a specificity
of 0.99 and a positive predictive value of 0.37 [9].
Scoliosis was usually detected through school screen-
ing program in Norway until 1994. Upon the advice by
the United States Preventive Services Task Force, many
western countries including Norway, abolished scoliosis
screening program in the nineties [36,37]. In the Scandi-
navian countries, Sweden is the only country with an on-
going scoliosis screening program [19]. In recent years,
The Scoliosis Research Society and the American Acad-
emy of Orthopaedic surgeons, the Paediatric Ortho-
paedic Society of North America, and the American
Academy of Paediatrics have endorsed scoliosis screen-
ing, while The Canadian Task Force on the Periodic
Health examination, the British Orthopaedic Associ-
ation, and the British Scoliosis Society do not recom-
mend screening [38,39].
The effectiveness of scoliosis screening is debated
[40-44]. Previous studies have reported that scoliosis
patients detected through screening had smaller curves
at diagnosis and had lower risk of having surgery
[40,41,43,45]. Researchers from the Netherlands reported
that screening reduced the need for surgery in a retro-
spective study [45], but later concluded that screening
did not reduce the need for surgery in a case control
study [46]. Studies on the impact of discontinuation of
school screening program have reported that the ma-
jority of cases are detected by family members and
friends, and detection was late with regards to benefit
from brace treatment [47,48].
The primary objective of the present study was to
evaluate the detection of scoliosis and to describe patient
characteristics and referral patterns to a scoliosis clinic
with regard to brace treatment in the absence of a
screening program during the period 2003–2011. The
secondary objective was to evaluate the impact of dis-
continuation of school screening scoliosis on the rate of
brace and surgical treatment of scoliosis by comparing
the yearly average numbers of brace and surgical treat-
ment in the period 2003–2011 when there was no
screening, to the period 1976–1988 when scoliosis
screening was still being conducted in Norway.
Methods
Study design
The study is a prospective study to describe the character-
istics of patients with late juvenile and adolescent scoliosis
referred for scoliosis evaluation during the period 2003–
2011 and to compare these data with historical control
data with respect to the number of patients who were
braced or operated during the period 1976–1988 when
scoliosis screening was still conducted in Norway.
During the period 2003 to 2011, data was collected by
6 experienced orthopaedic spine surgeons, 4 fellows in
spine surgery, and 10 resident orthopaedic surgeons.
The patients were recruited prospectively beginning in
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2003, and included all new referred patients to the spe-
cialist clinic at the orthopaedic department, Oslo Uni-
versity Hospital, Rikshospitalet. Norway has a public
universal healthcare system in which waiting times for
specialists’ evaluation of paediatric cases are generally at
an acceptable level. Rikshospitalet is a tertiary referral
centre designated to offer specialized services to the
Norwegian population of 4.7million inhabitants. It is
estimated that the specialist clinic offered scoliosis ser-
vices to approximately 80% of the Norwegian population
representing about 500.000 teenagers during the study
periods [49]. The surgeons filled in a standardised 2 page
chart based on patient data from interview, clinical
examination and radiological measures. The inter-
observer agreement of the methods used for collecting
data in the standardized chart has not been evaluated.
The inclusion criteria was late-juveniles (7 years and
older) and adolescents referred to idiopathic scoliosis
evaluation for the first time. Patients with infantile and
early-onset juvenile idiopathic, neuromuscular, congeni-
tal or syndromic scoliosis were excluded.
Patient records and surgical protocols during the years
1976–1988 were reviewed to estimate the number of late-
onset juvenile and adolescent idiopathic scoliosis patients
that were treated with Boston brace or operated with Har-
rington’s rods at the Sophies Minde Hospital. The Sophies
Minde Hospital was the name of the orthopedic depart-
ment of the Rikshospitalet during that period, and pro-
vided scoliosis services to the same segment of Norwegian
population as at now. The results of brace treatment in
these patients were previously reported in 3 publications
[50-52]. Indication for bracing was a major scoliotic curve
>20° with an observed progression >5° and the Risser sign
<3, and the indication for surgery was progressive curves
>45°-50° in adolescents with remaining growth [51,52].
Demographics
Age at scoliosis detection, at evaluation and at menarche
was recorded. Family history of idiopathic scoliosis was
obtained from the parents of the affected child based on
questioning them if any family member had consulted or
been braced or operated for scoliosis. The originator of
detection was classified into six groups: 1) the patient
himself/herself; 2) parents, family, siblings, grandparents,
aunt/ uncles and friends); 3) primary physicians; 4) hos-
pital specialists (orthopedic specialist, radiologist); 5) allied
health care provider (physical therapist community health
nurse, chiropractor, osteopath and 6) non-health care pro-
vider (dressmaker, sports instructor or hair dresser).
Referral patterns
Referral patterns of primary physicians, physical therapists
community health nurse, chiropractors and hospital spe-
cialists to the scoliosis clinic were noted. The duration
from time of detection to referral and evaluation was also
recorded.
Clinical assessment
Physical examination was conducted by observing the pa-
tient standing for assessment of asymmetries of the shoul-
der, ribs, scapula, waist and hips. Shoulder symmetry was
assessed by the relative position of both shoulders and
recorded as normal, asymmetry < 2 cm or asymmetry > 2
cm. Decompensation of the trunk over pelvis was
recorded as positive truncal shift. Coronal balance was
measured by the plumb line in cm as the lateralizing pos-
ition of the cervico-thoracic junction in relation to the left
or right of the gluteal cleft. Height and body weight were
measured by a nurse for calculation of body mass index
(BMI kg/m2). In the Adams forward bending position, the
thoracic rib cage prominence (angel of thoracic rotation
(ATR) or prominence of the paraspinal muscles in the
thoracolumbar/lumbar area was measured either in
degrees using a scoliometer or in centimeters using a
ruler. Half of the patients were measured using the scoli-
ometer and half measured in centimeters. Back pain and
perception of fatigue of the back muscles were recorded
by a verbal 5-point scale: never had pain, seldom pain,
sometimes pain, often pain, always pain.
Neurological assessment was performed by evaluating
the spinal reflexes, extremity weakness, hyper-reflexia and
abdominal reflexes to eliminate neurological etiology.
Radiological measures
Skeletal age was estimated by a radiologist using Risser
sign obtained from a postero-anterior radiograph at the
level of the iliac crest ossification [28]. The convexity
and magnitude of the curves were measured according
to the Cobb method from the radiographs of full
postero-anterior films by 2 experienced radiologists [53].
Scoliosis was classified by the orthopedic surgeons
according to the King Moe types [54]. Interrater agree-
ment of Cobb measurements and King-Moe classifica-
tions was not evaluated in the present study.
Recommended treatment
Prescribed or recommended treatment up to 6 months
follow-up after the first consultation was recorded as
further observation, brace treatment, surgery or dis-
charge. We assumed that additional patients had surgery
either after brace treatment was initiated or after further
follow-up. We therefore also reviewed surgical protocols
in order to estimate the actual number of patients who
were operated yearly during the period of the study.
Statistical analysis
Descriptive statistics of mean, median, standard devi-
ation, range, and frequencies were calculated using the
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Statistical Package for Social Science (SPSS), version
14.0 (SPSS Inc., Chicago, IL. We categorized curve size
(10.0° – 24.9°; 25.0° - 34.9°; 35.0° – 39.9°; 40.0° – 44.9°;
> 45.0°), BMI (<30 and >30) kg/m2, age (7–12 years; 13
and 14 years; 15 and 16 years; 17 years and older), and
back pain (absent, seldom, sometimes, often and all the
time).We applied multivariable logistic regression to es-
timate the association between back pain as the outcome
variable, with gender, curve size, and BMI as predictor
variables. Regression analysis was performed in order to
examine the confounding effect of curve size, and BMI
on the assumed association between back pain and gen-
der. The Hosmer-Lemeshow test was used to assess the
logistic model adequacy. Effect sizes were measured by
odds ratio (OR) and 95% confidential intervals were
calculated.
One-way ANOVA with correction for multiple tests
assuming non-equal variance was performed to analyse
differences between originator of detection in relation
to age and curve size. In addition, the non-parametric
Kruskal –Wallis test was used to test differences in patient
treatments, and Risser signs between various originators
of scoliosis detection. If significance was observed, the
non-parametric Mann–Whitney U test was used to de-
tect differences between two groups of originators.
The average number of patients treated with brace and
those operated in the two periods were calculated from
the prospective data and the administrative data (surgi-
cal protocols). Chi-squared statistics was used to com-
pare whether the number of those treated with brace
and those operated in the two periods differ from one
another. The proportions of the treatment modalities in
the two periods, mean difference between the propor-
tions, odds ratio (OR) and 95% confidential intervals
were calculated.
The study was approved by the Ethic Committee of the
Oslo University Hospital (reference number 12/11063).
Results
Demographics
There were 752 patients, 644 (85%) girls and 108 (14%)
boys. The age distribution is shown in Table 1. Mean
age at scoliosis detection was 14.6± 2.1 (7–20) years.
Mean age for girls was 14.5±2.1 and 15.5± 2.1 for boys.
Thirty-one percent had a family history of scoliosis with
9% being first degree (parents or siblings) or second de-
gree relations, respectively.
Originator of scoliosis detection
The originator of detection is shown in Table 1. Seventy-
one percent were detected by patients, family members
or friends, 27% by health care providers, and 2% by non-
health care providers. The distribution of patient
Table 1 Main patient characteristic
Characteristics Frequency (n) %
Gender (n=752)
Girls 644 86
Boys 108 14
Age/years
7-12 105 14
13-14 228 30
15-16 292 39
17 and older 127 17
Scoliosis detector
Patient him/herself 50 7
Parents/family/ friends 485 64
Primary physicians 93 12
Hospital specialists 12 2
Allied health care provider 96 13
Non-health care provider 16 2
Risser sign1
0 182 24
1 38 5
2 76 10
3 67 9
4 251 34
5 135 18
Cobb angle/°
10 - 24.9 119 16
25 - 34.9 229 31
35 - 39.9 114 15
40 - 44.9 91 12
>45 199 27
King Moe Classification2
1 220 32
2 259 37
3 164 24
4 40 6
5 9 1
Back pain3
Absent 307 42
Seldom 139 19
Sometimes 163 22
Often 93 13
All the time 30 4
Treatment recommendations
Brace 161 21
Surgery 195 26
Further observation 192 26
Discharged 204 27
1)Not reported, n= 3 2)Not reported, n= 60 3)Not reported n= 20.
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maturity, curve sizes and treatment modalities according
to the various originators of detection is shown in
Table 2.
Patients whose scoliosis were detected by parents,
family and friends were statistically younger compared
to those detected by the patients themselves (p=0.01).
Risser sign was lower in patients whose scoliosis were
detected by parents, family and friends compared to
those detected by patients themselves (p=0.005) or those
detected by primary physicians (p=0.019).There were no
differences in the curve size according to the originator
of detection. Community health nurses and physical
therapist detected patients with scoliosis that were suit-
able for brace treatment more than when the patients
detect scoliosis themselves (p=0.005).
Referral patterns
Sixty-one percent of patients were referred by orthopaedic
surgeons, 33% by primary physicians, and 5% by physical
therapists community health nurses or chiropractors. The
mean duration from detection to referral was 16±16.9
(0–27) months and the mean duration from referral to
first consultation at our clinic was 4.0 ± 2.6 months.
Maturity
The distribution of Risser sign is shown in Table 1. Sixty
percent were ≥ Risser 3. Seventy-eight percent of the
girls had had menarche at the time of the first visit with
36% of them ≥ 2 years earlier. Mean age at menarche
was 13.2±1.2 years.
Physical examination
Mean body mass index (BMI) was 19.7±3.2 (range 11.9 -
41.0) kg/m2. BMI was 19.7±3.2 in girls and 19.9±3.3 in
boys. Asymmetries of the shoulders were registered in
52%. Twenty –eight percent had coronal imbalance, but
only 10% were > 2 cm. Truncal shift was registered in
35%. The mean ATR was 8.4° in the thoracic region and
7.9° in the lumbar region of those measured with the
scoliometer, and 1.5 cm in the thoracic region, and 1.2
cm in lumbar region of those measured in centimeters.
All patients had normal neurological examination except
one girl who had an abnormal superficial abdominal re-
flex. A supplementary MRI revealed a Chiari malforma-
tion and syringomyelia.
Back pain
Boys reported more often (75%) that they seldom or
never had back pain compared with girls (58%), 7% of
the boys reported that they have pain often or almost all
the time compared with 18% of the girls. There is a sig-
nificant association between back pain and girls com-
pared with boys (p = 0.006, OR 2.88, 95%CI (1.36 to
6.19).
Radiological measures
The mean major curve at first consultation was 37.8°±
14.5° (range 10.95°); 37.8°±14.1°in girls and 37.5°±16.8°
in boys. Seventy-five percent of the primary curves had
convexity towards the right. The curve magnitude and
classification according to King-Moe are shown in
Table 1.
Treatment modalities
At the initial consultation, brace treatment was recom-
mended in 18%, surgery in 20%, 8% were discharged,
and 54% were scheduled for further observation. Curve
size, age, and Risser sign of these patients are shown in
Table 3. After 6 months observation, an additional 3%
were recommended for brace treatment, 6% for surgery,
35% were discharged, and 48% recommended further
follow-up. The recommended treatment modalities at
the first consultation and at 6 months observation are
shown in Table 1. This means that at the outpatient
clinic the yearly average number of patients recom-
mended for brace was 19, and 22 for surgery. The add-
itional review of surgical protocols reflecting a longer
follow-up period revealed that on average, 32 patients
were operated yearly during the study period.
Table 2 Age in years, Risser sign, curve size in degrees, and percentage of treatment modalities according to
originator of detection
Age Risser sign Median(range) Curve size Mean±SD Treatment modalities
Mean±SD Brace Surgery Observation* Discharged
Patient him/herself 15.4±1.9 4 (0 to 5) 40.6±15.6 8.0 24.5 24.0 36.0
Parents/family/ friends 14.5±2.0 3 (0 to 5) 38.8±14.5 21.9 27.5 26.7 24.0
Primary physicians 14.8±2.1 4 (0 to 5) 35.8±14.4 18.1 24.5 23.4 34.0
Hospital specialists 15.6±2.4 4 (0 to 5) 39.2±15.8 16.7 25.0 16.7 41.7
Allied health care provider 14.5±2.5 4 (0 to 5) 35.3±13.5 28.1 17.7 24.0 30.2
Non-allied health care provider 14.5±2.1 4 (0 to 5) 38.3±15.8 6.3 31.3 43.8 18.8
* After 6 months observation.
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Brace and surgical treatment 1976–1988
During the period 1976–1988, an average of 41 patients
were treated with the Boston Brace each year [51,52].
According to the surgical protocols, an average of 20
patients was operated each year with Harrington’s rods
for late- juvenile or adolescent idiopathic scoliosis dur-
ing the same period.
Comparison of treatment modalities
The number of patients treated with brace relative to
those operated during 1976–1988 was 41/19 and 20/32
during 2003–2011.The proportion of patients treated
with brace during 1976–1988 (68%) was higher than
during 2003–2011 (38%) and vice-versa for surgical
treatment (p=0.002, OR 3.5 95% (CI 1.6 to 7.5). The
mean difference was 30% 95% CI (10 to 47).
Discussion
The majority of patients detected with scoliosis in the
absence of screening were skeletally mature and had
curves that were not suitable for brace treatment.
According to internationally accepted guidelines brace
treatment is recommended in growing children with
progressive curves >25°, who has at least one year
growth potential [19]. The mean chronological age at
detection in the present study was 14 years, which is 2
years older than the ideal age [19,55]. At the first presen-
tation, 60% had Risser sign ≥3, and 78% of the girls were
post menarche, indicating that most patients were
detected late, and not suitable for brace treatment. A
large proportion of patients also had curves ≥40° at first
presentation which is beyond the international recom-
mendation for initiation of brace treatment [43]. The
present results are in agreement with two previous stud-
ies that have assessed the impact of discontinuation of
scoliosis program on detection, referral patterns and
management. In a Canadian study, 32% of patients with
AIS were referred too late with regard to brace
treatment [48] and in a study conducted in London,
United Kingdom, 56% of cases were detected when the
primary curve was >40° and not suitable for brace
treatment [47].
About 71% of cases were detected by non health care
providers either by patients themselves, close family
members or friends. It has been suggested that parents
should be educated to perceive asymmetries of the back,
shoulders, waistline, hips, and breast in their children as
early signs of scoliosis and seek early and appropriate
medical evaluation [42,48]. In the present study, only
27% of cases were detected by healthcare providers. We
found statistical differences in patient maturity, and
treatment modalities between different originators of
scoliosis detection. Close family members and friends
detected patients with scoliosis at a younger age com-
pared to scoliosis detected by the patients themselves.
Since majority of curves were large at detection, we
found no differences in the curve size according to the
originator of detection.
Community health nurses and physical therapists
detected patients with scoliosis that were suitable for
brace treatment more than when the patients detect
scoliosis themselves.
Referral patterns
Two thirds of all patients were first observed by ortho-
pedic surgeons at local hospitals on average 16 months
before being referred and only 1/3 of patients were re-
ferred directly by primary physicians or physical thera-
pists or community health nurses to the specialist clinic.
Norway, with its public universal healthcare system, pro-
motes referrals to specialized care and waiting times are
generally at an acceptable level for a specialist’s evalu-
ation of pediatric cases as shown in this study where the
mean waiting time from referral to specialist evaluation
was 4 months. A general guideline for primary physi-
cians is to refer suspected cases of AIS to local ortho-
pedic surgeons for diagnosis or refer directly to
specialist evaluation of high risk patients for progression.
Orthopedic surgeons at local clinics are authorized to
diagnose and observe AIS patients for progression and
to refer without unnecessary delay progressive curves
>20° in immature patients to specialist clinics for evalu-
ation. These orthopedic surgeons downstream the spe-
cialists’ clinics are however not authorized to prescribe
brace treatment. There is either a late detection of AIS
in the community in the absence of screening, or there
is a delay in the referral practices of health care provi-
ders to specialist evaluation due to their non- awareness
of existing guidelines, or failure of education on these
guidelines. The result is that many patients with AIS in
the present study were referred when mature, and with
curves approaching the upper limit of brace treatment
indications.
To ensure uniformity and quality of care for scoliosis
patients, we suggest that persons involved in child health
care like physical therapists community health nurses,
chiropractors, sports instructors, primary physicians and
orthopedic surgeons be better informed about guidelines
Table 3 Age in years and Risser sign and curve size in
degrees, at first consultation
Age Risser sign Curve size
Mean± SD Median(range) Mean±SD)
Brace treatment 12.8±1.9 0(0 to 4) 36.0±8.7
Surgery 14.4±1.7 3(0 to 5) 58.3±10.9
Further observation 15.0±2.0 4(0 to 5) 32.4±9.8
Discharge 16.2±2.0 5(0 to 5) 25.4±8.1
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for scoliosis detection. This includes the examination
of asymmetries of the back in the routine examin-
ation of the child [48]. Without objective screening
test, proper training and clear guidelines for referrals,
there is a risk of inappropriate referrals to the spe-
cialized care setting if one will suggest that commu-
nity health nurses, physical therapists, chiropractors,
sports instructors, refer patients directly to scoliosis
specialist evaluation without first referring to local
orthopedic surgeons. However, the magnitude of the
eventual inappropriate referrals is not known. Local
orthopedic surgeons still play important roles as
gatekeepers while offering reassurances to the fam-
ilies and proper follow-up for mild cases. We
emphasize therefore that in cases of confirmed scoli-
osis in immature patients, those involved in child
health care should refer to specialized evaluation
without unnecessary delay.
Patient characteristics
The majority of the patients were girls as reported before
[56]. The average angle of trunk rotation (ATR) is in
agreement with a previous report [57]. Family history of
scoliosis is consistent with earlier studies [11,12,14-16].
Curve classification according to King-Moe compares
well with the original publication reporting that type 2
curves were most common and type 5 were the least
common [54]. Neurological examination to eliminate
underlying neurological pathology was normal in all
patients except one patient who was subsequently
referred for neurosurgical treatment before brace treat-
ment commenced.
Scoliosis and back pain
Previous studies have reported slightly increased
back pain in adolescents with idiopathic scoliosis
compared to the normal population, but the pain is
not usually disabling [58,59]. These studies have not
showed any association between back pain and curve
size, gender, family history of scoliosis, or limb-
length discrepancy, but significant association be-
tween back pain and mature age and skeletal matur-
ity [58,60]. A recent study showed an association
between pain and maturity, overweight and larger
proximal thoracic curves [61]. In the present study
most patients (59%) reported some, but not disabling
back pain and only between 1-3% had back pain al-
most all the time. One previous study reported less
postoperative pain in male patients with AIS [62]. In
the present study, we also found a significant associ-
ation between back pain and girls compared with
boys but no association between back pain, curve
size, and BMI.
Comparison of treatment modalities during screening
years versus non-screening years
The efficacy of scoliosis screening is under debate
[40-44]. To justify screening, it should lead to early de-
tection and initiation of brace treatment at the appropri-
ate time to optimize its efficacy and reduce the option of
surgery. Earlier studies suggest that screening may im-
prove the outcome of bracing and either reduce the sur-
gical rate or optimize timing for surgery [43,45,63,64]. A
recent case control study reported that screening does
not reduce surgery in scoliosis patients [46]. In the
present study, we found that the average number of
patients braced each year during the period of screening
was significantly higher than in the period without
screening. Authors clearly acknowledge the methodo-
logical weakness, when numbers of those operated were
not retrieved from prospectively collected data, but from
administrative count data (surgical protocols) over both
periods. The Norwegian population has increased during
the study years from an average of 4.1 million inhabitants
during the screening years to 4.7 million during the non-
screening periods, but the population segment of 10–19
year olds who represent the risk population in the study
has remained relatively the same (634229 in 1976–1988
to 616715 during 2003–2011) [49]. Within the relatively
close periods in comparison, we assume that the preva-
lence, natural history, and the indications for idiopathic
scoliosis treatment have not changed [48]. The p-value in
the chi-square statistics comparing the proportions of
brace and surgical treatment was statistically significant.
Our results therefore suggest that the absence of screen-
ing for scoliosis has resulted in less patients being treated
with brace and more patients having surgery. However,
technical advances in scoliosis surgery in recent years
coupled with surgeon attitudes may also contribute to
the observed change in treatment trends exhibited over
the two periods. The Boston brace has remained the
choice of brace type at our institution, but surgical treat-
ment of scoliosis has evolved from the Harrington dis-
traction rods to third generation instrumentation with
segmental all pedicle screws construct in the course of
the two periods. In addition, during the screening period
bracing was administered by one spine surgeon, while
different spine surgeons were involved in brace treatment
during the period when there was no screening. The
issue of non-uniform health care provision has the
potential of introducing another bias in the compari-
son of treatment rates in the two periods.
Limitations of the study
Resident orthopaedic surgeons with variable experi-
ence in scoliosis management participated in the
study. The inter-tester reliability was not tested. This
variability in experience could influence evaluation of
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patient characteristics and the recommended treat-
ment. The assessment of back pain applied has not
been validated and recording by a surgeon may be less
valid than self-assessment by patients. The estimation of
surgical rates in the two treatment periods was based on
surgical protocols and not on the registration chart at the
outpatient clinic. There is an indication that, the number
obtained from in the surgical protocol is a more valid es-
timate of the true number of actually operated than the
recorded recommendations. It is also likely that some
patients were not registered at the outpatient clinic. In
view of the methodological weaknesses and other limita-
tions which the authors clearly acknowledge in the
manuscript, the results of the comparison of the rate of
brace and surgery treatments during the two periods
should be interpreted with caution.
Conclusion
In the absence of a scoliosis screening program, many
patients were referred late and presented with a mean
Cobb angle approaching the upper limit of brace treat-
ment indication. The present study suggests that fewer
patients are being braced, and more patients are having
surgery. However, we acknowledge methodological lim-
itations in comparing treatment from the two periods,
and cannot exclude factors other than screening to have
contributed to the observed changes. The majority of
cases were detected by lay persons and referred too late
for specialist evaluation. Scoliosis detected by parents,
family and friends were younger than scoliosis detected
by the patients themselves. Better dissemination of
guidelines for scoliosis referrals are suggested to improve
referral timing in the absence of school scoliosis screen-
ing programs. The reintroduction of scoliosis screening
may be considered in Norway in order to detect idio-
pathic scoliosis earlier than we do today.
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Abstract 
Summary of background data 
Adolescent idiopathic scoliosis can progress and affect the health related quality of life of the 
patients. Research shows that screening is effective in early detection, which allows for 
bracing and reduced surgical rates, and may save costs, but is still controversial from a health 
economic perspective. 
Study design 
Model based cost minimisation analysis using hospital’s costs, administrative data, and 
market prices to estimate costs in screening, bracing and surgical treatment. Uncertainty was 
characterised by deterministic and probabilistic sensitivity analyses. Time horizon was 6 
years from first screening at 11 years of age. 
Objective 
To compare estimated costs in screening and non-screening scenarios (reduced treatment 
rates of 90%, 80%, 70% of screening, and non-screening Norway 2012). 
Methods 
Data was based on screening and treatment costs in primary health care and in hospital care 
settings. Participants were 4000, 12-year old children screened in Norway, 115190 children 
screened in Hong Kong and 112 children treated for scoliosis in Norway in 2012. We 
assumed equivalent outcome of health related quality of life, and compared only relative 
costs in screening and non-screening settings. Incremental cost was defined as positive when 
a non-screening scenario was more expensive relative to screening. 
Results 
Screening per child was € 8.4 (95% CrI 6.6 to10.6), € 10350 (8690 to 12180) per patient 
braced, and € 45880 (39040 to 55400) per child operated. Incremental cost per child in non-
screening scenario of 90% treatment rate was € 13.3 (1 to 27), increasing from € 1.3 (−8 to 
11) to € 27.6 (14 to 44) as surgical rates relative to bracing increased from 40% to 80%. For 
the 80% treatment rate non-screening scenario, incremental cost was € 5.5 (−6 to 18) when 
screening all, and € 11.3 (2 to 22) when screening girls only. For the non-screening 
Norwegian scenario, incremental cost per child was € -0.1(−14 to 16). Bracing and surgery 
were the main cost drivers and contributed most to uncertainty. 
Conclusions 
With the assumptions applied in the present study, screening is cost saving when performed 
in girls only, and when it leads to reduced treatment rates. Cost of surgery was dominating in 
non-screening whilst cost of bracing was dominating in screening. The economic gain of 
screening increases when it leads to higher rates of bracing and reduced surgical rates. 
Keywords 
Cost minimisation analysis, Scoliosis screening, Scoliosis treatment, Health related quality of 
life 
Introduction 
Adolescent idiopathic scoliosis (AIS) is a complex three dimensional deformity of the spine, 
characterized by lateral curvature >10° and axial rotation, which affects 2-3% of otherwise 
healthy teenagers [1-3]. The deformity usually progresses with rapid growth of the spine and 
can affect health related quality of life of the patients [4]. Conventional treatment options are 
bracing and surgery [1-3]. Bracing is normally recommended for progressive curves of 20-
40° in immature patients to prevent progression and reduce surgery, whilst surgery is 
considered for curves >45°-50° to stop progression and correct the deformity [1]. In patients 
with AIS, only a minority have progressive curves requiring treatment [5], and 90% of those 
treated are girls [6,7]. Treatment outcomes are usually measured by radiographic changes of 
the curves, but increasingly also by changes in health related quality of life. Early detection 
by screening allows for monitoring curve progression, and timely initiation of bracing. A 
recent randomised study found bracing to reduce curves which progress to the threshold of 
surgery [5]. 
Screening is controversial and practices vary worldwide [8-10]. Opponents cite mainly 
increased costs and lack of effectiveness of the programs. Some previous studies have 
supported whilst others have discouraged screening [11,12]. The United States Preventive 
Services Task Force neither supported nor opposed screening in 1993 [12,13], but 
recommended against routine screening in 2004 [14]. Discontinuation of screening programs 
has led to late detection and high rates of surgeries in various countries [15-17]. Currently, 
most international scoliosis and child health societies support and recommend screening [18]. 
The Scoliosis Research Society’s International task force recently reported even before the 
BRAIST study [5] was published, that screening was effective in technical, clinical, program, 
and treatment efficacy, but could not make a statement on cost effectiveness due to lack of 
studies evaluating costs and health economic analyses [19]. 
Reviews and long-term studies suggest that health related quality of life of patients treated 
with brace or surgery are not different [1,2,6]. The aim of the present study was therefore to 
perform a cost minimization analysis (CMA) comparing only costs in screening and non-
screening settings, while assuming equal long term health related quality of life of patients 
whose scoliosis are detected through screening or without. 
Methods 
We used a model approach to compare costs in screening with non-screening scenarios. The 
main mathematical equation on which the model was based is shown in Additional file 1. 
Input model parameters were collected from screening and hospital care. Screening in 
Norway was performed once in 12-year old children, and did not detect patients suitable for 
bracing [20]. We assumed similar epidemiology and natural history of AIS in Hong Kong 
and Norway, and used suitable data from a large population-based cohort longitudinal 
screening study by Lee et al. from Hong Kong in 2010 as model input for screening [21]. In 
this study, 115190 children were screened: 3158 received X-rays, 59 had out-patient visits for 
further assessment only, 264 were braced, 10 had surgery, and 29 had both brace and surgery 
(85% brace and 15% surgery). The percent treated in Hong Kong was thus 2.63 per 1000 
children. 
Screening is no longer performed in Norway. According to administrative data from the three 
scoliosis clinics in Norway, 122 adolescents were treated for scoliosis in 2012, of which 
51(42%) were braced and 71(58%) had surgery, with about 10% of them having both brace 
and surgery. These 122 children, aged 11 to 17 is the number of patients out of the cohort of 
63421 children who were the target group for scoliosis treatment in Norway for that year. 
Thus, the percent of children treated in Norway in 2012 was 1.92 per 1000 children. 
Model input for the non-screening scenarios were based on Norwegian data when available. 
Otherwise, inputs were estimated from the Hong Kong data. 
Study perspective in relation to costs 
We used a health sector budget perspective focusing on the costs related to orthopaedic 
treatment in hospital care [22], and in addition, we included costs for the society due to 
transportation and parents’ opportunity cost of time during treatment of their children. 
Strategies being compared 
Screening for scoliosis may lead to over-referrals to X-rays and outpatient evaluations, 
increased rates of bracing, but reduced surgical rates compared to settings when children are 
not screened [23,24]. In non-screening settings, many children are diagnosed late when they 
are matured, with curves not suitable for bracing [15-17,23]. We therefore assumed that 
reduced numbers of children are treated for scoliosis in non-screening settings and estimated 
reduced treatment rates of 90%, 80%, and 70%, respectively of those treated in screening by 
Lee et al. We compared costs in these reduced treatment rates to costs in the screening setting 
in Hong Kong. Treatment in this context includes the percentage of children who have X-rays 
for diagnosis, those treated with brace or surgery, and those who have further follow-ups. The 
estimated treatment rate of non-screening in Norway 2012 was 73% of that in Hong Kong. 
We also compared costs in non-screening scenario in Norway 2012 with the costs in the 
screening setting in Hong Kong. Since AIS is more prevalent in girls, and 90% of those 
treated for AIS are girls [5,6], we performed separate analyses in girls. 
In all non-screening scenarios, we simulated different distribution rates of brace and surgery 
based on the available non-screening data from Norway (58% surgery and 42% brace), since 
this is the only available data on the distribution of brace and surgery in a non-screening 
setting. We used data from Hong Kong to estimate the frequency of X-ray examination and 
referrals since non-screening Norwegian data was not available (see Additional file 1). Based 
on this study, we estimated that about 15% of patients required referrals to X-ray and to 
specialist’s examinations. In all non-screening scenarios, these rates were adjusted 
accordingly. 
Incremental cost was defined as the cost of treatment in a non-screening scenario minus the 
cost of treatment and cost incurred in conducting the screening. A positive incremental cost 
therefore implies that screening is more cost saving compared to the non-screening scenario. 
How incremental cost change by varying the ratio of bracing to surgery was estimated for all 
the non-screening scenarios. The probability of the incremental cost being positive was 
estimated for all cases. 
Time horizon for cost estimations, discount rate 
The time horizon for estimating costs was six years from the first screening at 11 years of 
age. We assumed two screenings per child, based on the recommendations of the Scoliosis 
Research Society [18] at the age of 11 and 13 years, and anticipated that 60% of the scoliosis 
cases were detected at the first screening and the rest at the second. We based our assumption 
on the knowledge of age and gender- specific prevalence of scoliosis, as well as the length of 
time between detection and treatment. Since screening tests are not fully accurate, it has also 
been suggested that scoliosis screening programs should be planned as a continuous process 
and not just a once and for all project as there is a possibility of missing out on some cases if 
screening is performed only once. For the non-screening scenarios we also assumed a 
dispersion of the expected cost (bracing and surgery) of 10%, 15%, 20%, 20%, 15% 10%, 
and 10% for each age group from 11 to 17 respectively. The literature is scarce with regards 
to the true dispersion of expected costs in scoliosis treatment, but shows a peak of treatment 
around 13–14 years of age. We therefore assumed 25% expected costs before, and 35% after 
the peak years [2,5,6,25]. When aggregating costs over time, we used an annual social 
discount rate of 4% (as recommended by the Norwegian Directorate of Health [26]) to 
calculate the present value of costs. The social discount rate is an interest rate used to bring 
future value into the present when considering the time value of money [22]. 
Estimating costs and resources 
We used hospital’s costs and administrative data, and market prices to estimate the cost of 
screening, bracing and surgery. 
Screening 
Screening was performed once in 4000 twelve year old children as part of a vaccine and 
physical examination program from autumn 2006 to spring 2007 [20]. Community nurses and 
physical therapists performed the screening. All activities directly involved in the screening 
and follow-up of patients were identified, measured, and costs estimated (Table 1). 
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Bracing and surgery 
We estimated the costs of bracing and surgery based on data from hospital records. For 
bracing, we estimated the costs of the brace equipment, transportation, radiographic and 
clinical examinations during the period of brace wear, 3 days hospital hotel services for the 
child and one parent during brace fitting. Additionally, the costs of reimbursements for wear 
and tear of clothing and beddings from the National Insurance Scheme were included. For 
surgery, we estimated the costs of implants, salaries of the staff at the theatre, intensive care, 
intermediate postoperative care, regular ward costs, and costs of re-operations (Table 1). 
Surgery was usually performed using either a hybrid construct with an average of 5 pedicle 
screws, 8 hooks, and 5 to 6 sublaminar wires or an all pedicle-screw construct using 15 to 17 
pedicle screws. Two surgeons usually performed the surgery using an estimated average time 
of 180 minutes. One anesthesiologist, one anesthesiology nurse and two scrub nurses assisted 
them working on average for 300 minutes. After surgery, patients stayed in hospital for an 
average of 10 days. No braces were used postoperatively. During the first postoperative year, 
patients had two follow-up consultations. In addition, costs of radiological examinations, 
outpatient visits for follow-ups, transportation, and costs of complications and re-operations 
during the first year were measured. 
With the public universal healthcare system in Norway, there are no hospital fees for parents 
when children are braced or surgically treated. Cost per hour for different health professionals 
was estimated by adding social costs of employment (pension, insurance, sick-leave, and 
training) and overhead to the salary (inclusive income tax). The salary and social costs for 
hospital staff were estimated using the mean salary at the Oslo University Hospital and the 
estimates of the overhead costs were based on data from the Norwegian Central Bureau of 
Statistics [27]. Salary and social costs of public health nurses were based on data from the 
Norwegian Nurses organization, and local community administrations. 
Currency, price date and conversion 
All prices and costs were converted from 2006 to 2012NOK (Norwegian kroner) by using an 
inflation rate of 3.21% per year based on the yearly rate of change of one unit value within 
the Diagnosis –Related Group System (DRG) in Norway. The exchange rate used was 8 
NOK =1 € (Euro). 
Statistical analysis 
Values are given as numbers, percentages, means and mean differences. Results are presented 
with a 95% credibility interval (CrI), which show the 2.5th and 97.5th percentile of the 
outcome distribution. The uncertainty of input variables was assessed by one-way and multi-
way sensitivity analyses. Parametric uncertainty was analyzed by probabilistic sensitivity 
analysis (PSA), where all uncertainties in the relevant parameters were accounted for 
simultaneously [22,28]. The PSA was used to analyse the distribution of incremental cost 
estimations in all scenarios (100000 interactions) and to estimate the CrI for total incremental 
costs, which forms the basis for the Tornado diagram in Figure 1. In the PSA, we used 
gamma distributions for estimation of unit costs, beta distributions for the number of hours 
used and their probabilities. Poisson distributions were used for the number of children 
treated. 
Figure 1 Tornado diagram (sensitivity analysis) for comparing the 80% treatment rate 
of Lee et al. non-screening scenario to screening.
The screening study was approved by the Regional Ethical Committee for Medical Research 
in Norway. 
Results 
Cost estimations 
For all the relevant scenarios, the total estimated costs were € 8.4 (95% CrI 6.6 to 10.6) per 
child screened, € 10350 (8690 to 12180) per patient braced, and € 45880 (38040 to 55400) 
per surgery (re-operations included). The average time used to screen a child was 9 minutes 
(Table 1). 
Incremental costs and outcomes 
The incremental cost per child in a non-screening scenario of 90% treatment rate compared 
with screening was € 13.3 (1 to 27). The probability of the incremental cost being positive 
was 99%. In the 80% treatment rate non-screening scenario, incremental cost was € 5.5 (−6 to 
18) with the probability of the incremental cost being positive was 82%. When comparing 
non-screening scenarios to screening for girls only: the incremental cost was € 11.3 (2 to 22) 
for the 80% treatment rate scenario and € 4.3 (−4 to 14) for the 70% treatment rate scenario. 
The probability of the incremental cost being positive was 99% and 82%, respectively. The 
incremental cost per child in the non-screening Norwegian scenario compared with screening 
was € 0.1 (−14 to 16), and the probability of the costs being positive was 50% (Table 2). 
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Comparing the undiscounted cost per child in the non-screening scenario of 80% treatment 
rate, to screening, the cost of bracing per child of € 26.0 (21 to 33) was dominating in the 
screening scenario, whilst the cost of surgery per child of € 60.2 (48 to 75) was dominating in 
the non-screened scenario. 
Incremental cost in the non-screening 90% treatment rate scenario varied from € -6.3 (−13 to 
3) to € 27.6(14 to 44) as the percentage of surgery increased from 30% to 80%. For the 80% 
treatment rate scenario with 30% surgery, and 70% bracing, incremental cost was € -11.0 
(−19 to −3) favouring non-screening. With 80% surgery, and 20% bracing, incremental cost 
was € 18.2 (6 to 33) favouring screening (Table 3).
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Characterizing uncertainty 
The expected incremental cost estimates are shown in Figure 2. In the non-screening scenario 
of 90% treatment rates, the probability of a positive incremental cost was close to 100%. 
Results comparing non-screening scenarios to screening in girls are shown in Figure 3. 
Uncertainty is also illustrated in a tornado diagram for the non-screening scenario of 80% 
treatment rate. The most important contributor to uncertainty was the percent braced, 
followed by the probability of being re-operated (Figure 1). 
Figure 2 Incremental cost estimations in four non screening scenarios compared to 
screening both boys and girls.
Figure 3 Incremental cost estimations in four non screening scenarios compared to 
screening of girls only.
Discussion 
Scoliosis screening programs are considered to be beneficial from a clinical point of view 
[19], but are criticized for high costs due to high referral and treatment rates [8,11,13]. In the 
present study we used data from a large longitudinal screening study, and detailed costing of 
all activities in performing the analyses. Results suggest that screening is cost saving, unless 
both treatment rates and surgical rates are very low in comparative non-screening scenarios. 
In agreement with previously published studies reporting that discontinuation of screening 
has led to late detection and high rates of surgery [15-17], the model applied in the present 
study indicates that costs increase in non-screening scenarios with high rates of surgery and 
lower rates of bracing. 
The effectiveness of a screening program thus depends on the costs involved and the number 
of cases detected early that result in bracing and less surgery compared to a non-screening 
setting. In a recent clinical trial, bracing reduced the number of children with curve 
progression to the threshold of surgery [5]. 
The results of the present study show that, screening has a large potential of cost saving if 
only girls are screened. Selective screening of girls is most cost saving because they 
constitute about 90% of those treated for scoliosis. In Table 2, we showed that there is a high 
probability of cost saving when only girls are screened compared to non-screening scenarios 
with treatment rates widely ranging from 70% to 100% of those of screening. 
Table 3 shows that in the extreme non-screening scenario where treatment rates are 
approaching those of screening, screening both boys and girls was not cost saving. Likewise 
in the extreme non-screening scenario where treatment rates were very low approaching 60% 
of those treated in screening, non-screening becomes cost saving. However, these scenarios 
are the least likely to occur. In the non-screening scenarios where treatment levels are 90-
100% of those in screening, patients are probably younger at detection, and likely to be 
recommended bracing according to guidelines and the results of the recent RCT study on 
bracing [5]. This implies that the ratio of bracing/surgery is likely to be >1 and bracing will 
be the dominating treatment option. On the contrary, when treatment levels in non-screening 
scenarios are in the 60% to 70% range of that of screening, patients are likely to be older and 
curves too large and not suitable for bracing [15],and surgery is most likely to be the 
dominating treatment option(i.e. ratio of brace to surgery likely to be <1). 
In the Hong Kong study, about 15% of those detected by screening ended up having surgery 
compared to about 60% in non-screening Norway. Obviously, screening is not cost saving if 
the number treated in non-screening approximates that with screening and the surgical rate is 
15%. However, this scenario is very unlikely to occur and was therefore not included in our 
analyses. 
An interesting finding according to Table 3 is that screening both boys and girls tends to 
increase costs if the distribution of brace/surgery is 70/30 or 60/40 in a non-screening 
scenario. This scenario is also unlikely to occur. According to a previous Norwegian study 
non-screening scenarios of 30/70 or 40/60 are more likely to occur [15]. 
Our findings are in agreement with a review [29] on cost effectiveness of screening that 
found screening to be cost effective in one study [30], and recommended screening only for 
high-risk groups such as girls at twelve years of age in order to reduce over-referrals and 
over-treatment. However, the most recent review was not able to conclude whether screening 
was cost effective or not [31]. None of the studies cited in these reviews, however, applied 
recommended health economic evaluation principles [32]. 
Simulations in the present study suggest that the economic gain of screening increases when 
screening leads to higher rates of bracing and reduced rates of surgery. In a previous study, 
we reported higher rates of bracing and reduced surgical rates during a period of screening 
compared to a period without [15]. Similar findings have been reported from the Netherlands, 
Sweden and USA [23,24,33]. Bracing has been shown to reduce progression of curves to the 
threshold of surgery. In the recently published RCT study on bracing, the success rate was 
>70% and about 90% in those with high compliance [5]. Similar results were observed at 
long-term in a large Norwegian cohort study [6]. The current evidence of efficacy of bracing 
in the short term and good results at long-term indicates that patients with AIS should be 
detected early to allow for bracing. In addition, bracing avoids the complications of surgery, 
keeps the spine mobile, and might have positive long term effects. These benefits should be 
considered when interpreting the results of the present study. There has however been a lack 
of enthusiasm for bracing in the past amongst care providers. This is presumably due to the 
absence of high level of evidence of efficacy on bracing, and concerns of negative 
psychological impact on the patients. The results from the recent RCT study [5] on bracing 
do not however support this view. 
With the assumptions made in the current study, screening of both boys and girls would 
neither have increased nor decreased costs compared to the treatment of AIS in Norway in 
2012 where the estimated treatment rate was 73% compared to screening in Hong Kong, and 
58% had surgery. However, selective screening of girls only would have been cost saving in 
Norway; as shown in Table 2 above. 
Studies in the past have reported varying costs of scoliosis screening, and costs of bringing 
cases detected on screening to treatment, depending on how costs are measured [30,34-39]. 
The cost of screening in the current study is comparable to similar programs in Europe where 
total costs were included [34-36]. The estimated cost was based on two screenings per child, 
and community nurses performed the screening in conjunction with a vaccine program. 
Transportation costs and salaries of health professionals would have increased if screening 
had been performed in a different and isolated setting and not by community nurses. The 
estimated costs of bracing and surgery are comparable to those reported in the literature [40]. 
Many factors may influence the validity of our cost estimations. Treatment costs are likely to 
be underestimated in our study as bone grafts and intra-operative neuromonitoring were not 
used during surgeries, as compared with a study from the USA [40]. Our study perspective 
was limited to costs related only to expenses in an orthopedic department. We did not include 
costs related to primary health care, paramedics and alternative costs in relation to referred 
patients. In addition, we did not systematically register costs of patients’ out- of- pocket 
expenses like transportation in relation to adjuvant treatment for scoliosis. Though physical 
therapy and counseling are not routinely offered to AIS patients in Norway, it is estimated 
that 1/3 of the patients use physiotherapy whilst under brace treatment or postoperatively 
[6,41]. 
Several input parameters contribute to uncertainties in our analysis. The cost of regular wards 
in surgical treatment was difficult to estimate accurately despite considerable effort. AIS 
patients undergoing surgical treatment require increased nursing resources compared to 
caring for ordinary pediatric patients at the orthopedic ward. The main analyses may also 
underestimate the cost of surgery. 
The probabilities of positive incremental costs varied widely in the current study. There was 
however higher certainty in the incremental cost estimates when comparing non-screening 
scenarios to screening of girls only, as opposed to boys and girls combined. More research is 
warranted in order to reduce the uncertainties in future health economic evaluations of 
scoliosis treatment. 
Limitations and strengths 
Ideally, randomised studies or controlled prospective studies are needed to compare outcome 
in scoliosis treatment detected through screening or otherwise. However since the prevalence 
of scoliosis is low, it is difficult to include an adequate study sample even within a large 
country or internationally. Clinical trials including utility comparisons of bracing and surgery 
in both short and long terms are lacking. Utility scores may differ in shorter periods during 
treatment, for example by wearing a rigid brace, or postoperatively. 
We assumed similar prevalence and natural history of AIS in Hong Kong and Norway in 
performing the analysis. Studies, however, show regional variations in the prevalence of AIS, 
like higher prevalence in girls but not boys in higher latitudes than in lower latitudes [42]. 
However, those differences could be linked to environmental factors such as the difference in 
the onset of menses in different geographic locations [43], and different cultures and not 
related to genetics. It is also likely that mechanisms of referral may be very different in the 
two settings, and in various countries, due to healthcare systems structures and barriers to 
access. The presentation of AIS has also been reported to be linked to socioeconomic status 
and race [44]. A recent study however found equal prevalence of AIS in 12- year old children 
in Malaysia and Norway [20,45]. 
The main strength of the present work is the application of current recommended standards 
for reporting health economic evaluations in conducting the study [32]. This gives more 
transparency and complete reporting of methods and findings which will facilitate 
interpretation and comparison of similar studies. We also used data from the largest reported 
longitudinal study of screening cohorts [21]. Analyses were performed to assess the 
uncertainties. The percentage detected for bracing, costs of surgery, and re-operations were 
the major contributors to uncertainty. More accurate estimates of these factors could improve 
the reliability and applicability of future analyses. 
Generalisability 
The model approach used in the current study could be employed worldwide with local cost 
estimate variations. Our results provide the missing economic evidence for health policy 
makers and healthcare providers to consider reintroduction of scoliosis screening. 
In providing health services, policy makers are concerned about costs in view of limited 
healthcare resources, whereas patients and their families value the best treatment option 
available independent of costs. At present, there is a gap in the knowledge of the patient’s 
preference in choosing treatment options. In a recently published trial, bracing was preferred 
to observation by patients and their families leading to the interruption of the trial and 
subsequently continued as a preference study [5]. 
Conclusions 
Early detection through screening leading to bracing and fewer surgeries may save costs. 
Selective screening of high-risk groups like girls should probably be preferred. Screening is 
not likely to increase costs unless both treatment and surgical rates are very low in 
comparable settings where screening is not performed. 
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